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Abstract 
 
Data mining techniques have been used widely in many areas such as business, science, 
engineering and medicine. The techniques allow a vast amount of data to be explored in 
order to extract useful information from the data. One of the foci in the health area is 
finding interesting biomarkers from biomedical data. Mass throughput data generated 
from microarrays and mass spectrometry from biological samples are high dimensional 
and is small in sample size. Examples include DNA microarray datasets with up to 
500,000 genes and mass spectrometry data with 300,000 m/z values. While the 
availability of such datasets can aid in the development of techniques/drugs to improve 
diagnosis and treatment of diseases, a major challenge involves its analysis to extract 
useful and meaningful information. The aims of this project are: 1) to investigate and 
develop feature selection algorithms that incorporate various evolutionary strategies, 2) 
using the developed algorithms to find the “most relevant” biomarkers contained in 
biological datasets and 3) and evaluate the goodness of extracted feature subsets for 
relevance (examined in terms of existing biomedical domain knowledge and from 
classification accuracy obtained using different classifiers). The project aims to generate 
good predictive models for classifying diseased samples from control. 
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1. Introduction 
 
Recently, mass throughput technologies such as microarrays and mass spectrometry 
(MS) have been developed and widely used in the biomedical domain. A large number 
of biological datasets involving different types of diseases such as cancer and 
Alzheimer’s disease (AD) have been generated using these technologies (Ma & Huang, 
2008; Stoeckel & Fung, 2007). Microarrays allow thousands of genes to be measured 
simultaneously in a single experiment. MS technology produces enormous amounts of 
high-dimensional datasets about cellular functions. Examples of DNA microarray 
datasets include gene arrays with up to 500,000 genes and MS datasets with 300,000 
m/z (a unit of measure) values (Aliferis, Statnikov, & Samrdinos, 2006). 
 
Typically, biomedical research involving the above mentioned techniques is linked to 
prevention, diagnosis and drug development for treatment of diseases; with a focus in 
diseases such as cancer and Alzheimer’s disease.  According to Cancer Research UK 
and American Cancer Society, globally cancer is a leading cause of disease and cause of 
death. In 2008, 12.7 million new cancer cases and 7.6 million people died of cancer. 
The worldwide trend is predicted to be a significant increase of 22 million new cases 
each year by 2030 (American Cancer Society, 2011; Cancer Research UK, 2012), that is 
about 286 million people will be diagnosed to have cancer by 2030.  
 
According to the World Alzheimer 2012 Report, globally, about 36 million people have 
Alzheimer’s Disease or dementia and this number will increase to 66 million and 115 
million by 2030 and 2050 respectively, that is about one new case every four seconds 
(Alzheimer's Association, 2012; Alzheimer's Australia, 2012). There are no early 
diagnostic tests that are definitive for this disease, with a definitive diagnosis only 
possible following a post-mortem examination of the brain for evidence of the disease’s 
characteristic neuropathology  (MayoClinic, 2013).  However, the pathogenic processes 
of Alzheimer’s disease are likely to begin years before clinical symptoms are observed. 
Therefore, the need for biological markers (biomarkers) defined as “a substance, 
physiological characteristic or gene, that indicates, or may indicate, the presence of 
disease, a physiological abnormality or a psychological condition” (Biological marker, 
n.d.), whose measurable levels are altered prior to clinical symptoms is of paramount 
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importance. The need to detect Alzheimer’s disease via an “equivalent pregnancy test “ 
has been repeatedly stated in the literature (Trojanowskl, 2004). The ideal diagnostic 
test is one that is inexpensive, has a high specificity and can be carried out as easily and 
accurately as a “pregnancy test”; enabling diagnosis as early as possible (Hooper, 
Lovestone, & Sainz-Fuertes, 2008)  
 
While the availability of such datasets can aid in the development of techniques and drugs 
to improve diagnosis and treatment of diseases, the nature and the enormous volume of 
such mass throughput data challenge the power of data mining (DM) in terms of their 
analysis to extract useful and meaningful information. A fundamental problem in 
identifying biomarkers from high dimensional data involves a systematic search for 
relevant features; to reduce the dimensionality of the dataset to a small, yet highly reliable 
and discriminative subset that is representative, improving the classification accuracy and 
reducing the computational cost (Hanczar et al., 2003; Somorjai, Dolenko, & 
Baumgartner, 2003).  
 
1.1. Statement of the Problem 
 
Analysis of high dimensional data, in general, have problems that arise from ‘the curse 
of dimensionality’  (R. Clarke et al., 2008), which relates to a very large number of 
attributes (features) and ‘the curse of dataset sparsity’ (Somorjai et al., 2003), which 
relates to the small number of samples (e.g. in the case of  a  prostate cancer dataset 
with 12600 features and only 102 samples) in the dataset. These problems result in 
overfitting, inaccurate classification and high computational cost in searching through 
the feature subspace (Kim, Kim, Lim, & Kim, 2010). Owing to the complexity of the 
data it is very important that the number of features be reduced in order to improve 
classification accuracy and to perform the analysis with less computational cost (Liu, Li 
& Wong, 2002). Additionally, owing to the curse of dimensionality, traditional 
statistical approaches and machine learning techniques are not effective in analysing 
these types of datasets (Yu & Liu, 2004). 
 
One approach to find biomarkers is to use feature selection (FS) techniques to select the 
most relevant feature subsets. “Feature selection can be defined as a problem of finding 
a set of minimum number of relevant features that describe the dataset.” (Kim et al., 
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2009, p.2). It is the process of going through the vast amount of data, including a large 
number of features in the dataset, to select relevant feature subsets (possibly an optimal 
subset), which improve the classification accuracy in terms of sensitivity (a probability 
that the prediction is positive when the disease is present, i.e., true positive prediction) 
and specificity (a probability that the prediction is negative when the disease is not 
present, i.e., true negative prediction) (Dash & Liu, 1997, 2003). In addition the 
identification of an optimal subset of features, capable of providing absolute 
discriminatory information, can lead to the development of inexpensive diagnostic 
assays with a few features (genes) and which subsequently can be widely deployed in 
clinical settings. 
 
Another consideration in addressing the problem of finding relevant biomarkers is 
related to characteristics typically associated with biological datasets that make the DM 
task especially challenging. These include the following: 
 
 Noisy data: This can be attributed to differences in experimental setups; 
technologies and impression with their associated devices and software; and 
variances in biological observations.  
 Datasets typically are of small sample size but high dimensional: Unlike 
traditional domains associated with DM applications, biological datasets 
typically have only a small number of samples (at best in the hundreds), while 
the number of features, is typically in tens of thousands. This characteristic leads 
to the phenomena, curse of dimensionality and over-fitting in classification 
tasks. Algorithms developed to carry out DM in traditional domains are not 
suitable to be used to analyse these datasets. In addition, this characteristic will 
also create a scenario where there is a high likelihood of finding false positives 
in classification tasks owing to chance, and robust methods to validate the 
classification models are vital. 
 Complexities of interactions amongst features in a biological dataset. 
Features in the biological datasets are not independent; their correlation structure 
is not fully understood in many cases. Many data analysis approaches only 
involved evaluating each feature separately and do not consider possible 
correlations amongst features. However, from a biomedical perspective, groups 
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of features are known to work together as pathway components in a biological 
process. 
 Biological and diagnostic relevance 
Another point to note is that data obtained via mass throughput technologies 
such as microarray serves 2 functions:  
o biological relevance - by providing measurements related to mechanisms 
underlying the disease  and   
o diagnostic relevance  - as relevant features in the construction of accurate 
diagnostic classifiers for prediction. 
 
It is vital to understand the interplay between diagnostic and biological 
relevance -- that the former is neither a necessary nor a sufficient condition for 
the latter. First, high correlation between disease status and specific features do 
not necessarily imply that they have a causal relationship with the specific 
disease. Likewise, in constructing accurate diagnostic classifiers it is highly 
unlikely that all biologically relevant features may be utilized.  The outcome is 
that selected features on the basis of their diagnostic relevance need be validated 
for biological relevance by examination of the literature for relevance to the 
specific disease and by subsequent experimental analysis. Second, biological 
evidence suggest that typically multiple sets, each with a finite number of 
features, are responsible for a specific disease (i.e. multiple causes -- features 
can be combined in many different ways, all leading to a specific disease).  The 
outcome here is that identifying multiple sets of biomarkers is important for 
discovering correlations among features and to support evaluation of different 
combinations in the diagnostic phase. 
 Validation of results from data analysis and absolute ground truth:  
Absolute ground truths are not available in this field for validation of results 
associated with the data analysis. In other disciplines, experts can be readily 
available to provide ground truths but in the areas of proteomics and genomics, 
biomedical knowledge in terms of differential physiological behaviour pertinent 
to specific biological states is currently inadequate. The ultimate judge for 
validation would involve biological validation (e.g. clinical trials), for which one 
will have to focus on some specific subsets of minimal size. Results from data 
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analysis are also likely to be useful if they are position in context and can be 
subsequently followed up with more focused studies by biomedical researchers. 
 
Many FS algorithms have already been developed and used in various areas such as 
business, science, engineering, and in recent times, increasingly applied in the area of 
bioinformatics. Cho et al. (2003) used a genetic algorithm (GA) together with a neural 
network classifier to select relevant features from Alzheimer’s disease datasets. A 
Support Vector Machine (SVM) classifier was used in Mukerjee et al.’s study (1998) to 
select features from a Leukemia microarray cancer dataset.   
 
Existing work involving evolutionary approaches include Li, Liu and Bai (2008) 
incorporated a GA into filter and wrapper methods to search for feature subsets from a 
Prostate MS dataset; Deb and Reddy(2003) incorporated the method of weighted voting 
into a multi-objective evolutionary algorithm (MOEA) called non-dominated sorting 
algorithm (NSGA2) to search for multiple sets of optimal features for Leukemia, Colon, 
Lymphoma, GCM and NCI60 cancer data.   
 
Rough set theory (RST) (Pawlak, 1982) was developed on a mathematical basis and  
has been used in DM to analyse vague, uncertain or incomplete data in datasets and to 
remove redundant features effectively (Pawlak, 1997). RST has also already been used 
to select features for biomedical data in numerous studies (Punitha & Santhanam, 
2008). However approaches incorporate RST with an evolutionary algorithm (EA) such 
as MOEA (NSGA2) or GA to search for optimal set of features for high dimensional 
biological data are limited. For example, Banerjee et al. (2007) proposed an 
evolutionary Rough Set based FS technique for analysing gene expression data.  
 
The Nearest Shrunken Centroid (NSC) algorithm (Tibshirani, Hastie, Narasimhan, & 
Chu, 2002) with its most well-known software implementation being known as 
Prediction Analysis for Microarrays (PAM), has been widely used as a FS and 
classification method for high dimensional biomedical data in numerous studies (Ray et 
al., 2007). NSC selects features by shrinking a class centroid for each feature toward its 
overall centroid for all classes using a shrinkage threshold value.  
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Shrinkage threshold values associated with the application of NSC have usually been 
selected via 2 approaches, Cross Validation (CV)  (Tibshirani et al., 2002; S. Wang & 
Zhu, 2007; K. Yeung & R. Bumgarner, 2003) and empirical approach (Klassen & Kim, 
2009; Levner, 2005; Ray et al., 2007).  With the CV approach, the dataset is divided 
randomly equal into k parts, each part consists of approximate proportion of a number 
of samples and classes. One part takes turn to be the test set while the other k-1 parts are 
used as the training set. The procedure is repeated n times to obtain the prediction error 
rate for each time.  The overall prediction error rate is then calculated by averaging the 
errors from all iterations. The selected optimal threshold value is based on the CV 
prediction errors associated with the different threshold values. With the empirical 
approaches, the optimal shrinkage threshold was selected based on the lowest 
classification error over a range of shrinkage thresholds. However, threshold values 
selected using CV and empirical approaches are not precisely tuned for the specific 
dataset to obtain optimal classification results. This is due to the fact that these 
approaches are limited in terms of exploring the entire search space of threshold values 
in relation to the dataset, resulting in threshold values that may not be the optimal. 
Optimal shrinkage threshold values used in the NSC algorithm would make a vital 
difference in selecting optimal feature sets and subsequently, improving the 
classification accuracy.  
 
To address the challenges in the analysis of mass throughput data such as microarray 
data, FS is seen as a vital first step to identify relevant features for classification. 
Although many FS techniques have been developed and used for analysis of such high 
dimensional biological data, most of the existing work typically involved deterministic 
approaches, attempting to find a unique set of biomarkers. The development of 
techniques capable of extracting multiple potential sets of biomarkers for subsequent 
analysis and the incorporation of evolutionary algorithms, especially MOEA in these FS 
techniques is limited.  Following this direction, this research study aimed to develop 
evolutionary based FS techniques for analysis of high dimensional biological data 
generated from molecular biology techniques such as microarrays, metabolite profiling 
and mass spectrometry and to evaluate these techniques, both in terms of their 
performances and the validity of the extracted information. 
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1.2. The purpose of the study 
 
The aims of this project are:  
 to investigate and develop FS algorithms that  incorporate various evolutionary 
strategies, specifically investigating the use of  evolutionary strategies in 
conjunction with RST and NSC; 
 to evaluate  the developed algorithms in terms of finding the “most relevant” 
biomarkers contained in biological datasets and  
 to evaluate the goodness of extracted feature subsets for relevance (examined in 
terms of existing biomedical domain knowledge and classification accuracy 
form the perspectives of sensitivity and specificity associated with different 
classifiers). The project aims to generate sets of features for construction of good 
predictive models for classifying diseased samples from control. 
 
1.3. The contributions of this study  
 
The area of bioinformatics is “data rich”, as the breakthroughs in the development of 
mass throughput technologies resulted in huge volumes of data being produced. 
However, this area increasingly suffers from a situation where biomedical researchers 
lack the time and the appropriate tools to complete a sound and comprehensive analysis 
of these huge volumes of data in order to make biological sense and to use the data 
optimally.  The study contributes in the area of bioinformatics, in the development of 
FS techniques that aid in the analysis of datasets acquired using mass throughput 
technologies. Specifically, the study examines the development of FS techniques that 
incorporates evolutionary algorithms, especially MOEA. Unlike existing techniques, the 
developed approaches support FS by simultaneously considering tradeoffs between a 
number of criteria (e.g. high classification accuracy and a small number of features). 
Additionally, the developed techniques is cost and time effective, allowing researchers 
to use  computer time  to analyse realms of data as the output from the techniques are 
multiple sets of potential features (biomarkers) that can be further investigated to 
explore both diagnostic and biological relevance. The following section details the 
contributions of the study. 
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  A FS technique incorporating the use of GA, K-means and RST for 
analysis of high-dimensional biomedical data  
Use of RST as a FS technique in bioinformatics has been limited and this study 
investigated an approach of combining RST with a GA. The first step in this 
approach, RST-GA, employed the k-means algorithm to generate class centroids 
from the training data. The class centroids are used as initial seed values for RST 
to partition the data that subsequently led to the reduction of a large number of 
features. GA was then utilised as a search method to find sets of optimal 
features.  Unlike deterministic approaches that produce the same set of optimal 
features, this approach produced a different set of features from each run of 
RST-GA. Identification of multiple sets of biomarkers with high diagnostic 
relevance is important as it allows biomedical researchers to examine these sets 
using existing biological knowledge to determine sets to validate for biological 
relevance in subsequent clinical studies.  
  
 Use of evolutionary algorithms for enhancement of the NSC algorithm  
The NSC algorithm has been widely used as a FS and classification method for 
high dimensional biomedical data in many studies  (Bair & Tibshirani, 2004; 
Klassen & Kim, 2009; Lee, Lee, Park, & Song, 2005; Ravetti & Moscato, 2008; 
Ray et al., 2007; K. Y. Yeung & R. E. Bumgarner, 2003).  A shrinkage threshold 
value must also be provided to the NSC and this is normally selected via a 
manual “trial and error” process which can be very time consuming. The 
resulting shrinkage threshold value from this manual process may be limited by 
the granularity of the initial pre-determined values. In this study, evolutionary 
based approaches, NSC-GA, NSC-MA and NSC-NSGA2 involving GA, 
memetic algorithm (MA) and MOEA (NSGA2) respectively, were developed to 
find shrinkage threshold values automatically. These approaches eliminate the 
need to find the shrinkage threshold value manually and produced more precise 
shrinkage threshold values. For NSC-GA described in Chapter 5 and NSC-MA 
in Chapter 6, the shrinkage threshold value is determined on the basis of a single 
objective function which is an aggregation of 2 separate objective functions (i.e. 
evaluation criteria).  For NSC-NSGA2 described in Chapter 8, multiple optimal 
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shrinkage threshold values are obtained while simultaneously considering 
different tradeoffs amongst multiple objective functions.  
 
Unlike approaches (e.g. S. Wang and Zhu (2007)) that attempted to improve the 
performance of NSC by modifying it, the original NSC algorithm (Tibshirani et 
al., 2002)  is used here, thus potentially the proposed techniques can also be 
incorporated into any modified NSC. 
 
A point to note with regards to the nature of shrinkage thresholds is that rather 
than being an exact value, a narrow range of values maps to the same set of 
features. This implies that owing to the stochastic nature of evolutionary 
approaches, these approaches produced different results (i.e. different shrinkage 
threshold values resulting in different sets of features) from each run of the 
technique. However if these shrinkage threshold values are only slightly 
different, they mapped to the same set of features, thus in some cases, producing 
identical sets of features from a number of different runs. While having less 
variability, these approaches still produce multiple sets of biomarkers from the 
analysis of a dataset. 
 
Lastly, another advantage associated with the proposed approaches being able to 
produce more precise shrinkage threshold values is obtaining better 
classification accuracy when the corresponding optimal set of features is 
employed in NSC to classify unseen test datasets. 
 
 Investigate the impact of using different distance measures in the NSC 
algorithm  
The study investigated the impact of using different distance measures: 
Mahalanobis, Pearson and Mass Distance (MD), in the NSC algorithm 
employed in NSC-GA for analysis of high dimensional biological data. In the 
NSC (Tibshirani et al., 2002), Euclidean distance is employed as an evaluation 
measure in determining the score used to classify sample points. The Euclidean 
distance is not an effective nor a robust measure for classification when 
compared to other similarity measures such as Mahalanobis, Pearson and MD 
(Datta & Datta, 2003; Ding & Peng, 2005; Yona, Dirks, Rahman, & Lin, 2006). 
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This investigation contributes to a better understanding of using the different 
distance measures in NSC and the impact these have on the task of finding the 
most relevant features that can lead to higher classification accuracy for 
biological data.   
 
 Identification of a number of subsets of relevant features for Alzheimer’s 
disease, Colon, Leukemia, Lung, Lymphoma, Ovarian and Prostate cancer 
data.  
Approaches developed in this study were evaluated using seven datasets. 
Indirectly, each of these datasets was analysed for finding optimal sets of 
biomarkers, by considering tradeoffs between high classification accuracy and 
minimum number of features.  Most existing studies (Banerjee et al., 2007; Fan 
& Fan, 2008; Foss, 2010; Tai & Pan, 2007; S. Wang & Zhu, 2007) evaluate their 
developed techniques using various datasets and only reported their findings in 
terms of the size of the optimal feature sets and associated classification 
accuracy. However, besides examining the classification performance of a set of 
features, its relevance to its corresponding domain is crucial. Unlike previous 
work, this study lists the extracted features from the analysis of each datasets 
and where possible, examines the relevance of these features by searching the 
literature.  These subsets of relevant features can be used by biomedical 
researchers for further clinical investigation to validate their biological relevance 
to the specific disease. 
 
 Impact of using specific classifiers on sensitivity and specificity 
Sensitivity and specificity associated with classification are two measures that 
are of great interest to the biomedical community in their efforts to find 
biomarkers and to assess them as to how well they can predict relevant 
outcomes.  Sensitivity represents the probability of correctly diagnosing a 
condition (i.e. the proportion of truly affected (i.e. diseased)) in a sample 
population that is identified by the test as being diseased). On the other hand, 
specificity represents the proportion of truly non-diseased that the test identified 
as such. This study demonstrated that different classifiers constructed using the 
same set of features produced different sensitivity and specificity in the 
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classification of test data. In other words, there can be classifier-bias – for 
example,   classifier C, constructed using a set of features demonstrates high 
sensitivity  and low specificity; when in actual  fact, there may exists a number 
of other classifiers  constructed using the same set of features and demonstrating 
both high sensitivity  and high specificity. 
 
Thus in a DM analysis for finding suitable sets of biological markers, a number 
of classifiers should be used instead of just using one. This will avoid cases of 
missing out on sets of features with high discriminatory capabilities that should 
be further investigated in early diagnostic test developments but were rejected 
on the basis of their sensitivity/specificity obtained via a specific classifier. 
 
 A set of techniques for comprehensive analysis of biological datasets 
As mentioned previously, data from mass throughput technologies typically 
consists of a small number of samples where each is composed of thousands of 
features. Additionally these features have correlation relationships that are still 
not fully understood.  From a biomedical perspective, groups of features are also 
known to work together as components in a biological pathway. Given these 
complexities in the data, manual evaluation to find sets of features would be 
intractable.  Many existing data analysis approaches in bioinformatics only 
involved evaluating each feature separately (univariate analysis) and do not 
consider possible correlations amongst features nor the joint behavior of a 
combination of features. The set of techniques developed in this study attempts 
to address this limitation where the basis of the selection involved the evaluation 
of different combinations of features by simultaneously considering two or more 
selection criteria.  
 
Owing to the stochastic nature of the evolutionary based approaches developed in this 
study, multiple optimal sets, consisting of a varying number of features, and of high 
diagnostic relevance are obtained.  While the multiple sets of features obtained via RST-
GA (described in Chapter 4) showed a varying degree of overlap (in other words, 
different numbers of common features), NSC-based approaches, namely NSC-GA, 
NSC-MA, NSC-NSGA2 produced feature sets where a smaller set is always a subset of 
a larger set from analysis of a specific dataset. 
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An interesting consequence of this characteristic is seen when all these different sets of 
features obtained via a NSC-based approach (e.g. NSC-GA) is used to construct 
classifiers for classifying unseen test data. The domain expert can make informed 
decision based on the tradeoffs between classification accuracy and size of a feature set. 
For example, in the event where a set with 6 features produced the same classification 
accuracy as a set with 7 features,  the domain expert can examine the 7
th
 feature and use 
domain knowledge to decide on it potential relevance and make a decision about its 
inclusion in subsequent analysis. Equally in another scenario, if sets with 1, 2, 3, 4, 5, 6, 
7, 8, 9, 10, 21 and 23 features respectively resulted in classifiers producing the same 
classification accuracy on the unseen test dataset, it would then appear that a major 
contributing factor relates to 1 feature and the domain expert may validate this in a 
subsequent clinical trial. This sort of information from the analysis is important as 
reducing the number of features to a smaller promising set, for further investigations, 
would reduce costs associated with future experiments and development of diagnostic 
toolkits. 
 
In summary, this thesis contributes towards a better understanding of incorporating 
evolutionary approaches in the development of techniques for analysing biological data 
from mass throughput technologies. The techniques developed here can be used for a 
comprehensive analysis of a dataset, extracting information that biomedical researchers 
can use to make informed decisions with regards to evaluation of sets of biomarkers for 
biological relevance. The thesis also contributed to an increased understanding of the 
impact of employing different similarity measure in NSC and demonstrated the need to 
be aware of the possibility of classifier-biased when examining the sensitivity and 
specificity associated with a specific set of features. 
 
1.4. Significance 
 
 The developed techniques improves NSC and allows researchers using NSC to 
be able to obtain shrinkage thresholds automatically, thus reducing time and 
effort required. 
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 The developed techniques can be used for a comprehensive analysis of high 
dimensional biological dataset, extracting information that biomedical 
researchers can use to make informed decisions for subsequent investigations of 
sets of biomarkers.  Instead of traditional univariate analysis, the developed 
techniques allowed biomedical researchers to examine the joint classification 
behaviour of different sets of features in the development of diagnostic toolkits. 
 
1.5. Structure of the thesis 
 
The thesis consists of nine chapters. The primary theme in this thesis is the investigation 
of evolutionary approaches for feature selection in biological data and this thread of 
investigation starts with the pilot study described in Chapter 4, progressing to 
investigation of GA for automatically obtaining the shrinkage thresholds for NSC in 
Chapter 5, followed by the investigation involving memetic algorithms in Chapter 6 and 
culminating in the multi-objective approaches described in Chapter 8. Chapter 7 
described the investigations to examine the impact of different the secondary theme 
being the impact of different similarity measures in NSC. Some preliminary concepts 
and descriptions of the datasets for evaluation of the developed approaches are 
described in Chapter 3. 
 
The following section gives an overview of each of the remaining chapters in the study. 
 
Chapter 2 describes a literature review consisting of 2 major sections 1) a review of 
DM techniques and algorithms that have been previously developed by other 
researchers for FS and classification in the domain of bioinformatics; and 2) technical 
descriptions of algorithms that have been employed in the proposed approaches in this 
study. These include RST, NSC, GA, NSGA2, MA and different similarity distance 
measures (Euclidean, Mahalanobis, Pearson and MD) algorithms are discussed. 
 
Chapter 3 describes 7 biological datasets, Alzheimer’s disease, Colon, Leukemia, 
Lung, Lymphoma, Ovarian and Prostate cancer data, used in the study. Data 
configurations for training and test sets, 10 fold cross validation (CV) strategy, as well 
as general information of how the datasets were used to evaluate the developed 
algorithms are also detailed in this chapter. 
14 
 
Chapter 4 describes the proposed approach RST-GA, which incorporated RST and GA. 
K-means clustering method is used to find the centroid for partitioning data in the 
reduction of features using RST approach with a non-deterministic algorithm, GA. The 
results of evaluating the proposed are described using Colon and Leukemia cancer data. 
 
Chapter 5 describes the proposed approach of incorporating NSC into GA (NSC-GA) 
to automatically search for optimal shrinkage threshold values for NSC. In this chapter, 
the details of the proposed approach, NSC-GA that utilised the training dataset for 
obtaining optimal shrinkage threshold values for NSC automatically are described. Also 
in this chapter, the details of the proposed approach that employed NSC as an evaluator 
to evaluate the goodness of the feature subsets and GA as a search strategy to find 
optimal shrinkage threshold values for NSC are described. 
 
Chapter 6 describes the proposed approach of incorporating NSC into MA (NSC-MA) 
to improve the search for finding optimal shrinkage threshold values for NSC 
automatically. The details of a local search implemented in MA are also described in 
this chapter. 
 
Chapter 7 describes the proposed approach of incorporating different similarity 
distance measures (Mahalanobis, Pearson and MD), into the NSC-GA framework to 
improve the search for finding smaller sets of relevant features that lead to higher 
classification accuracy. 
 
Chapter 8 describes the proposed approach of incorporating the NSGA2 algorithm as a 
MOEA into NSC to find multiple solution sets of optimal shrinkage threshold values 
automatically for NSC. In this chapter, the details of the proposed approach, NSC-
NSGA2 that employed the NSC algorithm as an evaluator are also described. 
 
Chapter 9 summarises the main findings from the thesis and outlined the proposed 
approaches that have been developed in the study. Future work is also discussed at the 
end of this chapter. 
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1.6. Summary 
 
This chapter has provided the background and highlights some important aspects that 
lead to the use of FS algorithms and DM as necessary tools to select relevant features 
and analyse biological data. The purpose of the study and contributions from the study 
were also discussed. In the next chapter, previous studies associated with FS in 
bioinformatics are described. Techniques applicable to this study are reviewed.  
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2. Literature review 
 
This chapter consists of 3 sections: 1) Review of DM and FS techniques; 2) review of 
some existing work which applied FS techniques to select relevant feature subsets and 
classify data in the area of bioinformatics; 3) review of techniques which were 
incorporated in the implementation of proposed approaches in this study.  
 
2.1. Data mining and feature selection techniques 
 
As mentioned earlier in Chapter 1, microarrays and mass spectrometry techniques 
generate massive amounts of high dimensional data. It is good in terms of data 
enrichment and availability, but at the same time challenging in terms of selecting the 
most relevant features for classifying the data accurately. DM and FS are approaches 
that have been widely used for analysing high dimensional data. FS techniques are used 
to select optimal (of minimal size) sets of relevant features from a high dimensional 
dataset efficiently. The following sections describe the general concepts of DM and FS, 
and specially the three categories of FS methods: filter, wrapper and embedded.  
 
2.1.1. Data mining 
 
The task of automatically finding interesting patterns from large data repositories is 
known as DM, and it can be categorized into predictive and descriptive tasks (Tan, 
Steinbach, & Kumar, 2006). Classification techniques are associated with predictive 
tasks where the aim is to predict the target variable using values of other attributes of 
the dataset. This is known as a supervised learning classification technique because the 
classification algorithm has to be trained in the training phase to produce the predictive 
model which is then evaluated for its performance in the testing phase. For descriptive 
tasks, techniques like clustering, also known as an unsupervised learning classification 
technique, are used to classify data that do not have class labels. Thus, the classification 
model does not need to be trained prior to perform the predictive task. The unsupervised 
classification technique classifies data based on their similarity measures into a group 
(class), e.g., similar distance measures, similar gene profiles. General concepts of 
classification techniques are described in the following section.  
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2.1.1.1. Classification 
 
As mentioned earlier, classification is a type of supervised learning. The classifier needs 
to be trained with a training data, and evaluated with test data before being used for the 
classification on an unknown data (Tan et al., 2006).  The process of supervised 
learning may be illustrated by the following figure: 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-1 A general process of supervised learning for classification 
 
As seen in Figure 2-1, in the process of supervised learning, a dataset is split into a 
training set and a test set. The training dataset is used to train the classifier, generating a 
classification model, whilst the unseen test dataset (not seen in the training phase) is 
used to evaluate the classification model for its accuracy on prediction.  
 
One measure of the performance of the training model is the accuracy of its prediction. 
A smaller error rate in prediction indicates better and a more reliable a model. A 
confusion matrix table is used to show the number of correct and incorrect predictions 
for each class. Classification accuracy and error rates are calculated using Equation 
(2.1) and (2.2) (Tan et al., 2006), as follows. 
 
Accuracy        
number of correct predictions
Total number of predictions
    (2.1) 
 
Error rate   
number of wrong predictions
Total number of predictions
    (2.2) 
   Classification Algorithm 
   Classification model 
   Model evaluation 
   Training data 
   Unseen test data 
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According to Han, Kamber and Pei (2006), Tan et al. (2006) and Witten and Frank 
(2005), the performance of a classifier is evaluated by using one of the following: 
holdout, random subsampling, cross-validation and bootstrap techniques.  
 
 Holdout technique with stratification: the dataset is stratified into training data 
and test data (e.g. ½ for training and ½ for testing or 2/3 for training and 1/3 for 
testing). Stratification is the process where samples in the dataset are divided 
proportionally into the training and test datasets with balance in classes. The 
training data is used to build a classification model and the test data is used to 
evaluate the accuracy of the model. 
 Random subsampling: the principle is similar to the holdout method but the 
training and test process are repeated a number of times to obtain classification 
accuracy accordingly. Each time the data are splitted randomly into the training 
set and the test set (Dieterle, 2003). The average classification accuracy over a 
number of iterations is the overall result for the classifier’s accuracy. 
 Cross-validation (CV): is the method to divide the dataset into a number (k) of 
subsets, e.g. 10 fold CV where k=10. Each subset consists of a proportional 
number of samples with balanced number in classes (stratification). K-1 subsets 
are used as training data to train the classification model and the remaining 
subset is used as test data to evaluate the model. This procedure is repeated k 
times, e.g., for 10 fold CV the procedure repeated 10 times, therefore every 
subset, in turn, is used as a test set. The average accuracy over k times is the 
overall classification accuracy of the model. K-fold CV methods are normally 
used in conjunction with the stratified holdout method as a standard method for 
evaluating classification results, e.g., stratified 10 fold CV (Witten & Frank, 
2005). 
 Bootstrap: similar to random subsampling, but samples that have been selected 
for the training data still remained in the original dataset, so that they have a 
chance to be chosen again. Bootstrap 0.632 is a popular approach used to 
evaluate the classifier. With the Bootstrap 0.632 approach, the training set 
consisting of 63.2% of the samples and the test set consisting of 36.8% of the 
samples (Dieterle, 2003). The calculation of bootstrap .632 is shown in Equation 
(2.3) (Tan et al. (2006), as follows. 
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2.1.1.2. Feature selection 
 
Generic Steps in FS 
 
According to Dash and Liu (1997) and  Hall (1999) FS techniques consist of 3 major 
steps: 
 
Step 1: Apply a search strategy to obtain subsets of features. The search strategies 
include: evolutionary algorithms, e.g., GAs or MOEAs, greedy, best first search with 
forward search selection (FSS) and backward search selection (BSS). 
 
Step 2: Employ evaluation criteria such as distance measures, information measures, 
dependence measures or consistency measures. These measures are considered as a 
filtering mechanism, because they are independent processes to evaluate the candidate 
sunsets. Another measure is classifier error rate if a classifier is involved in the process 
of evaluating the candidate subsets. 
 
Step 3: Determine a stopping criterion to stop the iteration process of selecting subsets. 
Stopping criteria might be based on a pre-defined maximum number of generations to 
run the algorithm or the convergence of the algorithm or a solution is found 
(Lancashire, Rees, & Ball, 2008). The following figure illustrates the above steps: 
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Figure 2-2 Steps in a FS process 
  
Many FS techniques have been developed and applied to a variety of fields such as DM, 
bioinformatics and health related areas (Portinale & Saitta, 2002; Saeys, Inza, & 
Larranaga, 2007). In general, these techniques fall into three categories: filter methods, 
wrapper methods or embedded methods, which are described in the following sections. 
 
Filter methods 
 
Filter methods are performed prior to the use of a learning algorithm. Filter methods use 
separate independent techniques such as T-test, Kolmogorov Smirnov (KS) test and P-
test to rank individual features (Levner, 2005). Filter methods select relevant features by 
calculating scores for each feature. Features with low scores are eliminated from the list. 
Thus only a number of high scoring features are retained and considered as relevant 
features. At the end of the filtering process, only one feature subset is generated and 
used to construct the classifier.  
 
 
 
Feature Evaluation 
No Yes Optimal 
solution  
Feature subsets 
FS algorithm 
Dataset 
Stopping 
criteria? 
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Wrapper methods 
 
Wrapper methods are different from the filter methods described above. Instead of 
finding a relevant feature subset by a separate independent process, the wrapper method 
has its own machine learning algorithm (classifier) employed as part of the FS process. 
Unlike the filter method, numerous feature subsets are generated in the wrapper method 
and each of them evaluated using the machine learning algorithm. The process iterates a 
number of times until the best feature subset is found (Guyon, 2007; Guyon & Elisseeff, 
2006; Inza, Larranaga, Blanco, & Cerrolaza, 2004; Saeys et al., 2007).  The number of 
iterations depends on the total number of features in the dataset (i.e., more features, 
more subsets generated and thus more iterations are needed to obtain an optimal feature 
subset).  
 
According to Kohavi and John (1997), and Hall (1999), the learning algorithm 
(wrapper) is considered as a “black box” due to components of the black box, including 
FS, feature evaluation and the learning algorithm (classifier) itself, are not known from 
the outside. The way the method works is that the “black box” generates feature subsets 
using the training dataset and evaluates them using the classifier error or accuracy rate. 
The process stops when the termination condition(s) is met and the best feature subset is 
selected, and subsequently it is used for constructing the classifier.  
 
Embedded methods 
 
Embedded methods are methods that have a FS algorithm built into their classifiers, so 
that the search for relevant attributes can be done within the classifier itself using the 
dataset. As a result, a set of features is selected, and then a predictive model is generated 
and evaluated by the classifier.  
 
Due to the importance of relevant (optimal) features in classification of high 
dimensional data, developing an advanced FS technique that can select the most 
relevant features from this type of data is one of the foci of DM community. A large 
number of search strategies have been developed by many DM researchers for finding 
optimal feature subsets that can be used in the investigations for biomarkers. The 
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following sections describe some FS techniques that have been proposed in previous 
studies.  
 
2.2. Feature selection approaches have been developed in the area of bioinformatics 
 
The following sections describe some existing work related to FS approaches in the 
domain of bioinformatics. This section consists of 4 sub sections that described FS 
approaches involving evolutionary algorithms, rough set theory (RST), nearest shrunken 
centroid (NSC) and hybrid FS approaches, respectively.  
 
2.2.1. Feature selection using EAs 
 
2.2.1.1. Genetic algorithm  
 
The GA has been employed for FS as a standalone approach or as a hybrid approach 
which incorporates other algorithms such as SVM, k-Nearest Neighbor (k-NN) for 
finding feature subsets for high dimensional biological data. The following section 
describes some of these approaches. 
  
The GA was used in the study of  Yang and Honavar (1998) to select relevant features 
for the Wisconsin diagnostic breast cancer data. The overall fitness of sets of features is 
evaluated based on the aggregation of 2 objective functions: classification accuracy 
obtained from neural networks and the cost of performing the classification for each 
candidate feature subset (solution). The study has demonstrated that GA selected a set 
of features which is half the size of the entire feature space and still retained the same 
accuracy of 92.1% as to the case of using all the features. In the study of Handels, Rob, 
Kreusch, Wolf, & Poppl (1998), GA was also employed to select features for a tumour 
skin cancer dataset. Similarly, the fitness of candidate solutions are also evaluated based 
the aggregation of 2 objective functions, one for a number of features selected in the set 
and another one for its associated classification accuracy. That is, one objective function 
is employed for maximizing the minimal set of set features and another objective 
function is employed for maximizing the classification accuracy of the selected feature 
set. This study also showed GA selected a small subset of 5 features with the resulting 
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classification accuracy of 97.7% and GA outperformed other search methods such as 
the greedy and the ranking algorithms.  
 
Another approach using the GA in the process of selecting relevant features was carried 
out Jourdan, Dhaenens, & Talbi (2001). In this approach, the procedure of FS was 
carried out using GA and k-means in 2 steps: 1) The GA was utilized for searching 
optimal features with the aim to select a small subset of features from datasets with a 
large number of features, 2) selected features from step 1 are used as initial input 
features for a k-means clustering algorithm to cluster the data. As a result, the execution 
time of the algorithm is much faster than using k-means without GA; from 7500 
minutes down to 1 minute, and data were clustered effectively (Jourdan et al., 2001). 
 
In the study of Sun, Babbs and Delp (2005), the GA was compared to Adaptive 
Sequential Forward floating search (ASFFS) method for FS. Both methods were 
evaluated using a small dataset of images of Breast cancer that consisted of 296 normal 
regions and 164 cancerous regions. As a result, ASFFS outperform GA in terms of ROC 
(Receiver Operating Characteristic) analysis (Az). ASFFS achieved Az = 0.964 and the 
GA achieved Az = 0.917. The study concluded that, the GA application was more 
suitable for a large dataset, while ASFFS performed better for a small or medium 
dataset (Sun et al., 2005). 
 
The GA was also applied to select a relevant set of features for a prostate protein MS 
dataset in the study of Li et al (2008). Multivariate filter and wrapper methods were 
used as objective functions in the GA to determine the fittest individual. With the 
multivariate filter method, an evaluation criterion is built based on the scatter matrix and 
Bhattachayya distance. With the wrapper method, an evaluation function is built based 
on classification error rate and the posterior probability. This study achieved 92.7% 
classification accuracy for the multivariate filter method and 97.75% for the wrapper 
method. These results showed that the GA based multivariate filter and wrapper 
methods as its objective functions improved the classification accuracy when compared 
to other  FS methods such as PCA and sequential selection methods (Y. Li et al., 2008).  
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2.2.1.2. Multi-objective evolutionary algorithms 
 
In the study of Deb and Reddy (2003), a MOEA, called non-dominated genetic 
algorithm (NSGA2), was implemented with binary encoding representation to find 
multiple optimal feature sets for microarray cancer datasets: Colon, Leukemia and 
Lymphoma. Three objective functions, f1, f2, f3, were implemented in their approach. f1 
is for the size of gene subsets, f2 is for the number of mismatches (errors) in the training 
dataset and f3 is for the number of mismatches (errors) in the test dataset. The proposed 
approach, NSGA2, obtained 352 different three-gene sets that gave 100% classification 
accuracy. In addition, NSGA2 was employed in an approach where a local search 
strategy was incorporated into a MOEA in the study of Mitra and Banka (2006) for 
performing biclustering on yeast and human B-cells datasets. 
 
Rough sets and fuzzy set-based approaches for FS have also been combined with 
MOEAs to select features and classify high dimensional datasets in the domain of 
bioinformatics (Banerjee et al., 2007; S. Mitra & Hayashi, 2006). Banerjee et al. (2007) 
proposed an evolutionary rough set based FS technique for analysing gene expression 
data. The new FS approach was based on the RST with the application of MOEA to 
search for optimal subsets. NSGA2 was employed as a MOEA to optimize 2 objective 
functions simultaneously and generated a set of multiple optimal solutions. RST was 
employed to generate a distinction table of smaller sets of relevant features and used as 
initial inputs for NSGA2 to search for multiple optimal solution sets. This approach was 
evaluated using Colon, Lymphoma and Leukemia microarray cancer datasets. As a 
result, the number of relevant selected genes was smaller compared when to other 
selection methods, such as neural networks, t-test based FS and SVM, and also the 
accuracy of the classification was still retained at a very high level. This achievement is 
due to the fact that, RST was used to generate reducts  in the form of small subsets of 
relevant features initially and then NSGA2 optimized the reducts to find the best subset 
(minimal reducts) of relevant features with highest classification accuracy  (Banerjee et 
al., 2007). 
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2.2.1.3. Memetic algorithms (MAs) 
 
Zhu, Ong and Dash (2007) used a MA to search for relevant features for the Colon, 
Central Nervous System, Leukemia, Breast, Lung and Ovarian microarray cancer 
datasets.  They proposed the Wrapper-Filter Feature Selection Algorithm (WFFSA) and 
Markov Blanket-Embedded Genetic Algorithm (MBEGA) which involves MA. Both 
approaches were based on the traditional GA and a local search (LS) algorithm such as 
ranking filter method for WFFSA and Markov Blanket for MBEGA. In these 
approaches, binary representation was used for encoding chromosomes and the SVM 
classifier was employed to evaluate the fitness of individuals in the population. The MA 
based approach outperformed GA in terms of a faster convergence and smaller feature 
subsets with higher classification accuracies. 
 
Recently, Kannan and Ramaraj (2010) employed MA with a correlation based filter 
ranking method as the LS algorithm and the Naïve Bayes classifier as a fitness evaluator 
to evaluate the fitness of feature subsets. In their approach, binary representation was 
used for encoding chromosomes, Subset Size-Oriented Common Feature method was 
used for crossover and random bit flip method was used for mutation. The proposed 
approach outperformed the other search algorithm such as GA and ReliefF-based GA in 
terms of obtaining smaller feature subsets and higher classification accuracy. 
 
2.2.2. Feature selection using RST  
 
An approach incorporating a greedy search algorithm into RST for selecting relevant 
features was proposed by Zhong, Dong, and Ohsuga (2001). In their approach, RST was 
first used to generate reducts (sets of minimal features), which were evaluated using the 
Generalization Distribution Table and the Rough Set theory (GDT-RS) rules discovery 
system (Dong, Zhong, & Ohsuga, 1999; Zhong, Dong, & Ohsuga, 1998). GDT is used 
to evaluate the goodness of a rule and the RS theory is used to find the best rule. A set 
of indispensable features is called “CORE” and cannot be eliminated from the feature 
list, and can be also used to classify data.  (Zhong et al., 2001). A greedy search strategy 
was employed to search for optimal reducts from the reducts generated from the RST 
step. Firstly, features (reducts) obtained from the RST step were used as initial feature 
inputs for the  greedy search algorithm, and then the greedy algorithm finds relevant 
26 
 
features from the feature list using GDT-RS rules for feature evaluation. Features 
selected are then added to the reduct until the set of optimal features are obtained. As a 
result, the proposed approach selected the optimal set with 4 features for the Breast 
cancer data, and 17 and 19 features for gastric cancer data (Zhong et al., 2001). 
 
Midelfart et al. (2002) applied RST to select relevant feature sets and classify 
microarray gene expression data. High dimensional microarray data might contain 
irrelevant features that affect RST in terms of generating a large number of reducts of 
irrelevant features and therefore less accuracy in class prediction. In order to address 
this problem,  Midelfart et al. (2002) used t-test statistics to measure features; first by 
calculating the centroid of each class for each attribute and then to measure the 
difference between them for any significance. Only the features with highest t-test 
statistics were selected as significant features and subsequently used as feature inputs 
for RST. The approach was applied to the gastric cancer data and the number of features 
obtained in the selected subsets are from this approach range from 17-161 features 
(Midelfart et al., 2002). 
 
A new RST approach, called roughfication, was proposed to handle real values for 
microarray data in the study of Ślezak and Wróblewski (2007). In the traditional RST 
approach, real data values must be discretised prior to applying RST to generate reducts 
and to classify data. The Roughfication approach creates a new information system (IS) 
which based on the original IS. The new system used symbolic values (instead of real 
values in the original system) during rule generation processes. The symbols are used to 
form decision rules and subsequently used to predict the class for new samples. This 
approach was evaluated using the Breast cancer dataset and results obtained were 
compatible with other classification approaches (Ślezak & Wróblewski, 2007). 
 
2.2.3. Feature selection using NSC 
 
One of the popular FS and classification algorithms in bioinformatics is the NSC 
algorithm (Tibshirani et al., 2002) (due to its algorithm is simple and effective). It is 
also known as Prediction Analysis for Microarrays (PAM) which is a software 
implementation of the NSC. The NSC has been used in numerous studies (Arai & 
Barakbah, 2007; Klassen & Kim, 2009; Levner, 2005; Ray et al., 2007; Rocha de Paula, 
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Gómez Ravetti, Berretta, & Moscato, 2011; Tibshirani, Hastie, Narasimhan, & Chu, 
2003).  
 
Tibshirani et al. (2003) used the NSC to analyse the Small Blue Round Cell Tumours 
(SRBCT) and Leukemia datasets and obtained the set of 43 genes and 21 genes, 
respectively. The set of 43 genes constructed a classifier that achieved the classification 
accuracy of 100% and the set of 21 genes resulted in a higher classification accuracy 
when compared to analysis involving the same datasets in Golub et al. (1999) using 50 
genes (Tibshirani et al., 2003).  
 
Arai and Barakbah (2007) compared the NSC method with other classification methods 
such as Fisher’s Linear Discriminant Analysis (FLDA), Logistic regression 
(LOGISTIC), k-NN, SVM, Penalized Discriminant Analysis (PDA) using the SRBCT, 
Lung NSCI60 and Yeast datasets they showed that the NSC algorithm outperformed 
these other methods in terms of classification accuracy. 
 
In the study of Klassen and Kim (2009), the NSC algorithm was used to select features 
for 7 different microarray cancer datasets namely, the SRBCT, Acute Leukemia, 
Prostate, Lymphoma, Colon, Lung and MLL Leukemia datasets. From the analysis 
involving the application of NSC, 43 features were selected for SRBCT, 21 features for 
Acute Leukemia, 6 features for Prostate, 25 features for Lymphoma, 16 features for 
Colon, 5 features for Lung, and 52 features for the MML Leukemia datasets with 100%, 
94.11%, 90.91%, 86.6%, 75%, 93.7% and 95.4% test classification accuracy, 
respectively.  
 
Levner (2005) used the NSC algorithm to classify Ovarian (OC-H4, OC-WCX2a, OC-
WCX2b) and Prostate (PC-H4, PC-IMAC-Cu) MS cancer datasets. The study 
experimented with the use of 20 different shrinkage threshold values ranging from 0.5 
to 10 in increments of 0.5 to find the optimal shrinkage threshold. From their analysis, 
the average classification accuracy for the five datasets were 62.1% for OC-H4, 94.4% 
for OC-WCX2a, 97.2% for OC-WCS2b, 73.6% for PC-H4, and 76.4% for PC-IMAC-
Cu. The study also experimented with 200 different shrinkage threshold values ranging 
from 0.5 to 10 in increments of 0.05 and obtained the same classification results. 
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Ray et al. (2007) used PAM to analyse their Alzheimer’s disease dataset.  From this 
analysis, a set of 18 proteins were selected from 120 proteins. The set of 18 proteins 
were used in the classification of test samples (Alzheimer’s disease, Non-demented 
control (NDC), mild cognitive impairment (MCI)). The result from the analysis was an 
overall 89 % classification accuracy. The performance of PAM was better than other 
algorithms such as GA-ANN by Cho et al. (2003) (Ray et al., 2007). Following the 
discovery of the 18 protein biomarker from Ray et al.’s study (2007), Ravetti and 
Moscato (2008) and de Paula, Ravetti, Berretta, and Moscato (2011) also used the NSC 
algorithm to perform classification on the same Ray et al.’s Alzheimer’s disease dataset 
(2007). 
 
Many approaches have also been proposed for modifying the NSC algorithm with the 
aim of improving its performance. For example, Yeung and Bumgarner (2003) 
developed the uncorrelated shrunken centroid (USC) and the error-weighted, 
uncorrelated shrunken centroid (EWUSC) algorithms which are based on the NSC 
algorithm. The proposed algorithms removed redundant, correlated genes which 
reduced the number of features needed for classification. These algorithms were applied 
to different types of cancer datasets such as Colon, Leukemia and Ovarian. The results 
showed improvements in the classification accuracy and also in a smaller number of 
relevant features. S. Wang and Zhu (2007) proposed 2 methods, Adaptive L∞-norm 
Penalized NSC (ALP-NSC) and Adaptive Hierarchically Penalized NSC (AHP-NSC) 
with 2 different penalty functions. ALP-NSC method penalizes the maximum absolute 
relative difference (|dik|) between the class centroid and overall centroid for the i
th
 gene, 
if the maximum absolute |dik| is shrunken to 0 then all dik are automatically shrunken to 
0. ALP-NSC also penalizes each gene differently by using a pre-defined weighting 
scheme (wj); wj is small (i.e. less penalty applied) for genes that distinguishes different 
classes, and wj is large (i.e. more penalty applied) for genes that are similar and do not 
distinguish different classes. AHP-NSC penalizes the relative difference (dik) 
hierarchically, i.e., within i
th
 gene, different levels of dik are applied. The proposed 
methods were used to analyse the Leukemia. Their study showed ALP-NSC and AHP-
NSC outperformed NSC in terms of selecting smaller sets of features with similar 
classification accuracy.  
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Although there is extensive work involving the NSC, both from using it to analysis and 
from modifications for improvements, a major drawback is the determination of the 
shrinkage threshold value. This value is still being manually selected using CV or 
empirical methods. In addition, this value impacts on FS and classification in NSC. This 
drawback limits the NSC algorithm to perform its best, owing to the fact that if 
incorrect or sub-optimal shrinkage threshold values are provided to NSC, then the 
algorithm does not perform fully at its best in selecting optimal feature subsets and 
subsequently can lead to a lower classification accuracy. Thus, it is essential to develop 
methods that can automatically find the shrinkage threshold values for NSC. That is, the 
process of selecting the shrinkage threshold value is carried out automatically using the 
respective training data. Subsequently, the optimal shrinkage threshold value obtained 
from the automated process is used in the NSC algorithm to perform FS and 
classification. This would overcome the existing drawback of the NSC algorithm. The 
following section describes some of the hybrid approaches that incorporate a classifier 
and an EA for selecting relevant features. 
 
2.2.4. Feature selection using hybrid approach 
 
A hybrid approach that has been used to optimize the search for feature subsets is to 
incorporate an EA (e.g. GA) with another algorithm (e.g. SVM) (Pujari, 2001). The 
following section describes some studies that used hybrid EA approaches in FS and 
classification. 
 
In Peng, Xu, Ling, Peng and Du’s study (2003) study, GA was used in conjunction with 
SVM to select features from 2 datasets, namely the NCI60 and GCM cancer datasets. 
Unlike other search strategies that search for the best feature one at a time, GA searches 
for subsets of features in high dimensional data, hence the algorithm is able to select a 
small feature subset with a high accuracy of classification. The results of applying the 
approach to 4 cancer datasets (Colon, leukemia, NCI60 and GCM) has shown  that, the 
algorithm is able to find a smaller subset of relevant genes that produces a higher 
classification accuracy than previous methods such as rank-based gene selection and all 
paired binary SVM (AP-SVM) (Peng et al., 2003)  
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Cho et al. (2003) proposed an approach that incorporated GA and ANN for selecting 
relevant features to classify an Alzheimer’s disease dataset of 32 samples with 118 
features. An initial feature subset was generated, each feature in this subset was 
evaluated using ANN to determine their fitness. GA performed FS based on the fitness 
of the individuals. Only dominant features from each generation were selected. These 
selected features were used as a relevant feature subset to input for the neural network, 
which increased the network efficiency. Experimental results showed that 35 features 
were selected from 118 features, and the classification accuracy was 81.9% on the test 
data. GA was able to select relevant features to classify Alzheimer’s disease data from 
non- Alzheimer’s disease data, which was very useful for early detection of the disease 
(Cho et al., 2003) 
 
Jirapech-Umpai and Aitken  (2004) proposed a hybrid EA approach for multiclass 
classification. The approach combines GA and k-NN with the use of 6 ranking methods 
(Information gain, Twoing rule, Gini index, Sum minority, Max minority and Sum of 
variances) as fitness selection method to determine best features for GA. In the study, 
binary representation was used for chromosomes in the GA population, k-NN was 
employed as a measure function between samples using Euclidean distance. The 
proposed algorithm of GA and k-NN was evaluated using 2 microarray datasets: 
Leukemia and NCI60. The approach selected sets of features with 92% - 98% and 
76.23% classification accuracy on the 2 datasets, respectively (Jirapech-Umpai & 
Aitken, 2004). 
 
In the study of Li Li et al. (2005), the combination of GA and SVM (GA-SVM) has also 
been implemented to select an optimal subset of genes. The proposed GA-SVM used 
the power of GA for searching relevant features, and the SVM classifier to evaluate the 
goodness of feature subsets. The approach was applied to a diffuse large B-cell 
lymphoma (DLBCL) microarray dataset. From the analysis, 99% classification accuracy 
was obtained, which outperformed other FS methods such as the combination of GA 
and k-NN (GA-kNN), and filter methods (t-test, non-parametric scoring)  (Li Li et al., 
2005) 
 
Lu, Tian, Neary, Liu, and Wang (2008) proposed a hybrid FS approach, incorporating 
GA to improve FS on 2 microarray datasets: Colon and Prostate cancer dataset. The 
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hybrid algorithm uses the features selected from other selection methods: 2 from filter 
based methods (entropy-based and T-statistics) and 1 from a wrapper method (SVM-
RFE). The features selected from these three methods are combined together to form a 
feature population. GA uses this feature population as an initial population to start with 
and to produce an optimal (or near optimal) subset with a smaller size, but more 
accurate in prediction. The result from the study shows that, hybrid FS with GA is more 
effective, efficient and accurate in selecting small subsets than the other FS methods 
mentioned above. The study also found that top-ranked features do not necessarily give 
more accuracy than the lower-ranked features because interaction, correlation and 
redundancy between features are to be considered when classifying the data (Lu et al., 
2008) 
 
2.3. Techniques related to the implementations of proposed approaches in the study 
for FS and classification 
 
2.3.1. K-Means 
 
The k-means clustering algorithm was proposed by MacQueen (1967) . It is one of the 
most commonly used clustering algorithms for grouping data into different clusters for 
large datasets (Huang, 1998). The following figure illustrates a basic k-means 
algorithm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.  Generate initial cluster 
centroids randomly 
2. Allocate data points to clusters 
3. Re-calculate cluster centroids  
4. Cluster 
Convergence? 
Final 
Clusters  
Yes  No  
32 
 
 
Figure 2-3 Basic k-means algorithm 
 
As seen in Figure 2-3, step 1 is to generate initial centroids randomly for the k clusters, 
i.e., one centroid for one cluster; in step 2, each data point is placed into the cluster that 
has a closest centroid to the data point; step 3 is to re-calculate the new centroid for each 
cluster using the new data points and step 4 is to check for cluster convergence. Step 2 
and 3 are repeated until the cluster centroids do not change, i.e., convergence takes 
place.  
 
2.3.2. Rough Set Theory 
 
It is common for datasets to contain decision variables (classes) which cannot be used to 
differentiate the samples. For example, two or more samples have the same attribute 
values but belong to different classes and therefore the samples cannot be assigned 
correctly to the class they belong based on values for these types of variables. This 
causes problems in classification when the classifier tries to classify data to a certain 
class. A rough set (RS) approach was proposed by Pawlak (1982). This approach was 
developed on a mathematical basis and could be used to classify indiscernible data. The 
RS approach has also been used effectively in FS (Hu, Yu, Liu, & Wu, 2008; Pujari, 
2001; Swiniarski, 2001). According to Han, Kamber and Pei (2006), the RS is based on 
equivalence classes containing samples that are identical in terms of attributes 
describing the data. The RS classifies a class by using a lower approximation and an 
upper approximation for the class. The lower approximation for the class consists of all 
the samples that can be described as definitely belonging to the class, “positive cases”, 
whilst the upper approximation for the class consists of all the samples that are 
described as possibly belonging to the class, “possible cases” (Pujari, 2001, p. 57). 
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     A given class, C            Universe U 
 
        
         
         Lower approximation of C
      Lowe   (positive region) 
           
   Upper approximation 
               Upper approximation of C           (possible region)  
 
                           Negative region 
 
 
Figure 2-4 Rough set with lower and upper approximation of a given class, C, adapted 
from Han, Kamber and Pei (2006, p. 352) and Hu et al. (2008, p. 3582). 
 
The circle in Figure 2-4 represents a given class (C) that consists of the outlined cross 
hatched rectangular region (positive region) as a lower approximation, shaded 
rectangular region (boundary region) as an upper approximation. Each rectangle of the 
positive and boundary region represents an equivalence class. The samples of the 
positive region are identified as belonging to C; whilst the samples of the boundary 
region partly covered by C (i.e., samples with similar feature values which belong to 
more than one class) are possibly belonging to C, but that status cannot be verified with 
certainty. All the samples outside the boundary in the white rectangular region (negative 
region) are definitely not belonging to C.  
 
The lower approximation of class C:   = {         } where      is an equivalence 
class. Thus all the samples in the equivalence classes are in C. The upper approximation 
of class C:    = {           }. Thus not all the samples in the equivalence classes 
are in C. The result of the intersection between equivalence classes and C is a non-
empty set. The boundary region is the region of the difference between lower and upper 
region and is calculated as Boundary AC =   -   . The boundary region indicates the 
roughness of C. The smaller boundary region has the better confidence in classification. 
The negative region is the region outside the upper approximation region, NC = U-  . 
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The accuracy of the rough set is calculated by dividing the lower approximation by the 
upper approximation (lower/upper).  
 
Rough set can also be used to as a pre-processing approach to eliminate a number of 
redundant attributes for a high dimensional data based on the equivalence classes, lower 
and upper approximation (Jaaman, Shamsuddin, Yusob, & Ismail, 2009), prior to 
applying a FS or/and classification technique to select optimal feature subsets to classify 
data more effectively. 
 
2.3.3. Nearest Shrunken Centroid algorithm 
 
As mentioned earlier, the NSC algorithm has been used widely in bioinformatics as a 
FS and classification technique to select the most relevant features and to classify high 
dimensional biomedical data, e.g., Leukemia data. The following section describes the 
NSC algorithms in details.  
 
The NSC algorithm shrinks the class centroid for each feature (gene) toward the overall 
centroid for all classes by an amount of shrinkage threshold, ∆. The class centroid  ̅   
for class k for gene i is calculated using Equation (2.4). 
 
 ̅    ∑                (2.4) 
 
where     is a gene expression value for gene i =1...p and sample j = 1...m, Ck is an 
index of nk samples in class k.  
 
The overall class centroid  ̅i for gene i is calculated using Equation (2.5). 
 
 ̅i   ∑  i    
 
      (2.5) 
 
The relative difference,     is the difference in class centroid,  ̅   and the overall class 
centroid,  ̅i , standardized by the within class standard deviation of gene i, si. The 
formula for calculating relative difference    , is defined by Equation (2.6). 
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 ̅i - ̅i 
  (si so)
  (2.6) 
where  mk = √
1
nk
 
1
n
 
                s0 = median value of si over all genes 
 
The relative difference, dik is evaluated to 0 if it is equal to 0 or smaller than the 
threshold, ∆, else reduce dik by the threshold, ∆. The updated dik is called a shrunken 
relative difference, d’ik. The calculation for d’ik is shown in Equation (2.7). 
 
                 |   |       if |   |   . Otherwise 0     (2.7) 
 
Class centroid for gene i is updated by using the new value of       as shown in 
Equation (2.8). 
 
 ̅ i     ̅i     (si   so)          (2.8) 
 
If a gene is shrunk to zero for all classes, then it is considered not different from the 
overall centroid (i.e. irrelevant genes from a classification point of view) and is 
eliminated from the gene list (Klassen & Kim, 2009) Genes with at least one positive 
shrunken relative difference (over all classes K) are retained as relevant attributes           
(K. Yeung & R. Bumgarner, 2003). Selected attributes are then evaluated by calculating 
the discriminant score for class k for a new sample X* ={x
*
1, x
*
2 ,…, x
*
p}, as shown in 
Equation  (2.9). 
 
   (  )    ∑
          
 
        
  - 2 log    
p
i    (2.9) 
 
The first part of Equation (2.9) is the standardized squared distance of x* to the k
th
 
shrunken centroid, and the second term of Equation (2.9) is a correction based on the 
class prior probability   , where     = nk /n.  
 
Based on the discriminant score for each class, sample x* is classified to the class k that 
has a minimal discriminant score defined by Equation (2.10). 
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                 (2.10) 
 
where C(  ) is an assigned class of sample x,    (  ) is a class discriminant score,   ( 
 )  
is a minimal class discriminant score. 
 
The general steps of NSC algorithm are shown in the following figure. 
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Step 1. Calculate class centroid for attribute (gene) i of class k 
 ̅    ∑     
    
   
 
Step 2. Calculate overall centroid for all classes ( ̅i  
 ̅i   ∑ i    
 
   
 
 
Step 3. Calculate the relative difference (dik) 
 Calculate class standard deviation of attribute (si)    
si
2
 = 
 
   
 ∑ ∑      ( ̅    ̅  )
 
 
 Calculate so, median value of si over all attributes 
 Calculate   √
 
  
 
 
 
  
 Calculate relative difference     
 ̅  - ̅  
         
 
 
Step 4. calculate the shrunken relative difference (     )  
          if |   | ! threshold (∆)  
                  while |   |!threshold (∆)  
            |   | = |   |-∆ 
                         = sign(   ) (|   |) 
          else   
                   =0 
   
Step 5. Update class centroids for attribute i 
 ̅       ̅                    
Step 6. Repeat step 1 to 5 until all attributes are processed 
 
Step 7. Select relevant attributes with at least one positive shrunken relative 
difference (    ) over all classes 
 
Step 8. Evaluate the set of relevant attributes selected 
 calculate discriminant score for class k for a new sample (  ) 
          ∑
      ̅    
 
        
  -          
 
     
where    is a sample with attribute values      
 
   ..,  
 
   
      =   /    
 Assign sample    to the class k that has a minimal discriminant 
scores: 
                          
               
 
 
Figure 2-5 Steps of the NSC algorithm  
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2.3.4. Evolutionary Algorithm  
 
Evolutionary algorithm (EA) is a search method, based on the principle of survival of 
the fittest which was borrowed from the evolution of biological nature. Basically, a 
number of generations are iterated through EA; each generation consists of a numerous 
individuals. The later generations contain fitter individuals which maybe a subset of 
previous generations. Only individuals which survive as the fittest are retained from 
generation to generation, and the fittest individual subset is selected at the end of the 
process. GA and MOEA are the 2 typical types of EA which are described in the 
following section. 
 
2.3.4.1. Genetic Algorithm  
 
GA was proposed and developed by Holland (1975) and is based on Darwin’s theory of 
survival of the fittest. GA consists of components such as population representation, 
objective function, evaluation of population, selection, crossover, and mutation 
operators. Figure 2-6 shows the steps in a GA.   
 
Figure 2-6 Basic steps of GA 
39 
 
 Initial population 
Individuals in the population are randomly generated. 
 Fitness evaluation 
The algorithm uses an objective function (s) to evaluate the fitness of individuals in the 
population.  
 Selection 
Once the process of ranking the fitness of individuals is done then the selection of 
individuals is carried out in order to find which individuals will be combined to produce 
offspring.  Many selection techniques have been used in the area of GA and these 
include: Ranking selection, Roulette Wheel selection and Tournament selection. 
According to Miller and Goldberg (1995), an ideal selection technique is the technique 
that would be simple in implementation, efficient in performance and adaptable in 
different domains. Tournament selection has been widely used in GA because of its 
usefulness and  robustness, and it satisfied all the criteria mentioned above (Miller & 
Goldberg, 1995).  
 
Tournament selection is also known as a random tournament selection that selects k 
number of individuals randomly from  the population pool to form a tournament group 
of size k and the fittest individual from the group is then selected for  crossover  
(Goldberg & Deb, 1991; Hoefsloot, 2013; Miller & Goldberg, 1995). A binary 
tournament selection is a special case of random tournament selection in which, the size 
of the tournament group is 2. That is, two individuals are selected randomly from the 
population to form a tournament group of size 2 and the best individual of the group 
(i.e. the best of the two) is selected (Deb, Pratap, Agarwal, & Meyarivan, 2002; Suzuki, 
Takahashi, & Shibahara, 1995). The following figure describes the general process of 
selecting individuals using tournament selection.  
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Input: 
 Chromosome population (p) 
 Fitness population (Fp) 
Output: 
 Selected parent chromosomes (Cparents) 
Steps: 
   1. Set k = size of tournament 
   2. Set Tournament (Tk) = { } 
   3. Set n = max number of parents to be selected 
   4. For counter from 1 to n 
a. For counter from 1 to k 
 Select chromosomes randomly from p 
 Store selected chromosomes into Tk 
b. Compare fitness of individuals in Tk using Fp 
c. Select a chromosome with the best fitness (Cbest) 
d. Store Cbest into Cparents 
 
Figure 2-7 Tournament selection procedure 
 
 Crossover (recombination)  
The crossover process combines two or more selected parents from previous steps to 
produce offspring. This method depends on the type of chromosome representation, 
e.g., binary crossover (crossover with single, double, multi points, uniform and 
arithmetic) is used for binary representation. Generally, the steps in crossover involve: 
1) two parent candidates are selected for crossover, 2) a crossover parameter is used to 
determine whether the crossover operation will take place, 3) a random number is 
drawn, i.e., for one point crossover, in the case of multi points crossover then more than 
one random number need to be drawn, to determine the position (s) where the crossover 
take place on the parents, 4) the parents are crossed over at the randomly selected 
position(s) to produce the new individuals (offspring). The following figure illustrates 
one point binary crossover between two parents which is related to the study. 
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Figure 2-8 Example of a one point binary crossover  
 
As seen in Figure 2-8, two parents are split into ‘head’ (in blue) and ‘tail’ (in green) at 
the cross position (Cp), the ‘tails’ of 2 parents are inter-changed to produce 2 offspring.  
 
 Mutation  
After the crossover process, offspring are mutated to produce new individuals with 
different features which are not present in their parents. According to Eiben & Smith 
(2007), mutation operators can be applied for binary, integer, real and permutation 
encoding representations. The following section describes the bit flip mutation 
procedure for binary representation and uniform mutation procedure for real-value 
representation, both of which are used in this study. 
 
Bit flip mutation for binary representations:  
A bit flip mutation is the type of mutation where each bit in the chromosome is allowed 
to change its value independently with a small mutation probability (Pm). That is, if the 
random number generated for the bit is less than Pm and if the bit is 1 then it changes 
(flips) to 0 or if the bit is 0 then it changes to 1 (Eiben & Smith, 2007).  
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Input: 
 Chromosome (chrom) 
 Mutation probability (Pm) 
Output: 
 Modified chromosome (chromMod) 
Steps: 
     1. Set len = length of chrom 
     2. Generate a random number (Rn) in the range [0, 1] using a  
random number generator (RNG) 
     3. If Rn < Pm 
For counter =1 to len 
    Generate a random number (Rn) in the range [0, 1] using RNG 
                            If Rn ≤ Pm 
                                 Do bit flip on chrom [counter] 
  chromMod = chrom 
     4. Else  
No mutation 
 
Figure 2-9 Bit flip mutation procedure 
 
The algorithm for Uniform mutation for real-encoding representations is shown in 
Figure 2-10. 
 
Input: 
 Chromosome (chrom) 
 Mutation probability (Pm) 
Output: 
 Modified chromosome (chromMod) 
 Steps: 
1. Set len = length of chrom 
2. Generate a random number (Rn) in the range [0, 1] using RNG 
3. If Rn < Pm 
Find the lower bound value of chromLb 
Find the upper boundary value of chromUb 
For counter =1 to len 
    Generate a random number (Rn) in the range [0, 1] using RNG  
    If Rn ≤ Pm 
        Calculate chrom[counter] =chromLb + (Rn * (chromUb - chromLb))  
  chromMod = chrom  
       4. Else 
No mutation 
 
 
Figure 2-10 Uniform mutation procedure 
 
43 
 
 New population generation: 
Best offspring from selection, crossover and mutation process is placed into the new 
generation. The process of selection, crossover and mutation are repeated until the new 
generation of the population is completed.  
 
 Termination: 
The process of fitness evaluation, crossover, mutation and new population generation 
are repeated until a stopping condition is met. For example,  such as a solution is found 
after a pre-defined number of iterations.   
 
2.3.4.2. Multi-objective evolutionary algorithms 
 
In the real world, tasks are normally associated with multiple conflicting objectives such 
as the conflict between performance, cost, fuel efficiency, reliability, etc., For example, 
a car that performs well but consumes less fuel and is of a reasonable price. There is no 
single best solution that satisfies multiple conflicting objectives simultaneously, rather a 
set of solutions with trade-offs between conflicting objectives. Multi objective 
algorithms use more than one objective functions to optimize a problem. MOEA solves 
the problem effectively by dealing with multiple conflicting characteristics represented 
by the objective functions, and generates a set of optimal solutions, e.g., Pareto front of 
optimal solutions, which are the set of all non-dominated solutions (Ayala & Coelho, 
2008). 
 
MOEA is classified on the basis of its selection approach. There are three different 
types of MOEA (Coello & Lamont, 2004): 
 Aggregating function approach which combines all the objective functions into a 
single objective function. The weighting (w) of each objective function, which 
indicates the importance of one objective function over the others, is used in this 
approach, e.g., F= w1f1 +w2f2  … wnfn. The limitation of this approach is that it 
does not give a set of different possible best solutions to satisfy all objectives, rather 
than one general solution for all objectives.  
 Population based approaches which use the population to improve the diversity of 
the search but not incorporating the concept of Pareto front in the selection process. 
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Vector Evaluated Genetic Algorithm (VEGA) (Schaffer, 1985) is a typical example 
for this type of approach. At each generation, sub-populations are created based on 
objective functions, i.e., each objective function is used in turn in the selection 
process to generate a subpopulation of size of the total population size (M) over a 
number of k objectives. A new population of size M is then created from these 
subpopulations. Genetic algorithm evolves the new population with the use of 
selection scheme, crossover and mutation operator. The drawback of this approach 
is that if an individual has a good overall fitness for all objectives but is not the best 
individual for any individual objective, then it is discarded. 
 Pareto based approaches which incorporate the concept of a Pareto front into 
MOEA.  The objective function used to search for a Pareto Front which is a set of 
optimal solutions is defined by Ayala and Coelho (2008), as follows.  
 
Optimized F( ) = (f1 ( ), f2 ( ), … fn ( )) 
 
where n= 1, 2,.., k; decision variables x = ( 1,  2, …,  n)   X; X = feasible solution set; 
fn are objective functions. The concept of a Pareto front is discussed in Chapter 8. 
 
NSGA2 incorporates the concept of Pareto front into MOEA (Deb et al., 2002). This 
study uses NSGA2 in the approach of incorporating NSGA2 into NSC for finding 
multiple optimal shrinkage thresholds. NSGA2 will be described in Chapter 8. 
 
2.3.5. Memetic Algorithms (MAs) 
 
MAs are similar to evolutionary algorithms such as GA. A common definition of MA is 
“A memetic is an Evolutionary Algorithm that includes one or more local search phases 
within its evolutionary cycle” (Krasnogor & Smith, 2005, p. 2). Gene values in GA are 
known as memes (Dawkins, 2006) in MA. The term, meme, is referred to a unit of 
culture evolution or transmission where the local improvement for chromosomes takes 
place using local search (LS) algorithms such as hill climbing (Elbeltagi, Hegazy, & 
Grierson, 2005; Wu, 2001a). Thus MA is a hybrid of EAs which combines an EA and a 
local search (LS) to improve the fitness of chromosomes (Krasnogor & Smith, 2005; 
Wu, 2001a).  
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MA has additional steps of LS for improving the fitness of chromosomes in the 
population by finding local optimum neighbours in chromosomes prior to the normal 
process of crossover and mutation operations. Each new population is evolved locally 
using LS and then globally via GA. This cycle repeats until the stopping criteria such as 
global convergence takes place or the pre-defined number of generations has been 
executed.  
 
The combination of GA and LS makes MA more efficient and effective in terms of 
processing time for converging to optimal solutions, finding smaller sets of features, 
and improving classification accuracy when compared to other traditional EAs such as 
GA (Elbeltagi et al., 2005; Zhu et al., 2007). Different LS strategies such as pair-wise 
LS (Merz & Freisleben, 1999), improvement first strategy LS and greedy LS (Zhu et 
al., 2007) can be incorporated into GA in different ways. A LS strategy can be applied 
to  
 only elite chromosomes or  
 the entire population, or 
 either after the crossover and/or mutation operation 
 
The following section describes some strategies of implementing MA with different LS 
methods. 
 
Elbeltagi et al. (2005) described a LS using pair-wise swapping proposed by Metz and 
Freislenben (1999). A swapping strategy to interchange 2 memes (genes) was applied to 
chromosomes in order to find the best local neighbour in the chromosome. Figure 2-20 
illustrates the use of this pair-wise swapping strategy. 
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  Chromosome before LS (a) 
Meme1 Meme2 Meme3 Meme4 Meme5 Meme6 Meme7 Meme8 
 
   
Pair Swapping 
 
Meme2 Meme1 Meme3 Meme4 Meme5 Meme6 Meme7 Meme8 
 
  New chromosome after LS (b) 
 
 
Figure 2-11 An example of LS using pair-wise strategy 
 
As seen in Figure 2-11, the pair of ‘Meme1’ and ‘Meme2’ of chromosome (a) is 
swapped to form a new chromosome (b). The process of swapping between the pair 
continues for the remaining pairs, e.g., pair of Meme1 and Meme3, Meme1 and Meme4, 
...., Meme1 and Meme8, pair of Meme2 and Meme3, Meme2 and Meme4, ...., Meme2 
and Meme8, and so on.  The number of pairs (N) to be swapped is calculated using 
Equation (2.11). 
 
N = ½ (n (n-1))     (2.11) 
 
where n is the length of chromosome. 
 
For example, let chromosome A has the length, n = 1000, then N = ½ (1000(1000-1)) = 
499500. That is, LS needs to process 499500 pair-wise operations. This could involve a 
large computational time when using this LS strategy. According to Elbeltagi et al. 
(2005), in order to reduce the cost of computational time, the swapping between pairs 
stops as soon as the fitness of the chromosome is improved (Merz & Freisleben, 1999). 
This is known as an improvement first strategy (Zhu et al., 2007), i.e., no need to 
continue performing the swap for the remaining pairs once the first improvement of the 
chromosome has been found. The procedure of pair-wise LS with improvement first 
strategy is described below. 
      LS 
Pair-wise 
swapping 
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Input 
   Chromosome (chrom) 
   Fitness of chrom 
Output  
   Improved chromosome (chromImp) 
Steps 
   1. Calculate the number of pairs of memes, N=1/2 (n (n-1)) 
   2. For counter =1 to N 
         Swap the positions of the pair to create a new chromosome (chromnew) 
         Evaluate the fitness of chromnew 
         If the fitness of chromnew  > fitness of chrom  
      chromImp = chromnew 
     Stop swapping pairs and exit 
         Process the next chromosome  
 
Figure 2-12 Pair-wise LS with improvement first strategy used in Elbeltagi et al. (2005) 
 
The adding subtracting LS strategy involves searching for a better chromosome in 
terms of fitness by adding or subtracting a small random value to a meme (gene) value 
in the chromosome to create a new chromosome. The fitness of the new chromosome is 
then evaluated, if an improvement is obtained then the new chromosome is retained 
otherwise discarded. The process continues for the rest of the memes in the 
chromosome (Elbeltagi et al., 2005). This is called a greedy search strategy (Zhu et al., 
2007) or a hill climbing search strategy where the search progresses from the current 
chromosome to the one that has a better fitness (Kohavi & John, 1997; H. Wang, Wang, 
& Yang, 2009). According to Elbeltagi et al. (2005), MA using the adding and 
subtracting LS with a greedy strategy outperformed GA in terms of a better 
classification accuracy and processing time. The procedure of adding and subtracting 
LS with a greedy strategy (Elbeltagi et al., 2005) is described in Figure 2-13. 
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Input 
   Chromosome (chrom) 
   Fitness of chrom (chromfit) 
   Population size (S) 
   Chromosome length (len) 
Output  
   Improved chromosome (chromImp) 
Steps 
     1. Generate a random value, Rn 
     2. For counter1 =1 to S 
  For counter2 =1 to len 
      Add Rn to chrom[counter2] to create a new chromosome (chromnew) 
      Evaluate the fitness of chromnew 
      If fitness of chromnew > chromfit 
             chromImp = chromnew 
 update chrom = chromnew 
      Else  
             subtract chrom[counter]from Rn to create chromnew 
             evaluate the fitness of chromnew 
             if fitness of chromnew > chromfit 
                 chromImp = chromnew 
     update chrom = chromnew 
              
 
Figure 2-13 Procedure of greedy search strategy using adding and subtracting LS 
(Elbeltagi et al., 2005) 
 
According to Zhu et al. (2007), the improvement first strategy LS outperformed the 
greedy strategy LS. Their study also found that when applying the improvement first 
strategy LS on a few of elite chromosomes, results obtained were better than those 
obtained from applying LS on all chromosomes.   
 
Elbeltagi et al. (2005) proposed another MA approach where the LS is applied to 
offspring after the crossover or mutation process.  In the Guided Local Search (GLS) 
Based Memetic Algorithm (Krasnogor & Smith, 2005), the LS is applied to offspring 
after the crossover and mutation operations.  
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2.3.6. Similarity distance measures 
 
From the literature, it can be seen that different similarity measures have been used to 
cluster gene expression data into groups of similar genes and in classification. A 
similarity measures is used in the process for grouping genes into clusters, whereby 
genes in the same cluster are as similar as possible, and are very different from genes in 
another cluster. For example, Pearson correlation measure considers the correlation 
between two genes for measuring the similarity between genes. Similar genes have a 
positive correlation and are related (Leale et al., 2013). Genes that similar in expressions 
(i.e. close in similarity distance measure) are grouped into a cluster (class) (Deshpande, 
VanderSluis, & Myers, 2013). Genes in the same cluster are likely to be involved in the 
same cellular processes and biological functions (Paul & Maji, 2014). The set of 
selected features from a biological perspective implies that the level of expressions 
associated with the selected biomarkers differ significantly between disease and non-
disease. There’s little existing evidence as to which measure is most effective but 
previous studies have shown that the use of different similarity measures have an impact 
on the clustering/classification results. The following sections describe some commonly 
used similarity distance measures. These include Euclidean, Mahalanobis, Pearson 
correlation and Mass distance. 
 
2.3.6.1. Euclidean distance  
 
Euclidean distance satisfies the triangle inequality and is the most commonly used 
distance measure. It is the method of measuring the distance between 2 points based on 
Pythagoras’ theorem (A2 = B2 + C2). For example, points with 2 dimensions A {  ,   } 
and B {  ,   }, the squared distance between A and B is the total of squared differences 
of coordinates between A and B. Hence the distance is the square root of     –    
2  
     –    
2
, as shown in Equation (2.12). 
 
EucliDAB = √    –    
2       –     
2     (2.12) 
 
Points in multi-dimensional space, e.g., A{  ,   , ..,   } and B{  ,   , ..,   }, the 
Euclidean distance measure is calculated as follows: 
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EucliDAB = √∑ (      )
 
   
2
      (2.13) 
 
Euclidean distance have also been used in classification to classify a sample with 
multiple features,  {  ,   , ..,   } to a class. In this case, a sample is assigned to a class 
based on the distance between the sample and its class centroid. The Equation (2.13) is 
re-written as follows. 
 
       √∑ (      )
 
   
2
    (2.14) 
 
Where     is the mean of class k of j
th
 feature 
      is the sample of j
th
 feature 
    n is a number of features. 
 
2.3.6.2. Mahalanobis distance 
 
Mahalanobis distance is a popular method that has been used widely as a distance 
measure in clustering and classification (Wölfel & Ekenel, 2005). Mahalanobis distance 
(Mahalanobis, 1936) is the method of measuring the distance between the centroids of 2 
classes or the distance between a variable and a class centroid. Unlike Euclidean 
distance, in which the different class densities are considered to be equal and only the 
distance from a data point to a class centroid is a criterion for classification, in 
Mahalanobis distance, the different class densities are taken into account when 
classifying data (McLachlan, 1999).  Figure 2-14 illustrates Mahalanobis distance 
measure. 
 
   Data density           Data density 
 
 
 
 
            Class A           Class B 
 
Figure 2-14 Mahalanobis distance measure 
x 
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Variance of each variable and the co-variance between variables are taken into 
consideration in the Mahalanobis distance calculation. It handles problems associated 
with poorly and highly correlated features in a dataset. 
 
Mahalanobis distance measure is calculated as follows. 
 
MahaD ² = (x - µ)
T Σ-1(x - µ)         (2.15) 
 
where µ: class centroid 
          superfix T: matrix transpose 
     Σ-1: inverse covariance matrix 
 
2.3.6.3. Pearson distance  
 
Pearson correlation (Pearson, 1895) is a method for measuring the correlation between 2 
variables. The correlation is measured in the range of -1 to +1.  +1 means the correlation 
is a perfect positive linear relationship, 0 implies an uncorrelated relationship and -1 is a 
perfect negative linear relationship. Pearson correlation is calculated as follows. 
 
 (r) = 
∑ (x- ̅) (y- ̅)
√(x- ̅)
2
 √(y- ̅)
2
      (2.16) 
 
Pearson Distance (PD) = 1- r     (2.17) 
 
where x is variable value 
            ̅ is class centroid 
 
According to Equation (2.17), when r approaches 1, PD approaches 0, i.e., the distance 
is 0, thus attributes have a linear relationship; when r approaches to 0, PD approaches to 
1 (PD = 1-0), i.e., the distance is 1, thus attributes have an uncorrelated relationship; 
when r approaches to -1, PD approaches to 2 (PD =1-(-1)=2), i.e., the distance is 2, thus 
attributes have negative linear relationship. 
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The problem of using the Pearson distance as defined by Equation (2.17) is that the 
relationship between the distance and correlation coefficient is not mapping 
appropriately for measuring the correlation distance between variables.  To address this, 
D. Wang, Wang, Lu, Song and Cui’s study’s (2010) used the absolute Pearson’s 
correlation coefficients, | r | to measure the similarity for microRNA, PD is calculated 
using | r | instead of r. Thus Pearson correlation distance is now calculated as follows. 
 
PD = 1 - | r |        (2.18) 
 
According to Equation (2.18),  when r approaches to 1 or -1 then  | r | = 1, PD 
approaches to 0 (PD=1- |-1|), that is the distance is 0 and attributes have a positive or 
negative linear relationship; when r approaches to 0, PD approaches to 1 (PD = 1 - 0), 
that is the distance is 1 and attributes have an uncorrelated relationship. 
2.3.6.4. Mass distance  
 
Euclidean, Mahalanobis and Pearson distance do not consider the background 
distribution of attributes while calculating the distance (Yona et al., 2006).  
 
MD measure is a method that has been used for evaluating gene expression similarity 
and takes into account the background distribution of attribute values in the calculation 
of the distance (Yona et al., 2006). Unlike the other measures such as Euclidean, 
Mahalanobis and Pearson, MD calculates the distance between two variables by 
measuring the relative difference between the variables and by measuring their 
probability mass (volume). Two variables are more similar (closer) when they have 
smaller volume (Yona et al., 2006).  
 
The equations used to calculate MD for 2 variables (a, b) are taken from Yona, et al. 
(2006).  
 
Calculation of probability mass for 2 variables a and b for sample i: 
 
            ∫            
         
         
    (2.19) 
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Where                    =(
 
 
  √  )    
 
      
     is the normal distribution for 
sample i.                    
          (
 
 
  √  )    
 
      
     (2.20) 
 
Where     is a class centroid 
               is a standard deviation of the class 
 
            
       
 
  (2.21) 
 
  max and min are the maximum and minimum value of the variables  
 
Hence           can be re-written using Equation (2.20) and (2.21) as follows. 
 
            (∫ (
 
 
  √  )    
 
      
   
         
         
)  (
       
 
  )  (2.22) 
 
Mass Distance (MD) of variable a and b is obtained by first calculating the total volume 
of measurement values bounded between the 2 variables and followed by taking the 
product over all samples, as shown in Equation (2.23). 
 
          ∏           
 
      (2.23) 
 
where d is the number of samples. 
 
2.4. Discussion and Summary 
 
From the review of the literature, it can be seen that the biomedical area is data rich 
through the development of high throughput technologies such as microarrays, mass 
spectrometry and from the international genome projects. Development of new 
computational techniques to analyse these data is vital for progress to be made from 
bio-information to in the bio-knowledge and followed by drug discovery. One approach 
involved feature selection and techniques involved evolutionary approaches, rough set 
54 
 
theory, various machine learning techniques and hybrids of some of these approaches. 
However given the characteristics associated with biological datasets, approaches 
involving traditional statistical approaches and machine learning techniques as 
described in Section 2.2 may not effective in their analysis. 
 
From a biomedical perspective, groups of features are also known to work together as 
components in a biological pathway. However, as seen in the review, many existing 
data analysis approaches in bioinformatics may only involve evaluating each feature 
separately (univariate analysis) and do not consider possible correlations amongst 
features nor the joint behavior of a combination of features. There is an increasing need 
for development of techniques that attempts to address this limitation and where the 
basis of the selection involved the evaluation of different combinations of features by 
simultaneously considering two or more selection criteria. 
 
In summary, this chapter has briefly described fundamental concepts associated with 
DM and FS methods.  Existing work related to FS and classification approaches for 
analysing high dimensional biological data were also outlined. Lastly Section 2.3 
presented a review of the various techniques associated with the proposed approaches in 
this study.  
 
The next chapter describes common elements in this study. These include the seven 
datasets used to evaluate the approaches in this study, the CV strategy, the process of 
checking for the state of convergence and termination conditions for the GA.   
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3. Datasets, Evaluation strategy, Convergence and Termination 
criteria  
 
This chapter has four main sections that described common elements employed in this 
study. The first section described the datasets used for evaluating techniques developed 
in this study, the second section outlined the CV approach, and Section 3 and 4 detailed 
the process of checking the state of convergence and termination conditions for the GA, 
respectively.  
 
3.1. Datasets 
 
This section describes 7 biomedical public datasets associated with various diseases, 
ranging from Ray et al. Alzheimer’s Disease (AD)  (Ray et al., 2007), Alon et al. Colon 
cancer (Alon et al., 1999), Leukemia cancer (Golub et al., 1999), Lung cancer (Gordon 
et al., 2002) Lymphoma cancer (Alizadeh et al., 2000), Ovarian cancer (Petricoin et al., 
2002) and Prostate cancer (Singh et al., 2002).  
Table 3-1 showed a summary description of these seven datasets.  
 
Table 3-1 Summary of seven public datasets used in the study 
Dataset Type of data 
No of 
features 
No of 
classes 
No of 
samples 
Data type 
Ray et al. AD  
(Ray et al., 2007) 
Protein 
immunoassay 
120 2 259 
Continuous 
Alon et al. Colon  
(Alon et al., 1999) 
Cancer 
microarray 
2000 2 62 
ALL-AML Leukemia 
(Golub et al., 1999) 
7129 2 72 
Lung  
(Gordon et al., 2002) 
12533 2 181 
Lymphoma 
(Alizadeh et al., 
2000) 
4026 2 47 
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Prostate  
(Singh et al., 2002) 
12600 2 136 
Ovarian (Petricoin et 
al., 2002) 
Proteomic 
spectra 
15154 2 253 
 
These datasets have already been used in the evaluation of  FS and classification 
techniques in previous studies associated with bioinformatics (Banerjee et al., 2007; 
Cao, Lee, Seng, & Gu, 2003; Klassen & Kim, 2009; Ravetti & Moscato, 2008; Ray et 
al., 2007; Rocha de Paula et al., 2011; Yeung, Bumgarner, & Raftery, 2005). All 
datasets (except the AD dataset) are taken from Kent Ridge Bio-medical Dataset 
Repository (J. Li & Liu, 2002). Each dataset is a publicly available dataset. Details of 
data collection techniques for each dataset can be referred to the original author’s paper. 
 
One of the seven datasets (AD) in Table 3-1 is from Alzheimer’s disease domain and 
generated using protein immunoassay technologies, and 5 datasets are associated with 
cancer, namely Colon, Leukemia, Lung, Lymphoma and Prostate cancer, all of which 
are generated using microarray technologies. Lastly, the Ovarian cancer dataset is 
generated using proteomic spectra technologies. The AD dataset consists of a relatively 
small number of attributes (120 attributes), while each of the remaining seven datasets 
has a large number of attributes ranging from 4026 to 15154, with the number of 
samples in these datasets being extremely small in comparison to the number of 
attributes. For example, the Prostate cancer dataset consists of only 136 samples, with 
each sample having 12600 attributes. This is a typical example of datasets in the 
biomedical domain. The samples in all these datasets are classified into 2 classes, 
diseased versus non-diseased. The attributes are continuous variables and the format of 
the data files is either in Excel or text format. The following sections describe each of 
these datasets. 
 
3.1.1. Ray et al. Alzheimer’s Disease (AD) datasets 
 
The assay dataset used in Ray et al.’s experiment (2007) consists of 259 plasma samples 
from 6 categories, namely Alzheimer disease (AD), Non-demented control (NDC), 
Other Dementia (OD), Mild Cognitive Impairment (MCI), Other Neurological Disease 
57 
 
(OND) and Rheumatoid Arthritis (RA). Each sample is characterized by measurements 
associated with 120 known signalling proteins (attributes), saved in a Microsoft Excel 
file format. Table 3-2 showed the breakdown of information for this dataset. This study 
used the same training set and test sets as determined in the Ray et al.’s study (2007). 
 
 Table 3-2 Description of subsets associated with the Ray et al.’s dataset (2007) 
Dataset:   259 samples 
                120 attributes 
Type of data & 
Number of samples  
 
 
 
Alzheimer disease (AD)  (85)    
Non-demented control (NDC) (79)                                                                   
Other dementia (OD)  (11)                
Mild cognitive Impairment (MCI) (47) 
Training set (83) 
AD: 43 
NDC: 40 
AD test set  (92)  
AD: 42 
NDC: 39 
OD: 11 
MCI test set (47) 
MCI -> AD:   22 
MCI -> OD:   8       
MCI -> MCI: 17 
Other neurological disease (OND) (21) 
Rheumatoid arthritis (RA)  (16) 
Not used for AD classification 
 
 
 Of the 259 samples, 85 samples belong to the AD group and 79 samples 
belong to the NDC group.  Samples from these two groups are allocated into 
2 sets: training and test set. The training set consists of 43 samples 
belonging to AD group and 40 samples from the NDC group.  
 There are two additional test sets used in this study: the AD test set consists 
of 42 AD, 39 NDC and 11 OD making a total of 92 samples and the MCI 
test set consists of 47 cases of MCI. In the case of MCI, after 2-6 years of 
follow-up diagnosis, 22 cases developed to AD, 8 cases developed to OD 
and 17 cases still remained as MCI, i.e., not developed to AD or OD (Ray et 
al., 2007). 
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 According to Ray et al. (2007), an additional set, consisting of 21 OND and 
16 RA from the 259 samples, was not used for classification. 
 
For more information regarding the methods used to produce the data and the 
description of the 120 proteins in the dataset, please refer to Ray et al. (2007) 
 
3.1.2. Alon et al. Colon cancer data 
 
The Colon cancer dataset consists of 62 samples that was analysed using Affymetrix 
oligonucleotide arrays. Samples were taken from tumours and normal tissues. Each 
sample has 2000 attributes with continuous values obtained from the microarray 
analysis. Data is saved in text file format. Table 3-3 shows the detailed breakdown of 
the dataset.  
 
Table 3-3 Description of subsets of Colon data 
Dataset:   62 samples 
               2000 attributes 
Type of data & 
Number of samples 
 
 
Tumour colon cancer (T) (40)        
Normal tissues (N) (22) 
Training set (46) 
T: 30 
N: 16 
Test set  (16) 
T: 10 
N: 6 
 
As seen in Table 3-3, two groups consisting of 40 tumour (T) tissue samples and 22 
normal (N) tissue samples are distributed  into a training set consisting of 46 (30 T and 
16N) samples, and a test set consisting of 16 (10T and 6N) samples. This distribution of 
samples in this dataset into the training and test sets followed the same configuration as 
used in the study conducted by Klassen and Kim (2009). 
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3.1.3. Leukemia cancer data 
 
Leukemia dataset contains 72 bone marrow samples from acute leukemia patients. It 
includes samples from Acute Lymphoblastic Leukemia (ALL) and Acute Myelogenous 
Leukemia (AML), with each sample having 7129 attributes with continuous values. The 
data is stored in text format. A summary of this dataset is shown in Table 3-4. This 
study used the same training set and test sets as determined in the study conducted by 
Golub, et al. (1999), J. Li & Liu (2002) and Klassen and Kim (2009). 
 
Table 3-4 Description of subsets of Leukemia data 
Dataset:   72 samples 
               7129 attributes 
Type of data & 
Number of samples 
 
 
Acute Lymphoblastic Leukemia (ALL) (47)        
Acute Myelogenous Leukemia (AML) (25) 
Training set (38)  
ALL: 27 
AML: 11 
 Test set  (34) 
ALL: 20 
AML: 14 
 
As seen in Table 3-4, the groups of 47 ALL samples and 25 AML samples from a total 
72 samples are allocated into a training set consisting of 38 (27 ALL and 11 AML) 
samples and a test set consisting of 34 (20 ALL and 14 AML) samples.  
 
3.1.4. Lung cancer data 
 
The Lung cancer dataset contains 181 samples from adenocarcinoma (ADCA) and 
malignant pleural mesothelioma (MPM) patients. Each sample has 12533 attributes that 
are continuous values. Dataset is stored in text format. A summary of this dataset is 
shown in Table 3-5. This study used the same training set and test sets as determined in 
J. Li and Liu’s study (2002) 
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Table 3-5 Description of subsets of Lung data 
Dataset:  181 samples 
              12533 attributes 
Type of data & 
Number of samples 
 
Adenocarcinoma (ADCA) (150)        
Malignant Pleural Mesothelioma (MPM) (31) 
Training set (149)  
ADCA: 134 
MPM: 15  
Test set  (32) 
ADCA: 16 
MPM: 16 
 
As seen in Table 3-5, the groups of 150 ADCA samples and 31 MPM samples from the 
total 181 samples are distributed into a training set consisting of 149 (134 ADCA and 
15 MPM) samples and a test set consisting of 32 (16 ADCA and 16 MPM) samples.  
 
3.1.5. Lymphoma cancer data 
 
Lymphoma cancer dataset contains 47 samples of Diffuse large B-cell lymphoma 
(DLBCL), including Activated B-like DLBCL (ACL) and Germinal Centre B-like 
DLBCL (GCL). Each sample has 4026 attributes of continuous values. Dataset is stored 
in text format. A summary of this dataset is shown in Table 3-6. 
 
Table 3-6  Description of subsets of Lymphoma data 
Dataset:   47 samples 
               4026 attributes 
Type of data & 
Number of samples 
 
 
Germinal Centre B-like (GCL) (24)  
Activated B-like (ACL) (23) 
Training set (34) 
GCL: 17 
ACL: 17  
Test set  (13) 
GCL: 7 
ACL: 6 
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As seen in Table 3-6, the distribution of samples in this dataset followed the same 
configuration as used in the study conducted by L. Li, Weinberg, Darden and Pedersen 
(2001)  whereby the groups of 24 GCL samples and 23 ACL samples from a total 47 
samples are allocated in the following manner: a training set consisting of 24 (17 GCL 
and 17 ACL) samples, and a test set consisting of 23 (7 GCL and 6 ACL) samples.  
 
3.1.6. Prostate cancer data 
 
Prostate cancer dataset contains 136 samples from tumour and normal tissues. These 
samples were analysed using Affymetrix oligonucleotide microarrays resulting in each 
samples having 12600 attributes with continuous values. Dataset is stored in text 
format. A summary of this dataset is shown in Table 3-7. This study used the same 
training set and test sets as determined in J. Li and Liu’s study (2002) 
 
Table 3-7 Description of subsets of Prostate data 
Dataset:   136 samples 
               12600 attributes 
Type of dataset 
 
 
Tumour tissues (T) (77) 
Normal tissues (N) (59) 
Training set (102)   
T: 52 
N: 50 
Test set  (34) 
T: 25 
N: 9 
 
As seen in Table 3-7, the groups of 77 tumour (T) samples and 59 normal (N) samples 
from the total 136 samples are allocated in the following manner: a training set consists 
of 102 (52 T and 50 N) samples, a test set consists of 34 (25 T and 9 N) samples 
 
3.1.7. Ovarian cancer data 
 
The Ovarian cancer dataset contains 253 samples of cancer and normal tissues. Each 
sample has 15154 attributes (continuous values) was analysed using mass spectroscopy. 
Dataset is stored in text format. A summary of this dataset is shown in Table 3-8. 
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Table 3-8 Description of subsets of Ovarian data 
Dataset:     253 samples 
                  15154 attributes 
Type of dataset 
 
Cancer disease (D) (162)  
 
Normal control (N) (91)  
 
Training set (126)   
N: 45 
D: 81 
Test set (127) 
N: 46 
D: 81 
 
As seen in Table 3-8, the distribution of samples in this dataset followed the same 
configuration as used in the study conducted by J. Li and Liu (2002) whereby the 
groups of 91 normal control (N) samples and 162 cancer samples (D) from the total 253 
samples are allocated in the following manner: a training set consisting of 126 (45 N 
and 81 D) samples  and a test set consisting of 127 (46 N and 81 D) samples. 
 
This section described the various datasets used to evaluate the techniques developed in 
this study and the next section will describe the evaluation method for assessing the 
performance of the developed techniques in this study.   
 
3.2. Evaluation Strategy 
 
Predictive DM is one branch of DM where a model formulated using some existing data 
is used to predict future behaviour/outcomes. There are a number of ways to measure 
the performance of these models, namely: classification accuracy, error rates, lift charts 
(charts are used to measure the performance of the prediction model by plotting the 
number of true positive predictions against the total number of samples) and ROC 
curves (charts are used to measure the performance of the prediction model by plotting 
the number of true positive predictions against the total number of negative predictions) 
(Witten & Frank, 2005). However, an issue associated with the use of these models for 
prediction is that while they perform effectively on classifying training data, they may 
perform badly on future unseen data. Evaluation of these models then becomes 
important in terms of the reliability of the predicted results, with CV being the most 
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widely used approach for evaluating these models (i.e., the generalization ability of the 
models) (Witten & Frank, 2005). Other methods which also have been used for model 
evaluation include holdout and bootstrap 0.632 (Wood, Visscher, & Mengersen, 2007). 
Cross validation (CV) is a statistical approach that consists of iterations where subsets 
of the data (training data) are first used to fit a model and followed by the testing of  the 
performance of that model using  the rest of the data (validation data). However, if the 
approach is not carried out properly, selection bias can occur and the resulting 
classification results can be optimistically biased (Ambroise & McLachlan, 2002).  
Typically in mining mass throughput data such microarray data, the first step involves 
employing FS techniques to reduce the number of attributes to a small number. 
Selection bias occurs if the whole dataset is first used in the FS process and then 
followed by the CV process.  This is due to the fact that the selection of these features 
already incorporated information on the test set. Thus in order to avoid the selection 
bias in the process of selecting the training model, “the test set must play no role in the 
feature-selection process for an unbiased estimate to be obtained” (Ambroise & 
McLachlan, 2002, p. 6566). 
 
Other issues that must be considered as part of the evaluation strategy are stratification, 
and the number of folds in the CV process, number of repetitions of a CV process and 
computation resources and lastly, simulation of prediction of new data.  Stratification is 
a process for ensuring that each class associated with the dataset is properly represented, 
with samples of each class being in the right proportion in both the training and test sets.  
According to Witten and Frank (2005), a 10-fold is sufficient to obtain the best error 
estimate. If stratification is incorporated into a 10-fold CV procedure then the 
evaluation approach is known as a stratified 10-fold CV. In addition, consideration must 
also be given to the number of repetitions of the CV process as a single 10-fold 
stratified CV will not be able to guarantee a reliable error estimate.  Repetitions of CV 
need considerations of computation resources and lastly, simulation of prediction of 
new data implies having an untouched validation dataset as this is the only way to 
simulate prediction of new data. The following section outlines the evaluation strategy, 
that addressed the issues discussed above and, is used in this study. 
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Unseen test dataset (U) 
 
Training dataset (T) 
 Fold 1 
Fold 2  
Fold 3 
Fold 4 
Fold 5 
Fold 6 
Fold 7 
Fold 8 
Fold 9 
Fold 10 
 
Figure 3-1 General mining structure: the breakdown of a dataset into an unseen test 
dataset (U) (brown colour) and a training dataset (T) (green colour), in which (T) is 
further split into 10 folds for 10 fold CV. 
 
The evaluating strategy consists of 3 major steps: 1) partitioning the dataset into a 
training dataset (T) and an unseen test dataset (U), 2) performing evaluation of 10 fold 
CV on the training data (T) and 3) performing test classification on the unseen test data 
(U). The following section describes these steps in details. 
 
Step 1. Partition the full dataset into a stratified training dataset and a stratified unseen 
test dataset. 
 Randomly assign each sample from the dataset into one of two groups: training 
(T) and unseen test dataset (U). As part of this allocation process, ensure that 
each class associated with the dataset (e.g. disease and healthy control) is 
appropriately represented in both the training and unseen test dataset, thus 
incorporating stratification. In this study, the split ratio (into training and unseen 
test datasets) and the proportion of samples for each of the classes, e.g., Cancer 
and Normal in Ovarian cancer dataset, into the training set and unseen test set 
respectively, from each of the full dataset, followed the configurations used by 
65 
 
either the original authors or authors who have also used the same datasets in 
their subsequent studies. 
 
Step 2. Perform 10 fold CV using the training dataset (T). 
 Randomly assign samples from the training dataset (T) into 10 folds to obtain 10 
stratified subsets. 
 Select 1 subset (fold) as the validation set and use the remaining 9 subsets as a 
training set. For example, in Figure 3-1, fold 1 may be set to be the validation set 
and the training set then consists of fold 2 to fold 10. 
 Using a selected approach developed in this study and 9 folds, generate the 
classification model and evaluate its performance using the validation set. This 
process is repeated 10 times (i.e. 10 folds), with each subset in turn being the 
validation set and the remaining subsets (9 folds) being a training set. Calculate 
the performance of 10 fold CV by averaging the classification error rate over the 
10 folds. 
 
Step 3. Perform classification on unseen test dataset (U). 
 Using the selected approach used in Step 2  and the training data (T), generate 
the classification model and evaluate its performance on the unseen test dataset 
(U) to obtain the unseen test classification accuracy.  This stage may also be 
seen as simulating the prediction of new data as the unseen test dataset has been 
kept totally separate from the training dataset. 
 
The entire classification process (Steps 2 and 3) is repeated 15 times (15 independent 
runs) which means including 15 times of 10 fold CV. The final training classification 
accuracy of 15 times of 10 fold CV and classification accuracy of the unseen test dataset 
are calculated by averaging their respective accuracy rates over the the15 independent 
runs. Running multiple times is also essential for evaluating the quality and 
performance of evolutionary algorithm such as GA (Alba, Garcia-Nieto, Jourdan, & 
Talbi, 2007). For example, 5 independent runs were used  in Huerta, Duvalm and Hao’s 
experiment (2006),  10 runs were used in studies (Alba et al., 2007; Bala, Huang, 
Vafaie, DeJong, & Wechsler, 1995; Kenneth A DeJong & Spears, 1990; Sharpe & 
Glover, 1999);  and 20 runs (Stein, Chen, Wu, & Hua, 2005; Zhang & Sun, 2002). Thus 
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in this study,  15 runs are considered as a sufficient number for estimating the 
classification accuracy and the performances of the proposed approaches, bearing in 
mind the tradeoffs – the need for sufficient number of runs  for evaluating the 
performance of proposed techniques and  the computational overhead associated with 
the analysis of  high dimensional biological datasets.  
 
3.3. Termination criteria 
 
According to many researchers (Safe, Carballido, Ponzoni and Brignole (2004), 
Koumousis and Katsaras (2006), Milton (2009) and Ong and Fukushima (2011)), the 
most common criteria used to terminate GA are: full population convergence to a single 
solution, fitness of the population has not improved over a pre-define number of 
consecutive generations, a pre-defined maximum number of generations (or fitness 
evaluations) have been executed, or the best fitness values found over a number of 
generations. The following section describes the stopping criteria employed in this 
study for terminating GA. An additional check using the strategy of detecting the 
convergence status as described in the previous section 3.3 is also conducted after the 
GA is deemed to have converged.  
 
The termination criteria employed here for terminating the GA consists of a 
combination of two conditions: executing for a predefined maximum number of 
generations and that the fitness of the population did not change over a pre-defined 
number of consecutive generations. In order to implement this termination approach, for 
each of generations in the GA, the following calculations are carried out, 1) fitness of 
each chromosome/individual in the entire population, 2) the maximum fitness of the 
population, and 3) the average fitness of the population. Whilst a pre-defined maximum 
number of generations are not reached, the average fitness of the population is checked 
for any changes (improvement), if it does not change (improve) over a pre-defined 
number of consecutive generations (100 generations), then the population  is considered 
as having converged and the GA terminates . The choice of 100 consecutive generations 
for termination is based on the results of parameter tuning that has been completed for 
all the datasets in this study, as described in Section 5.3. The number of 100 consecutive 
generations is large enough for avoiding a pre-mature convergence. This termination 
approach not only avoids premature convergence but also reduce the total 
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computational time because there is no need to keep executing the algorithm when the 
population in question has already converged (Kumar & Rockett, 2002; Ong & 
Fukushima, 2011).  
 
The following algorithm describes the procedure of terminating GA. 
 
Input 
 Individual fitness in population (Find) 
 Population size (s) 
 A pre-defined maximum number of generations (Gmax) 
 A pre-defined maximum number of consecutive generations of  
convergence  
(Cmax) 
 
Output 
 Maximum population fitness (Fmax) 
 Average population fitness (Favg) 
 
Steps 
    1. Set counter = 0 
    2. For 1 to Gmax 
a. Calculate total population fitness (Ftotal) = ∑     
 
  
b. Calculate Favg = Ftotal / s 
c. If Favg does not change then 
 Increase counter by 1 
 If counter = Cmax then 
Terminate GA 
d. Else  
 Reset counter back to 0 
 
 
Figure 3-2 Termination procedure for GA  
 
To minimize the likelihood of premature convergence, this study has incorporated the 
following: 
 
 Selection of parameter settings from one of the four sets of “standard parameter 
values” for GA from the literature and these have been described in Section 
5.3.1. This study has also used tournament selection, elitism and an appropriate 
crossover probability to ensure a balance between diversity and selection 
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pressure, so as to avoid premature convergence. Details are shown in Table 4-1 
and Table 5-2. 
 
 In addition, this study  instituted a mechanism consisting of  three parts for 
checking for the occurrence of premature convergence: an approach proposed by  
Srinivas and Patnaik (1994) for checking for  premature convergence and 
checking that the maximum fitness, at the point of convergence, approaches the 
theoretical maximum fitness value associated with the different fitness functions 
and the termination criteria described in Section 3.3 and 3.4 of the thesis 
respectively. In this check, the function defined by  Srinivas and Patnaik 
approaches zero and the maximum fitness, at the point of convergence, 
approaches the theoretical maximum fitness value associated with the different 
fitness functions and termination condition (that is, the fitness of the population 
did not change over a pre-defined number of consecutive generations). 
 
3.4. Genetic Algorithm and state of convergence 
 
The GA is incorporated in a number of approaches developed in this study. It is 
important to ensure that the GA has achieved convergence as a premature convergence 
will result in a local optimal solution instead of a global optimum. To check  the 
algorithm is converging to the global optimum, this study used an approach proposed by  
Srinivas and Patnaik (1994) to check for premature convergence. This can be done by 
checking the difference between the average fitness (favg) and maximum fitness value 
(fmax) of the population after the GA has converged.  A plot of the values for fmax – favg  is 
used to detect the state of convergence of GA. That is, the smaller the difference 
between fmax and favg, the better the global convergence and a better optimal solution 
obtained from the algorithm,  thus avoiding  premature convergences (M. Srinivas & 
Patnaik, 1994).  
 
Figure 3-3 shows an example of the convergence plot for one GA execution over 300 
generations. The blue line shows the plot of the maximum fitness of the population for 
each generation and the red line shows the plot of the values of (fmax – favg ). The vertical 
axis on the left-hand side indicates maximum fitness of each generation and the vertical 
axis on the right hand side indicates the values for (fmax– favg ). Note that (fmax – favg) 
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approaches to values approximately close to zero around 211 generations. This 
coincides with the max fitness having a value of 0.954 (1 is maximum). Figure 3-2 also 
shows a local optima that occurred in the execution of the algorithm over 300 
generations. The 2 vertical green lines in Figure 3-2 illustrate the local optimum (a1) 
found prior to the algorithm reaching global convergence (the vertical blue line). If the 
algorithm stopped when this local optimum found, then it was a premature convergence, 
where (fmax – favg) approaches to values not so close to zero (a2) and it coincides with the 
maximum fitness having a smaller value of 0.938 (a1), compared to 0.954 (b1) and (fmax 
– favg) is close to zero (b2) in the case of the global convergence. 
 
 
Figure 3-3 An example of a convergence status plot 
 
3.5. Summary  
 
This chapter has described the details of common elements associated with this study. 
These include: 1) the dataset of AD, Colon cancer, Leukemia cancer, Lung cancer, 
Lymphoma cancer, Ovarian cancer and Prostate cancer dataset in terms of the training 
and unseen test sets, 2) the evaluation strategy used to evaluate the proposed 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.75
0.8
0.85
0.9
0.95
1
1
1
2
2
3
3
4
4
5
5
6
6
7
7
8
8
9
1
0
0
1
1
1
1
2
2
1
3
3
1
4
4
1
5
5
1
6
6
1
7
7
1
8
8
1
9
9
2
1
0
2
2
1
2
3
2
2
4
3
2
5
4
2
6
5
2
7
6
2
8
7
2
9
8
3
0
9
Max  
fitness 
fmax-favg  
fitness 
Global  
convergence  
 
Generations 
 
Local  
optimum 
 
(a2) 
 (b2) 
 
(a1) 
 
(b1) 
 
Max fitness 
 
 
 
fmax-favg  
70 
 
approaches, 3) check the state of convergence for GA, and 4) GA termination criteria. 
These common elements are applied to the evaluation of proposed approaches 
developed in this study.  
 
In Chapter 4, the proposed approach of incorporating RST into GA for searching 
optimal feature sets is described. Chapter 4 is the pilot study in this thesis and involved 
modifying Banerjee et al.’s (2007) approach for generating the distinction table.  
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4. Rough set theory and GA approach (RST-GA) 
 
Chapter 3 described the seven datasets used in this study. It can be seen that these 
datasets belongs to the category of “binary classification” problems, specifically, normal 
versus diseased or two variants of diseased samples. Common characteristics of these 
datasets are very high dimensionality and small number of samples. The challenge when 
classifying this type of data arises from the limited availability of a small number of 
samples in comparison to the large number of features associated with each sample. With 
a large number of features, of which, some maybe redundant or irrelevant, the 
classification process can be computationally intensive. Furthermore, with a small 
number of samples, over-fitting in training is likely to occur and can lead to higher 
classification errors when the trained classification model is used to classify unseen test 
data (data not used as part of the training).  
 
Chapter 4 is the pilot study in this thesis and involved modifying Banerjee et al.’s 
(2007) approach for generating the distinction table. This chapter is an extended version 
of the paper “Incorporating genetic algorithm into rough FS for high dimensional 
biomedical data” (Dang, Lam, & Lee, 2011). It describes the first investigation that was 
carried out in this study to explore EA-based approaches for FS and classification of 
such high dimensional biological data. In Section 4.1, a hybrid approach, incorporating 
GA and RST, for searching for the best subset of optimal features is described. A 
description of a parameter tuning process for the GA is then outlined in Section 4.3. 
Using optimal sets of features generated from the proposed approach, classification was 
carried out using k Nearest Neighbour (k-NN) classifiers to evaluate their performance 
in classifying unseen test data. Classification results involving classifiers from WEKA 
(Waikato Environment for Knowledge Analysis) (Hall et al., 2009) are also shown in 
Section 4.4, and followed by a discussion in Section 4.5. 
 
Please note that in this thesis the term “feature” and “attribute” are used interchangeably 
and represent the same thing. 
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4.1. The proposed approach, RST-GA 
 
 
Figure 4-1 Framework of the proposed approach, RST-GA 
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Figure 4-1 illustrates the framework of the proposed approach, RST-GA, incorporating 
k-means clustering, RST and GA. As shown in the figure, the proposed approach uses a 
3-phased process, consisting of: 
 
Phase 1: This phase carries out the feature reduction step.  Owing to k-means being 
employed to find threshold values associated with each feature, a normalization step was 
first carried out on all the features.  The normalized values are then used to partition each 
corresponding feature in the process of generating a reduced attribute table.  The 
objective of this step is to do an initial cull, completing a preliminary coarse reduction in 
redundancy amongst the features.     
 
Phase 2: In this phase, a distinction  table (Wroblewski, 1995), which is a variant of the 
discernibility matrix, is constructed using the reduced feature table generated from Phase 
1. The distinction table is in the form of binary matrix.  
 
Phase 3:  GA was employed in the third phase as an optimization method to search for  
the optimal set of features based on the distinction table that has been generated from 
Phase 2.  
 
RST-GA, is an initial attempt to explore approaches for analyzing high dimensional 
biological data and is based on Banerjee et al.’s approach, using RST and  incorporating 
GA as a search algorithm However, the proposed approach makes improvements by  
using quartile statistics and K-means clustering to obtain optimal centroids for 
partitioning data in the first phase. 
 
The steps associated with each of these three phases are described in the following 
sections.  
 
4.1.1. Phase 1: Feature reduction 
 
K-means is employed in this phase to generate centroids of each attribute which are 
subsequently used for its partitioning step. K-means is one of the most popular 
clustering technique and widely used in the DM community to cluster high dimensional 
data (Yedla, Pathakota, & Srinivasa, 2010). K-means clustering groups data into 
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separate clusters based on the Euclidean distance between the data points and the 
centroids (Nazeer & Sebastian, 2009).  According to Nazeer and Sebastian (2009), there 
are 2 steps associated with k-means.  The first step is to determine the value of k (i.e. the 
number of clusters) and to initialize each of these cluster centres to a random number. 
The second step involves the use of a similarity measure (e.g. Euclidean distance 
measure) to calculate the respective distances of each data point to these centroids and 
assignment of the data points to the closest centroid. The new centroid for each cluster 
is re-calculated and the respective distances of each data point to the updated centroids 
are also re-calculated, and subsequently, data points are re-assigned to the clusters based 
on the new values of the re-calculated distances of the data points to each of the updated 
centroids. The process of updating cluster centroids, re-calculating the distance between 
data points and centroids, and re- assigning data points to the clusters continue until the 
convergence of clusters takes place, i.e., when there is no more changes to the cluster 
centroids.  
 
In addition, Visalakshi and Thangavel (2009, p. 168) have also stated that “the 
clustering results can be greatly affected by differences in scale among the dimension 
fro , which the dista ces are co puted”. Thus to address this issue, a normalization 
process needs to be carried out to transform raw data consisting of attribute values to a 
specific range such as [0, 1] prior to employing k-means clustering. In this proposed 
approach, min-max normalization is first used to normalize the data. 
 
a) Normalization  
The min-max normalization method (Han & Kamber, 2006) is applied to the training 
and test datasets, converting attribute values into the range of [0, 1] using Equation 
(4.1). 
 
a'j = (aj (xi) – minj) / maxj - minj     (4.1) 
where maxj and minj are respectively, the maximum and minimum expression value of 
attribute aj  from all samples.  
 
The following figure illustrates an example of normalization. 
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 (a) Raw data                              (b) Normalized data 
     Attributes             min-max normalization  Attributes 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-2 Example of part of normalized data using min-max normalization 
 
As seen in Figure 4-2, each attribute (column) shown in the table of Raw data (Figure 4-
2 (a)) consists of values with differences in a wide range (blue box), which are 
normalized to values between 0 and 1 (red box) shown in the table of Normalized data 
(Figure 4-2 (b)). Thus, after normalization, values of each attribute are standardized in 
the same scale (i.e. between 0 and 1). 
 
K-means is also very sensitive to the starting points (i.e. initial centroids) and these 
subsequently impact greatly on  its ability to achieve global versus local optimum in 
terms of accuracy (i.e. clustering results) and efficiency (i.e. computational time spent to 
perform clustering) (Bradley & Fayyad, 1998; Nazeer & Sebastian, 2009; Yedla et al., 
2010). In this study, a quartile statistics technique is first employed to find more 
appropriate initial starting centroid values for k-means rather than using random values 
for initial centroids. The following section describes the quartile statistics procedure for 
calculating the initial starting centroids for each attribute.  
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b) Quartile statistics  
As seen in Chapter 3, the datasets used in this study are from the bioinformatics domain 
and belongs to the category of “binary classification” problems, specifically, normal 
versus diseased or two variants of diseased samples. Values associated with attributes of 
such datasets typically falls into a number of categories: a normal range where it is 
considered to be associated with a “non-diseased condition” and a value that’s too high 
or too low may indicate abnormality and that it is associated with a “diseased 
condition”. For example, a measurement associated with blood glucose level that’s 
below 70mg/dl (milligrams per decilitre) is considered to be associated with  a low 
blood glucose condition and a measurement above 180mg/dl is considered to be 
associated with a high blood glucose condition (hyperglycemia) – a condition which is 
known to be associated with diabetes, while a measurement  between 70mg/dl and 
180mg/dl is considered to be associated with a normal blood glucose level (Euglycemia) 
(W. L. Clarke et al., 2005).  
 
On the basis of the above characteristic, the approach employs quartile statistics to find 
three values associated with each attribute: 25
th
 percentile, 50
th
 percentile and 75
th
 
percentile; with the value at 50
th
 percentile being used to reflect a value associated with 
the normal range and the remaining two to reflect values associated with conditions 
considered to be either too low or too high. These three values are then used as 
initialization values for centroids of three clusters in the third step – the application of 
K-means algorithm. The steps used in the calculation of quartile statistics are shown 
below (Banerjee et al., 2007). 
 
 Sort values associated with each attribute in ascending order. 
 Partition the sorted values for each attribute equally into small class intervals (δ). 
 Calculate quartile statistics for each attribute to obtain the lower threshold value 
(Thl), middle threshold value (Thm) and upper threshold value (Thu) using the 
formula defined in Banerjee et al. (2007), and shown as follows. 
 
        
           
   
      (4.2) 
where   Lc is the lower limit of the Cth class interval 
 Rk is the rank of the kth interval value  
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 Rk 
N k
p
   with p = number of partition  
N is a number of objects  
k = k
th
 partition value, k=1, 2, 3 for 4 partitions 
       is the cumulative frequency of the immediately preceding class interval 
such that    
                        
      is the class frequency 
  δ is the class interval width 
 
    
        
              
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-3 Example of partial table of Thl, Thm andThu threshold values generated as 
initial starting points for k-means using the quartile statistics method. 
 
As seen in Figure 4-3, each attribute with its values shown as a row in the table of 
Normalized data (Figure 4-3(a)) is partitioned into 3 levels of thresholds, lower (Thl), 
middle (Thm) and upper (Thu) shown as a row in the table of Thresholds (Figure 4-3(b)). 
The three threshold values associated with each attribute are used as initial centroid 
points for the K-means clustering step for partitioning each attribute.  
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c) K-means  
The k-means algorithm employed here has been described in Section 2.4.1. Figure 4-4 
shows the refinement of the cluster centroids before (initial) and after k-means (final) 
for one attribute.  The initial centroid value (red square) in each cluster (C1, C2, and 
C3) shifts towards the centre of the cluster, i.e., red squares move to the green triangles 
which are closer to the centre of the clusters. Subsequently, the final centroids obtained 
from the k-means step are used in the RST process to produce a distinction table. 
 
  
Figure 4-4 Example of cluster centroid positions before and after k-means 
 
d) Partition data 
Attributes are considered to be “of interest” if their values have a decisive role in 
differentiating between individuals belonging to different classes (e.g. diseased vs. non-
diseased). Using the previous example, blood glucose level can be an attribute of 
interest if the task is to decide whether an individual is suffering from diabetes – 
specifically in the case where the blood glucose level is either very high or very low. 
This implies that this value associated with this attribute differs between the diseased 
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and non-diseased individuals, with diseased individuals having values outside the norm. 
Using this rationale, the attributes in the datasets are processed in the following manner: 
Using the final centroid values obtained in the k-means clustering step, thresholds Thl 
and Thu are assigned as the lower and upper attribute thresholds respectively. These 
values are subsequently used for transforming the values of each attribute into 0, 1 and 
“ ”, with “ ” is considered as a “do ’t care” condition (Banerjee et al., 2007, p. 625).  
The implication here is that the range of interest is when the attribute value is at the 
extreme ends. The following rules are used to process each attribute: 
 
1. If an attribute value is less than or equal to its associated Thl then assign the  
    value of 0.  
2. If an attribute value is greater or equal to its associated Thu then assign the     
    value of 1.  
3. If an attribute value is greater than its associated Thl and less than its  
    associated Thu assigned it to “ ”  
 
As seen in Figure 4-5, values in each attribute (blue box) are compared to its respective 
Thl and Thu threshold value and has been converted to 0 or 1 or “ ” (red box) based the 
conditions as specified above. As a result, a table of 0, 1 and “ ” values are created. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-5 Example of a “01*” table 
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e) Generate reduced attribute value table 
Based on the “ ” values in the “0 *” table generated from the previous step, the 
average frequency of “ ” is computed from the whole dataset (table) and then used as a 
“ ” guided threshold value (Th avg) to eliminate attributes. As mentioned earlier, 
attributes with a majority of “ ” are considered as not being significant in separating the 
different classes. Therefore, attributes with a total number of “ ” greater than or equal to 
Th*avg are eliminated from the attribute list. As a result, a large number of attributes are 
eliminated and a reduced attribute value table (Ar) is produced.  
 
4.1.2. Phase 2: Generate a distinction table  
 
In this phase, the reduced attribute table, Ar, is then used to create a distinction table. 
The distinction table is a variant of the discernibility matrix which is based on the 
indiscernibility relation approach. Objects are divided into equivalence classes based on 
equivalence relations such that two objects are in the same class (equivalence class) if 
and only if they have the same attribute values (equivalence relation). A discernibility 
matrix (Dm) is defined as a matrix of m rows by n columns of an information system (S) 
of N samples and A attributes. A discernibility matrix of an information system, Dm (S), 
with the i
th
, j
th
 entry (Eij) is defined as          {          (  )}         
(Hoa & Son, 1996). According to Banerjee, et al. (2007), a distinction table created 
based on the following criteria is greatly reduced in dimension and the computational 
time involved is shorter. This distinction table is called a “d-Distinction” table, the same 
name used here as in Banerjee, et al (2007, p. 626). 
 
The following rules are used for generating a d-Distinction table: 
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1. Insert 1 for object pairs of different classes having different values (e.g., {0,1}  
    or {1,0}). 
 (       )  = 1 if ai(xk) ≠ ai(xj) 
2. Insert 0 for object pairs of different classes having the same value (e.g., {1, 1}  
    or {0,0}). 
 (       )= 0 if ai(xk) = ai(xj) 
3. Insert 0 for either object of the pair has “ ”. 
4. Object pairs of the same class are ignored. 
5. Rows with all 0s are not allowed. 
 
A d-Distinction table created using the above criteria has a smaller dimension of m1 * 
m2 in comparison to a discernibility matrix of (m*(m-1))/2, where m = m1+m2, and m1, 
m2  =  the number of samples in class 1 and 2, respectively.  For example, let m1 is 22 
and m2 is 40, therefore m1 * m2 = 22 * 40 = 880 rows (sets) of objects, which are much 
less than ((22+40) * (22+40)-1))/2 = (62*61)/2= 1891. Therefore, in terms of search 
space, it would reduce computational cost when using GA to find the optimal feature 
subset. The following figure shows an example of a cut down version of d-Distinction 
table. 
 
 
 
0 1 0 : : 0 1 1 
1 0 1 : : 1 0 1 
: : : : : : : : 
: : : : : : : : 
0 1 1 : : 1 0 0 
0 1 1 : : 1 1 0 
1 0 0 : : 0 1 0 
0 1 0 : : 0 0 1 
 
 
Figure 4-6 An example of d-Distinction table 
  
Attributes  
1 n 
1 
m 
Sets of objects  
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4.1.3. Phase 3: Feature selection via GA search optimization 
 
The first task of phase 3 is to determine the representation of chromosomes. There are 
different types of chromosome representations. These include binary, integer, real 
numbers, single character, and permutation representation. One of key components in 
application of GA is the representation of the solution using chromosomes (Qin, 1999). 
This is due to the fact that GA searches for solutions (chromosomes) to solve a problem, 
so it is very difficult for GA to find an optimal solution with an unsuitable chromosome 
representation for the specific problem. In fact “the use of different chromosome 
encoding schemes would lead to different search performances.” (Chaiyaratana, 
Piroonratana, & Sangkawelert, 2007, p. 3). 
 
The aim here is to process the d-Distinction table for sets of relevant features associated 
with high dimensional biomedical data using GA. In the studies of Felix and Ushio 
(1999), Duval & Hao (2010) and Perez and Marwala (2012), strings of n binary bits 
(binary chromosomes), e.g. {0 1 0 1 0 1 0 1 1 1 0 0}, were used to represent solutions 
for GA. The length n is the number of features (genes) in the dataset. That is, a binary 
chromosome represents a set of features and binary bits (gene values) of 0s in the 
chromosomes indicate features are not present (not selected for classification), and 
binary bits of 1s indicate features are present (selected for classification) in relation to 
the dataset (Banerjee et al., 2007; Deb & Reddy, 2003; Duval & Hao, 2010; Liu & Iba, 
2002; Perez & Marwala, 2012; Vafaie & De Jong, 1992). For example, a chromosome 
{0 1 0 1 0 1 0 1 1 1 0 0} represents a total of 12 genes in the dataset and genes with 
value of “1” (2nd, 4th, 6th, 8th, 9th and 10th genes) are used for classification, whilst genes 
with value of “0” are not used. The following sections detail the steps associated with 
the application of GA. 
 
a) Population initialization 
The population of chromosomes is initialized by randomly selecting sets (rows) of 
objects from a d-Distinction table generated from the RST step. The number of sets of 
objects selected randomly from the distinction table equals the population size. That is, 
the number of sets of objects are randomly selected depending on the size of the 
population, e.g., if the size of the population is set to 100 (100 chromosomes) then 100 
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sets of objects are selected randomly. The following figure describes the algorithm used 
to initialize the population. 
 
Input: 
 d-Distinction table (Td) of m rows and n columns 
 Size of population (p) 
Output: 
 An initialized population of p rows and n columns 
Steps: 
    1. Set chromosomes as strings of binary of length n 
    2. Set initial population of size p (Ip) = { } 
    3. For counter from 1 to p 
a. Generate an integer random number (Rn) in the range [1, m] using a  
RNG 
b. Search indexes of rows (sets of objects) in Td using Rn 
c. Select row[Rn] in Td 
d. Store the selected row to Ip  
 
Figure 4-7 Algorithm for initialisation of population using d-Distinction table 
 
b) Fitness evaluation 
Fitness function in RST-GA,    of a chromosome is defined using the formula shown in 
Equation (4.3). 
  = w1*   + w2*         (4.3) 
Where w1 and w2 are the weightings for    and   , respectively, with w1 + w2 =1 
    and   are the objective function 1 and 2, respectively 
   is an overall objective function  
The fitness of a chromosome,    is defined as an aggregation of two objective functions, 
   and   . The objective function    is for maximizing the fitness of chromosomes (sets 
of features) with the least number of “1”s (features), whilst objective function    is for 
maximizing the fitness of chromosomes that discerns the most number of objects, i.e, 
maximizing accuracy. Thus, the objective function,  ,  guides GA to find an optimal 
subset of relevant features that has the least number of features but gives higher 
accuracy in discerning between objects . 
 
Since the objective function is an aggregation of 2 objective functions, f1 and f2, 
associated weightings, w1 and w2, are assigned to    and   , respectively. These 
weightings of f1 and f2 would affect the search optimization process for finding optimal 
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chromosomes (solutions). Therefore, an empirical experiment for obtaining the 
appropriate values of w1 and w2 was conducted in this study. Different combinations of 
w1 and w2 values were applied, e.g., w1 = 0.1 and w2 = 0.9 or w1 = 0.2 and w2 = 0.8, etc. 
As a result, w1 = 0.9 and w2 = 0.1 were found to work best for the 2 datasets used in this 
study.  Coincidentally, these two weighting are the same as those used in Banerjee et al. 
(2007)’s experiment and allowed a comparison with results from Banerjee et al.’s. As 
RST-GA incorporated quartile statistics and K-means methods to partition data, an 
approach different from Banerjee et al., this comparison of results allows an 
examination of the effectiveness of using quartile statistics and K-means for partition 
data in phase 1 of the approach.  
 
Equation (4.4) and (4.5) define objective functions f1 and f2, respectively (Banerjee et 
al., 2007). 
 
      
 
→  = 
   
 
→
 
     (4.4) 
    
 
→  = 
 
 
→
       
     (4.5) 
where 
N is the length of the candidate chromosome 
 
 
→ is a number of “1”s in the candidate chromosome 
        are the number of objects belonging  to class 1 and 2, respectively 
 
 
→ is a number of objects distinguished by the candidate chromosome. 
 
The following Figure 4-8 describes the algorithm used to calculate the fitness of 
chromosomes. 
 
Input: 
 d-Distinction table (Td) of m rows and n columns 
 Initial population (p) 
Output: 
 Fitness of chromosomes as an array of p rows and n columns 
Steps: 
    1. Set Size = size of population, p 
    2. Set weighting for w1 and w2 with w1+w2=1 
    3. Set f = fitness of chromosome 
    4. Set fitness population (Fp) = { } 
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    5. For counter from 1 to Size 
a. Calculate objective function f1 using  Equation (4.4) 
b. Calculate objective function f2 using Equation (4.5) 
c. Calculate fitness of chromosome f using Equation (4.3) 
d. Store f into fitness population (Fp) 
 
Figure 4-8  Algorithm for fitness calculation using f1, f2 and f objective functions 
 
c) GA operators 
Selection, crossover and mutation operators for binary-value encodings are used in the 
proposed approach. Tournament selection is a simple but efficient operator that has 
been commonly used in the GA (Miller & Goldberg, 1995). In the proposed approach, 
the tournament selection is employed to select 2 chromosomes from the population for 
crossover operation. Two chromosomes are selected randomly from the population of 
size k, a fitter chromosome is then selected for crossover. The tournament selection has 
been described in Section 2.3.4.1. 
 
Single point crossover (Back, Hoffmeister, & Schwefel, 1991) is a technique that can be 
applied to binary value encodings to exchange parts of two chromosomes at a randomly 
selected crossover position. That is, 2 selected parents are split into 2 parts at the 
crossover position and then the second part of the 2 parents is inter-changed to produce 
2 offspring. Single point crossover has been described in Section 2.3.4.1 and is 
employed in this study to recombine the chromosomes using the probability rate (Pc) as 
listed in Table 4-1. 
 
Bit-flip mutation is the most common mutation operator used for binary encoded 
chromosomes. The bit value of a gene is flipped, i.e., if the bit value is 0 then change it 
to 1 and vice versa, independently based on a predefined mutation rate, (Eiben & Smith, 
2007). As a result, mutated offspring are produced by the process of mutation. The bit-
flip mutation has been described in Section 2.4.4.1 and is employed in this study to 
modify the chromosomes using the mutation rate (Pm) as listed in Table 4-1.  
 
d) New population generation 
The 2 best chromosomes are selected from the pool of parents and resulting offspring 
obtained from the previous step involving selection, crossover and mutation. These are 
then placed into the new population. Also a single elitist strategy is employed in this 
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study to allow the best candidate solution in the previous generation to be retained and 
placed into the new generation to improve the search in evolutionary algorithms (Ahn & 
Ramakrishna, 2010). The process of selection, crossover and mutation continue until the 
generation of the new population is completed. The following figure describes the 
procedure to generate a new population. 
 
  Input: 
Chromosome population (p) 
Fitness population (Fp) 
Crossover probability (Pc) 
Mutation probability (Pm) 
Elite chromosome (Elite) 
 
   Output: 
New population (Np) 
   Steps: 
1. Set Size = size of population, p 
2. Set new population (Np) = { } 
3. Store Elite into Np 
4. For counter from 1 to ½ Size 
     a. Select 2 parent chromosomes from p 
 Perform tournament selection to select parent1, parent2 
     b. Create 2 offspring chromosomes using parent1 and parent2 
b1. Generate a random number (Rn) in the range [0, 1] using RNG 
b2. If    Pc  ≥ Rn 
 Perform one point crossover on 2 parents to produce 2 offspring 
           b3. If    Pm  ≥ Rn 
 Perform bit-flip mutation on each bit of offspring  
       b4. Evaluate fitness of parent and offspring chromosomes 
       c. Store the best 2 chromosomes into Np 
 
Figure 4-9 Algorithm for generating a new population  
 
e) Checking for convergence in NSC-GA 
 
The process of fitness evaluation, selection, crossover, mutation and new generation is 
repeated until the convergence of population in fitness takes place or a predefined 
maximum number of generations have been executed. The procedure of verifying the 
convergence status and terminating the GA have been described in Section 3.3 and 3.4, 
respectively. Upon the convergence the fittest chromosome (optimal solution) is 
selected. 
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In order to evaluate the proposed approach, a suitable set of parameter values are needed 
for all the parameters associated with GA. The following section describes the parameter 
tuning process to obtain the best parameter set for GA. 
 
4.1.4. Parameter tuning for the GA 
 
Convergence of fitness in the GA is important as premature convergence will result in a 
local optimal solution. Parameter tuning for the GA is necessary to ensure that the 
algorithm has executed  using the best parameter setting, owing to the fact that the 
crossover probability (Pc) and the mutation probability (Pm) are vital for the optimal 
performance of the GA (M. Srinivas & Patnaik, 1994). Parameter tuning for Pc and Pm in 
this study is completed using the approach proposed by Srinivas and Patnaik (1994). 
This process involves varying different values of Pc and Pm, and observing the difference 
value between the average fitness (favg) and the maximum fitness value (fmax) of the 
population to verify the convergence status for GA (i.e. local or global convergence).  As 
a result of this parameter tuning, the best parameter values of Pc and Pm are found to be 
0.7 and 0.03, respectively. The complete set of parameter values used to run RST-GA in 
this study is shown in Table 4-1. 
 
Table 4-1 A set of parameters used to run GA 
Parameters Values / Methods 
Population Size 100 
Chromosome length -  
           Binary Encoding 
The number of reduced 
attributes (genes) 
Pc 0.7 
Pm 0.03 
Generation 1000 
Selection Tournament 
Crossover Single point 
Mutation Bit-flip 
Elitist Single 
 
 
  
88 
 
4.2. Experiment results 
 
 The proposed approach was evaluated using both the Colon and Leukemia cancer 
datasets described in Chapter 3. For each dataset, 15 independent runs of the proposed 
approach were executed using the respective training data. The optimal set obtained for 
each run was used to construct corresponding k-NN classifier with k = 1, 3, 5, and 7. The 
selected optimal set of features is evaluated using 10 fold CV strategy described in 
Section 3.2 and then further evaluated using unseen test datasets.  
 
Steps in conducting one run of the experiment involved: 
- Invoke the algorithm using an input training file and parameter setting file. The 
training dataset and unseen test dataset are prepared based on the procedure 
outlined in Section 3.1 and 3.2.   
- Use the optimal feature set, to construct corresponding k-NN classifier with k = 
1, 3, 5, and 7. Record results. Repeat this step using another training fold until 10 
fold CV has been completed. 
- Use the optimal feature set, to construct corresponding k-NN classifier with k = 
1, 3, 5, and 7 to classify the unseen test dataset respectively. 
 
The classification results for classifying the unseen test data using each of these k-NN 
classifiers were recorded and shown in Table 4-2. The following sections detail the 
results obtained from applying the approach on each of the two datasets. 
  
4.2.1. Alon et al. Colon cancer data 
 
Banerjee, et al. (2007) split the colon cancer dataset, with 50% for training and 50% as 
the unseen test dataset. Each of these two datasets consists of 20 Cancer (C1) samples 
and 11 Normal (C2) samples. In this study, the Colon cancer dataset was partitioned in 
the same way as that of Banerjee, et al.’s (2007). 
 
Using the parameter settings in Table 4-1 and the training data for the Colon cancer 
dataset, the optimal subset of features from each of the 15 independent runs of RST-GA 
were obtained, evaluated using 10 fold CV evaluation strategy described in section 3.2, 
as well as tested on the unseen test set. The k-NN classifier with different k values of 1, 
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3, 5 and 7 were used to classify the Colon unseen test dataset. The classification results 
obtained using the optimal set from each of the 15 independent runs on the unseen test 
data are shown in Table 4-2. 
 
 
Figure 4-10 A typical convergence plot for maximum fitness and (fmax – favg) associated 
with the Colon dataset 
 
A convergence plot from one of the typical runs is shown in Figure 4-10. As seen in this 
figure, the algorithm converged to a global optimum with the maximum fitness of 0.99 
(approaching the theoretical maximum fitness of 1). The values of (fmax – favg) was 
relatively high (values shown on the right-hand vertical axis) in the earlier generations 
(<5) and it decreases to values very close to zero after 17 generations. This value 
coincides with the maximum fitness value of 0.99.  Note that the convergence after 17
th
 
generations is due to the initial population of individuals being selected from the d-
Distinction table, which consists of chromosomes (binary strings) that have already been 
processed for redundancy reduction of features.   
 
Premature convergence occurs when the evolutionary algorithm (e.g. genetic 
algorithms) gets stuck in local optima and returns suboptimal solutions (Vanaret, 
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Gotteland, Durand, & Alliot, 2013). On achieving global convergence, the population is 
genotypically very similar, thus individuals in the population has very similar fitness 
value. The state of convergence of each of the 15 runs of RST-GA is evaluated using 
the check mechanism outlined in Section 3.4, and typically, a plot like the graph in red 
in Figure 4-10 is obtained for fmax - favg. In addition, to gain a understanding of the 
behaviour of RST-GA across the 15 run, a whisker plot for the maximum fitness value 
of all 15 runs is shown in Figure 4-11 . At the point of convergence, the fitness value 
approaches the theoretical maximum fitness of 1 and the spread of the fitness value is 
very small across the 15 runs for each of those generations, thus showing global 
convergence. 
 
 
Figure 4-11 A whisker plot for maximum fitness for 15 runs 
 
The fitness maximum value obtained at convergence for each of the 15 run of RST-GA 
for the Colon cancer dataset are 0.9907, 0.9917, 0.991, 0.992, 0.9907, 0.9914, 0.9914, 
0.9922, 0.9929, 0.9917, 0.992, 0.9898, 0.9896, 0.9902 and 0.9836 respectively.  The 
first value of 0.9907 is associated with Set 1 in Table 4-3, 0.9917 with Set 2, and the 
mapping of the sets following this order until with Set 15 being mapped to 0.9836. 
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Table 4-2 Results associated with RST-GA (proposed approach) and  from Banerjee, et 
al. (2007) using k-NN classifiers, with k=1, 3, 5, and 7 on the Colon unseen test set 
 
 
Table 4-2 shows the results obtained via RST-GA and those obtained in Banerjee, et 
al.’s study (2007). The column headings C1 and C2 in the table stand for classification 
accuracy (%) on the Colon unseen test dataset for the Cancer class and Normal class, 
respectively. The column heading “Net” stands for the overall classification (%) for all 
classes on the Colon unseen test dataset and “Net” is calculated using Equation (4.3).  
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Net (%)   
       
                 
     (4.3) 
 
where    is true positive for correct prediction to C1 class 
              is true negative for correct prediction to C2 class 
              is false positive for incorrect prediction to C1 class 
              is false negative for incorrect prediction to C2 class 
 
From 15 independent runs, RST-GA found 15 sets of features consisting of 1 set of 10 
features, 3 sets of 7 features and 11 sets of 6 features. Each of the 15 sets is used to train 
a k-NN classifier with k = 1, 3, 5, and 7 and each row of Table 4-2 is associated with the 
classification results obtained on the unseen test dataset. The row highlighted (in blue) 
in Table 4-2 shows the highest classification accuracy obtained for classifying the 
unseen test set. It can be seen that the proposed algorithm found a smaller set with 6 
genes that gave a higher classification accuracy in comparison to those  involving the 
larger set of 15 features reported by Banerjee, et al. (2007).  It is not possible to evaluate 
whether there are any commonality in the sets of features found by RST-GA, with the 
set obtained by Banerjee et al. (2007)  as the list of their 15 features is not listed in their 
paper.  
 
In addition to examining the importance of the classification performance of a set of 
features, its relevance to its corresponding domain is crucial. Table 4-3 lists the selected 
genes by accession numbers for the 15 sets found by the proposed approach.  As seen 
from the table, some genes are common across a number of these sets (e.g. H08393 are 
found in set 1, 3, 5, and 12). These are coded in the same colour in the table for ease of 
identifying them in the different sets.   
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Table 4-3 List of genes associated with the Colon Cancer dataset for each of the 15 
optimal sets of features obtained from 15 independent runs of RST-GA 
 
 
As seen in Table 4-3, the feature set obtained from each of 15 runs of the RST-GA is 
different, with only a small number of features in common across the different sets. This 
is due to a characteristic associated with feature selection methods, namely, the stability 
of feature selection methods. Stability is a term used to describe the sensitivity of a 
feature selection algorithm to small variations in the training data and in the settings of 
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the algorithmic parameters, resulting in different feature sets being produced by the 
algorithm. Small variations in the training data include using a different partition of data 
samples, reordering of samples and adding/removing a few samples. In addition, in 
stochastic algorithms, using different random seeds and different parameter values will 
also result in different results from the algorithm. Both Rough Set theory and the GA 
are algorithms known to have feature selection instability.  
 
An important point to note is that each execution of the RST-GA approach consists of 
three phases, and the application of GA is only in the third phase. The first two phases 
of RST-GA involved application of Rough Set Theory to generate the d-Distinction 
table, used as input,  in the third phase (i.e. the GA phase). The initialization of 
population in the third phase (i.e. GA phase) involved 100 individuals randomly 
selected from the d-Distinction table (e.g. in the case of the Colon Cancer dataset, size 
of the d-Distinction table = 480). Thus the input to the GA phase is different in each of 
the 15 runs (besides having the random seed being different). Given that the GA is a 
feature selection instability method, different results is obtained in different runs since 
the input data is different. Other potential causes for the feature selection instability here 
is due to redundancy of features in high dimensional biological datasets, where multiple 
features contribute to the same diseased effect and with the availability of only a small 
number of samples in relation to the high number of features as exemplified by 
microarray datasets. 
 
Set #3 (“Set #3” column highlighted Table 4-3) is one of the 15 sets selected using the 
proposed approach which gave the highest classification accuracy on the unseen test 
data. This set consists of 6 genes which have been reported in biomedical literature as 
being associated with cancer and other diseases. U31248 (Human zinc finger protein 
(ZNF174) mRNA) is related to the expression of colon tissues (Williams, Khachigian, 
Shows, & Collins, 1995). L08069 (Human heat shock protein, E. coli DnaJ homologue 
mRNA ) is not only “shown to increase tumorigenicity in rat colon cancer” 
(GSAEmulator, n.d.), but also associated with tumour development in human 
(Diesinger et al., 2002). H49870 (yo24h10.s1 Soares adult brain N2b5HB55Y) is 
involved in the detection of over-expression for olon cancer disease (Laping, 1999). The 
M18216  (Human nonspecific crossreacting antigen mRNA) is considered as a major 
component of Carcinoembryonic antigen involved in expression of lung cancer, tumour 
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specimens, and tumour cell lines at mRNA levels (Hasegawa et al., 1993), and also 
increasing level of expression in Colon cancer (Hinoda et al., 1997). H08393 
(yl92a10.s1 Soares infant brain 1NIB) is involved in the process of degrading activity 
of Colon cells.  It is also one of 66 differently expressed genes for Colon cancer data 
(Shaik & Yeasin, 2007).  M22538 (Human nuclear-encoded mitochondrial NADH-
ubiquinone reductase 24Kd subunit mRNA) is involved in schizophrenia, bipolar 
disorder, and Parkinson disease (Nishioka et al., 2010) and is the only feature of this set 
that has not been shown to have an established linked to some form of cancer. This 
result may be the trigger for biological studies to include this feature for subsequent 
investigations. 
 
Sensitivity and specificity associated with classification are two measures that are of 
great interest to the biomedical community in their efforts to find biological markers 
(also known as biomarkers) and to assess the utility of these biomarkers as to how well 
they can predict relevant outcomes.  Sensitivity represents the probability of correctly 
diagnosing a condition (i.e. the proportion of truly affected (i.e. diseased) in a sample 
population that is identified by the test as being diseased). On the other hand, specificity 
represents the proportion of truly non-diseased that the test identified as such. Ideally, a 
biomarker should have high sensitivity and high specificity – resulting in the majority of 
the truly at-risk cases being correctly identified, and the majority of the truly not-at-risk 
cases also correctly identified as not having the diseased condition.    
 
From Table 4-2, the k-NN classification results associated with each of the 15 sets of 
features mostly showed high sensitivity but low specificity, implying the majority of the 
truly at-risk cases will be correctly identified, but the majority of the truly not-at-risk 
cases will also be incorrectly identified as at-risk. For example, in the case of the 
highlighted row, sensitivity is 90% but specificity is only 72.7% for k = 1.  A further 
investigation was carried out using the same set of 6 genes and 22 different classifiers 
from WEKA software (Hall et al., 2009) to classify the unseen test dataset. WEKA is a 
data mining software program that has been developed and maintained by WEKA team 
since 1994 (Markov & Russell, 2006). WEKA consists of a large number of classifiers 
that can be used to analyse datasets and perform classification. WEKA classifiers used 
in the thesis are categorized into six types of classifiers including Function, Bayes, 
Lazy, Meta, Rules and Tree classifiers (Hall et al., 2009). Function classifiers are 
96 
 
simple and used for attributes with all numeric values, and a “linear boundaries between 
classes” strategy is used for classifying data. Bayes classifiers are implemented based 
on Bayes’s rule for probability and use density estimators to map attributes to the 
probability. Lazy classifiers are simple and use a distance function to measure the 
distance between data points and classify data. Meta classifiers use weighting or voting 
or ensemble schemes to classify data, for example, AdaBoost classifier classifies data 
based on the class with highest total weight (Witten & Frank, 2005). Rules classifiers 
use “a separate-and-conquer” strategy to identify rules for classifying data (Beasley, 
Martin, & Bull, 1993, p. 171). Tree classifiers use “the simple divide-and-conquer” 
strategy to generate decision trees for classifying data (Beasley et al., 1993, p. 159) . 
Further details of WEKA classifiers can be found in Witten and Frank (2005) and Hall 
et al. (2009). The aim here is to see if this trend (as in the case of k-NN) in terms 
sensitivity and specificity is a result of using a specific classifier, in this case k-NN 
classifiers. The classification results for the 22 classifiers constructed using the same set 
of 6 features as that in training the k-NN classifiers are shown in Table 4-4. Note that 
Multilayer Perceptron, Decorate, Random Committee and Random Forest are classifiers 
that may return (slightly) different results from different runs, thus, these classifiers 
were executed 10 times with different seeds and results with * is an average on these 10 
executions. 
 
As seen in Table 4-4, mixed results were obtained.  Using KStar (in bold) on the unseen 
test set produced results showing high sensitivity and high specificity (90%). However, 
there are also other classifiers showing behaviour similar to that of the k-NN classifiers. 
Also interestingly, there are a number of classifiers demonstrating higher specificity 
(shaded cells) than sensitivity. These results demonstrated that the use of specific 
classifiers may have an impact on the sensitivity and specificity. Thus in a DM analysis 
for finding suitable sets of biological markers, a number of classifiers should be used 
instead of just using one. This will avoid cases of missing out on sets of features with 
high discriminatory capabilities that should be further investigated in early diagnostic 
test developments but have been rejected on the basis of their sensitivity/specificity 
relating to a specific classifier.  
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Table 4-4 Results of classification for the 6 selected genes (highlighted in blue in Table 
4-2) with 22 WEKA classifiers on the Colon unseen test set 
Classifier 
Set of 6 genes 
C1 C2 
SMO 70 81.8 
Simple Logistic 65 100 
Logistic 65 100 
Multilayer Perceptron 83.5* 89* 
Bayes Net 85 18.2 
Naïve Bayes 80 63.6 
Naïve Bayes Simple 80 63.6 
Naïve Bayes Up 80 63.6 
IB1 90 72.7 
KStar 90 90.9 
LWL 70 63.6 
AdaBoost 80 63.6 
ClassVia Regression 80 63.6 
Decorate 85* 58.2* 
Multiclass Classifier 65 100 
Random Committee 77.5* 55.4* 
j48 90 54.5 
LMT 65 100 
NBTree 80 54.5 
Part 90 54.5 
Random Forest 79* 59.9* 
Ordinal Classifier 90 54.5 
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4.2.2. Leukemia cancer data 
 
Using the same approach as outlined in Section 4.2, 15 independent runs involving 
RST-GA were carried out using the parameter settings in Table 4-1 and the Leukemia 
training dataset. The optimal subsets of features were obtained and evaluated using 10 
fold CV evaluation strategy described in Section 3.2, as well as tested on the unseen test 
dataset. The k-NN classifier associated with each of the optimal subsets of features and 
with k values of 1, 3, 5 and 7 were used to classify the Leukemia cancer unseen dataset. 
A convergence plot from one of the 15 independent runs is shown in Figure 4-12 and 
the classification results of the 15 runs are shown in Table 4-5. 
 
 
Figure 4-12 A typical state of convergence plot for maximum fitness and (fmax – favg ) 
values associated with the Leukemia cancer dataset 
 
As seen in Figure 4-12, the algorithm converged to a global optimum with the maximum 
fitness value of 0.928. The value for (fmax – favg ) was relatively high (values shown on 
the right-hand vertical axis) in the earlier generations (<7) and  it decreases to values 
approximately close to zero around 64 generations. This value coincides with the 
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maximum fitness having a value of 0.928 (1 is the maximum). Similar to the Colon 
dataset, the convergence is also quick although it occurred after 64 generations in 
comparison with 17 generations for the Colon dataset. This is due to the fact that samples 
in the Leukemia dataset have a larger number of genes (features), 7129, compared to 
2000 features for the Colon cancer data. The 15 optimal sets of features obtained from 
15 runs for the Leukemia cancer data using RST-GA, consisted of 2 sets of 4, 6, 7, 10 
and 14 features, 3 sets of 5 features, 1 set of 11 features, and 1 set of 12 features. Each 
row in Table 4-5 is associated with classification results for the unseen test dataset using 
the k-NN classifier constructed from one of the 15 sets of features. The proposed 
algorithm found a set of 5 and 14 genes (rows highlighted in blue and green in the table, 
respectively)  that gave a similar classification accuracy compared to those involving 
the larger set of 19 genes reported by Banerjee, et al.(2007).  It is not possible to 
evaluate whether there are any commonality in the sets of features found by RST-GA, 
with the set obtained by Banerjee et al. as the list of their 19 features is not listed in 
their paper. Table 4-5 shows the classification accuracy for the unseen test data for the 
classifier associated with each of the 15 sets. The lists of genes associated with each set 
are shown in Table 4-6 by their accession number. Again, the differences between the 
sets of selected features from each of the 15 runs are due to the same reasons as outlined 
in the analysis of the Colon Cancer dataset. 
 
As seen from Table 4-5, the k-NN classification accuracies associated with classifiers of 
the set of 5 genes (the row highlighted in blue) and 14 genes (the row highlighted in 
green) obtained from RST are compatible with the classification accuracies associated 
with classifiers of the set of 19 features reported in Banerjee, et al. (2007).  
  
100 
 
Table 4-5 Results for RST-GA (proposed approach) and Banerjee, et al.(2007) using for 
k-NN classifier with k=1, 3, 5, and 7 on the Leukemia unseen test set. The column 
heading “Net” stands for the overall classification (%) for all classes on the Leukemia 
unseen test dataset and “Net” is calculated using Equation (4.3). 
Approach 
# 
attr 
k=1 k=3 k=5 k=7 
C1 C2 Net C1 C2 Net C1 C2 Net C1 C2 Net 
Banerjee 
et al. 
(2007) 
19 90 50 73.5 90 57.1 76.5 95 14.3 61.7 100 14.3 64.7 
RST-GA 
4 70 7.1 44.1 55 21.4 41.2 55 14.3 38.2 90 0 51.9 
4 85 35.7 64.7 85 35.7 64.7 90 28.6 64.7 95 35.7 70.6 
5 90 28.6 64.7 100 21.4 67.6 100 35.7 73.5 100 35.7 73.5 
5 65 42.9 55.9 90 14.3 58.8 95 21.4 64.7 95 21.4 64.7 
5 100 35.7 73.5 100 28.6 70.6 100 21.4 67.6 100 14.3 64.7 
6 75 42.9 61.8 85 0 50 95 0 55.9 96.3 45.5 55.9 
6 80 50 67.6 95 42.9 73.5 95 35.7 70.6 100 28.6 70.6 
7 70 50 61.8 95 28.6 67.6 80 35.7 61.8 85 7.1 52.9 
7 95 35.7 70.6 100 21 67.6 100 28 70.6 100 21.4 67.6 
10 95 28.6 67.6 95 14.3 61.8 95 21.4 64.7 96.3 27.3 61.7 
10 85 50 70.6 90 7.1 55.8 85 7.1 52.9 95 0 55.9 
11 75 42.9 61.8 95 35.7 70.6 95 35.7 70.6 95 28.6 67.6 
12 65 57.1 61.7 75 57.1 67.7 70 50 61.7 90 50 73.5 
14 85 50 70.6 95 57.1 79.4 95 50 76.5 95 50 76.5 
14 75 64.3 70.6 85 64.3 76.5 85 50 70.6 85 57.1 73.5 
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Table 4-6 List of 15 sets of genes selected for the Leukemia cancer dataset using RST-
GA. 
 
 
Table 4-6 lists the selected genes by accession numbers for the 15 sets found by RST. 
The highlighted columns (“Set #5” in blue and “Set #14” in green) in the table are the 
corresponding set of 5 and 14 genes associated with classifiers that produced 
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compatible unseen test classification accuracies in rows highlighted in blue and green, 
respectively, in Table 4-5. As seen from the table, some genes are common across a 
number of these sets, e.g., D64158 are found in Set# 3, 8, 10, 11, 12 and 14 (shaded 
cells). These common genes are coded in the same colour in the table for ease of 
identifying them in the different sets. 
 
As seen in from Table 4-6, Set #5 (“Set #5” column highlighted in Table 4-6) is one of 
the 15 sets obtained using the proposed approach, which gave a high classification 
accuracy with a smaller number of features. This set consists of 5 genes which have 
been reported in the literature as being associated with cancer: D10495 (protein kinase 
C delta-type) is the gene whose expression is commonly down-regulated in acute Adult 
T-cell leukemia (ATL) (Tsukasaki et al., 2004), D13628 (Angiopoietin 1) is the gene 
that is over-expressed in extramedullary plasmacytomas (Hedvat et al., 2003), D42072 
(Neurofibromatosis type 1 (NF1)) is known as an autosomal disorder gene and highly 
associated with malignancy (Suzuki et al., 1995), D50683 (Alteration of the 
tra sfor i g growth factor β ( G B)) is a down-regulated gene that  modifies 
expression and effects of TGFB in pancreatic carcinomas (Albrechtsson, Axelson, 
Heidenblad, Ludmilagorunova, & Höglund, 2001) and D83004 (ubiquitin-conjugating 
enzyme E2) is one of Atherosclerotic phenotype determinative genes that can be used in 
diagnosis, treatment and drug screening methods for Atherosclerosis (West, Nevins, 
Goldschmidt, & Seo, 2005). No existing information found to indicate its role in terms 
of this disease. 
 
Also seen in Table 4-5, similar to the Colon cancer data, the k-NN classification results 
associated with the selected set of 5 and 14 genes mostly showed high sensitivity but 
low specificity when classifying the unseen test data.   For example, the k-NN classifier 
involving the set of 5 selected genes showed 100% classification accuracy for C1 and 
35.7% for C2 ( i.e. high sensitivity and low specificity) . Further investigation, similar 
to that conducted with the Colon cancer dataset, was also carried out here using the sets 
of 5 and 14 genes to train  22 classifiers from WEKA and then to use them to classify 
the  Leukemia unseen test dataset.  The classification results of 22 classifiers are shown 
in Table 4-7.  
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Table 4-7 Results of classification for the 5 and 14 selected genes (highlighted in blue 
and green, respectively, in Table 4-6) with 22 WEKA classifiers on the Leukemia 
unseen test set 
Classifier 
Set of 5 genes Set of 14 genes 
 C1  C2  C1  C2 
SMO 100 14.3 95 64.3 
Simple Logistic 100 14.3 80 50 
Logistic 100 14.3 90 64.3 
Multilayer Perceptron 100* 7.1* 85* 64.3* 
Bayes Net 95 42.9 75 71.4 
Naïve Bayes 100 14.3 80 57.1 
Naïve Bayes Simple 100 14.3 80 57.1 
Naïve Bayes Up 100 14.3 80 57.1 
IB1 100 35.7 85 50 
KStar 95 14.3 100 42.9 
LWL 95 42.9 70 35.7 
AdaBoost 100 42.9 95 50 
ClassVia Regression 95 42.9 80 57.1 
Decorate 100* 24.6* 86.7* 62.7* 
Multiclass Classifier 100 14.3 90 64.3 
Random Committee 100* 13.4* 95.5* 45* 
j48 100 14.3 70 57.1 
LMT 100 14.3 80 50 
NBTree 100 14.3 80 57.1 
Part 100 14.3 70 57.1 
Random Forest 100* 17.3* 95.5* 46.4* 
Ordinal Classifier 100 14.3 70 57.1 
 
Again, it can be seen that the classification results of 22 WEKA classifiers constructed 
using the selected set of 5 and 14 genes showed mixed results in terms of sensitivity and 
specificity. The 22 classifiers associated with the set of 5 genes showed that they can 
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classify the diseased instances (C1) very well and are very poor in classifying the non-
diseased cases (C2) (i.e. high sensitivity and low specificity). For the classifiers 
associated with the set of 14 genes, most showed similar trends as the k-NN classifiers 
but one classifier (Bayes Net) showed similar specificity and sensitivity.  
 
4.3. Discussion  
 
As described in the previous section, the optimal set of features, generated from each 
independent RST-GA run, is then used with the training set to produce the various k-
NN classifiers. These classifiers are then used to classify the unseen test set, with the 
classification results reported in Table 4-2 and Table 4-5 for the Colon cancer and the 
Leukemia datasets respectively.  As shown in Table 4-3 and Table 4-6 
Table 4-6, the optimal set of features obtained from each independent run of RST-GA 
has differences and varying degrees of overlap in terms of the selected features. This is 
a typical outcome when using a non-deterministic approach such as RST-GA. Potential 
benefits include: 1) the generations of smaller sets of features, (e.g. sets ranging from 4 
to 14 features in comparison to the original dimensionality such as 7129 features in the 
Leukemia dataset), with high discriminatory capabilities that can be further investigated 
for early diagnostic test developments, and 2) examination of  the overlap between the 
sets of features which then can lead to construction of feature sets for further 
investigations.  
 
A number of observations emerged from examining the classification results in Table 4-
2 and Table 4-5 relating to the issues of sensitivity and specificity of a classifier 
associated with selected set of features. First, it can be seen that different classifiers, 
trained using the same set of features, can produce different values for these two 
measures in their evaluation of a test dataset. Second, as demonstrated in the analysis 
involving the Leukemia dataset, sets with different number of features (e.g. set of 5 and 
set of 14 genes) when used to train the same classifier will also produce different values 
for these two measures in their evaluation of a test dataset. For example in the case of 
the Bayes Net classifier, when trained with the set of 5 genes, the classification result 
showed high sensitivity (95%) and low specificity (42.9%) and when trained with the 
set of 14 genes, the sensitivity and specificity is not too different (75% versus 71.4 %). 
Yet, most of the remaining 21 classifiers when trained with the same set produced 
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classification results that showed high sensitivity and low specificity. This implies that 
decisions, in terms of evaluating sets of features to be further investigated in early 
diagnostic test developments, need to take into consideration these observations - to 
avoid eliminating potential sets of features during an early stage of investigation.   
 
The proposed approach, RST-GA can be used as an exploratory tool in terms of the 
generation of multiple optimal sets with the most relevant features. By utilizing these 
sets of features to train multiple classifiers and followed by classification on unseen test 
datasets would provide biomedical researchers with more information about selecting 
potential sets for further investigation. The comparison of classification results of these 
different optimal sets with different classifiers in conjunction with domain knowledge 
could be the starting basis for further investigations and developments leading to 
development of panels of biomarkers related to a disease. 
 
However, given the feature instability nature associated with RST-GA, resulting in 
feature sets obtained from each different runs of the RST-GA on a specific dataset being 
different and only having a small number of common features across the different sets.   
From examining the analysis involving two datasets, it was obvious that the degree of 
feature instability across different runs could be significant and the approach may not be 
most ideal to explore biomedical data for finding potential biomarkers. The decision 
was then to explore approaches that could work better with evolutionary approaches and 
with minimal feature instability. 
 
4.4. Summary 
 
This chapter describes the proposed approach of a hybrid algorithm (RST-GA) which 
incorporates GA and RST for finding the optimal subset of significant features. The 
approach utilizes the k-means clustering for getting the initial cluster centroids of each 
attribute for RST, the rough set-based approach for generating sets of good candidate 
solutions, and GA for finding the reducts (optimal subsets of features). The evaluation 
process used the same Colon and Leukemia cancer datasets as in Banerjee, et al. (2007). 
The set of 6 genes and 5 genes for Colon and Leukemia cancer data respectively, 
produced from the proposed approach, have similar classification results in comparison 
to those obtained by Banerjee, et al. (2007) using a larger number of features.  
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In the next chapter, an approach of incorporating the NSC algorithm with GA for 
searching for an optimal shrinkage threshold value that leads to the selection of an 
optimal set of features will be described. 
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5. Incorporating NSC and GA, NSC-GA 
 
5.1. Introduction 
 
Chapter 4 described an initial attempt in this study to develop FS techniques 
incorporating the use of evolutionary algorithms and RST for analysis of high-
dimensional biomedical data. One limitation of this approach is that the result of the 
optimal set of features obtained is not constant in every independent run. This is a 
typical issue when employing a non-deterministic algorithm such as GA. To ensure less 
variability in the optimal set of features from each independent run, a deterministic 
method can be incorporated in the approach. This chapter is an extended version of the 
paper “NSC-GA: Search for Optimal Shrinkage Thresholds for Nearest Shrunken 
Centroid” (Dang, Lam, & Lee, 2013). It describes the second approach in this study that 
incorporates EA and a deterministic algorithm for analysing biological data.  This 
hybrid approach incorporates the NSC method (Tibshirani et al., 2002) and GA to 
automatically search for an optimal range of shrinkage threshold values for the NSC. 
The optimal shrinkage thresholds obtained are used in NSC to obtain a set of features. 
The feature sets obtained using this hybrid approach has less variability as in NSC, 
shrinkage threshold values with small differences map to the same feature set . 
 
The NSC method, with its most well-known software implementation being known as 
Prediction Analysis for Microarrays (PAM), has been widely used as a FS and 
classification method for high dimensional biomedical data in numerous studies (Bair & 
Tibshirani, 2004; Klassen & Kim, 2009; Lee et al., 2005; Ravetti & Moscato, 2008; Ray 
et al., 2007; K. Y. Yeung & R. E. Bumgarner, 2003).  A shrinkage threshold value must 
also be provided to the NSC method as input and normally, this is selected manually by 
executing the NSC method many times using a number of predetermined shrinkage 
threshold values. The optimal shrinkage threshold value is then obtained by minimizing 
the cross-validated error rate on the training data.  This process can be time-consuming 
and the optimal shrinkage threshold value may be limited by the granularity of the 
predetermined values.  
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The selection of a shrinkage threshold value is crucial as the NSC works on the 
principle of shrinking the relative difference between the class centroid and the overall 
centroid of all classes, moving the class centroid towards the overall centroid of all 
classes using the shrinkage threshold value. 
 
Figure 5-1 Shrinkage of threshold of 2 class centroid toward overall centroid in NSC 
 
As seen in Figure 5-1, the class centroid  ik1 and  ik2 (associated with Class 1 and Class 
2 respectively) of attribute i are shrunk toward overall class centroid ( K) by a shrinkage 
threshold (∆) value iteratively. The relative difference, dik1and dik2, is the distance 
between the class centroid,  ik1 and  ik2, and the overall centroid,  k, respectively. If the 
relative difference of an attribute is shrunk to zero for all associated classes, then it is 
considered as not an important attribute and is eliminated (i.e. class centroids and 
overall class centroid are not different). Attributes with at least one positive relative 
shrunken class centroid are considered as important attributes and are selected (i.e. class 
centroids and overall class centroid are different). 
 
The shrinkage threshold value for NSC is important in terms of FS and classification as 
it affects the selection of features. Using inaccurate shrinkage threshold values will lead 
to irrelevant features being selected and subsequently will lead to a lower classification 
accuracy. Two approaches, CV (Tibshirani et al., 2002; S. Wang & Zhu, 2007; K. 
Yeung & R. Bumgarner, 2003) and empirical approach (Klassen & Kim, 2009; Levner, 
2005; Ray et al., 2007) are normally used to find the shrinkage threshold values.  With 
Relative 
difference 
(dik1) 
Relative 
difference 
(dik2) 
 (dik2 - ∆)  (dik1 - ∆) 
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the CV approach such as 10 fold CV, the dataset is divided randomly equal into 10 
parts, each part consists of approximate proportion of a number of samples and classes. 
One part takes turn to be the test set while the other 9 parts are used as the training set. 
The procedure is repeated 10 times to obtain the prediction error rate for each time.  The 
overall prediction error rate is then calculated by averaging the errors from all iterations. 
The selected optimal shrinkage threshold value is based on the CV prediction errors 
associated with the different shrinkage threshold values. The shrinkage threshold value 
that gives the minimum CV prediction error is selected as the optimal shrinkage 
threshold value. For example, in Tibshirani, Hastie, Narasimhan and Chu’s study (2002) 
the optimal shrinkage threshold value was chosen based on the average errors of a 10 
fold CV resulting in a set of 43 genes that was associated with the minimum CV errors.  
 
With the empirical approaches (Klassen & Kim, 2009; Levner, 2005; Ray et al., 2007), 
the optimal shrinkage threshold was selected based on the lowest classification error 
over a range of shrinkage thresholds. For example, in Levner’s study (2005), 
experiments were first carried out with 20 different shrinkage threshold values in the 
range of [0.5, 10] with increments of 0.5. This study also experimented with another 
200 different shrinkage threshold values in the range of [0.5, 10] with increments of 
0.05, and obtained the same classification results. In general, CV and empirical 
approaches for determining the optimal shrinkage threshold value are based on “trial 
and error”.  However, such shrinkage threshold values may not be precisely tuned for 
the specific dataset for obtaining optimal classification results. This is due to the fact 
that it is limited in terms of exploring the search space of shrinkage threshold values in 
relation to the dataset. It is vital to address the issues described above. Thus, a new 
approach incorporating GA for automatically searching for the optimal shrinkage 
threshold for the NSC is proposed in this study.  
 
Besides investigating evolutionary approaches for obtaining the shrinkage threshold 
values, similarity measures used in NSC is another area of investigation. The 
investigation is structured in the following way: the investigation of evolutionary 
approaches for the NSC and followed by investigation of the impact of different 
similarity measures. Chapter 5 and 6 described investigations involving GA and 
Memetic algorithm and followed by the description of investigations if similarity 
measures in Chapter 7.  
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The following section describes the proposed approach (NSC-GA) involving GA.  
Section 5.3 describes the parameter settings for GA. Using seven datasets described in 
Section 3.1, the performance of the proposed approach is examined using the evaluation 
strategy as described in Section 3.2. The evaluation results are reported in Section 5.4 
and the summary is in Section 5.5. 
 
5.2. The proposed approach, NSC-GA 
 
Figure 5-2 illustrates the framework of the proposed approach, NSC-GA that 
incorporates NSC and the GA to search for the best optimal range of shrinkage 
thresholds for the NSC algorithm. The basic concepts of NSC (Tibshirani et al., 2002) 
and GA (Goldberg, 1989) algorithms have  already been reviewed in Section 2.3.3, and 
2.3.4.1, respectively. 
 
The two main steps are: 
 
Step 1:  This step carries out the procedure of automatic calculation of Thmax. This 
procedure is performed once only at the beginning of the proposed approach, NSC-GA, 
to obtain Thmax. 
 
Step 2: The GA is employed in this step as an optimization method to search for optimal 
sets of shrinkage thresholds for NSC algorithm that lead to the selection of optimal 
subsets of features. Also in this step, the NSC algorithm is employed as a fitness 
evaluator to evaluate the fitness of each chromosome in terms of the number of selected 
features and its training classification accuracy. 
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Figure 5-2  Framework of the proposed approach, NSC-GA 
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5.2.1. Issues related to the proposed approach, NSC-GA 
 
Encoding chromosomes, estimating the initial range of values for the shrinkage threshold 
and fitness evaluation are the issues that need to be first addressed in NSC-GA. The 
following section describes these issues. 
 
5.2.1.1. Encoding chromosomes 
 
The aim of the proposed approach is to optimize a range of shrinkage threshold values 
consisting of real numbers for NSC. The most appropriate encoding representation for 
chromosomes in this study would be real-encoding. Each chromosome, consists of 
number of genes, representing a range of n shrinkage threshold values, e.g. {1.23 0.56 
4.23 5.32 6.0 0.87 in the case of n = 6}. This allows the optimization of a range of 
shrinkage threshold values and the use of the GA crossover operator. Without using 
crossover to recombine chromosomes, GA would rely solely on a mutation operator and 
has a higher probability of being stuck in a local optimum (Back et al., 1991).  
 
5.2.1.2. Estimate initial range of values for shrinkage thresholds 
 
Shrinkage threshold values of chromosomes are generated randomly using a RNG. 
Theoretically, shrinkage thresholds can be in the range [0, ∞]. However, in practice, 
there is a finite number of attributes associated with the dataset to be analysed. The 
lower limit (Thlower) associated with shrinkage thresholds is a value where all attributes 
from the dataset are selected and the maximum value (Thmax) is a value where only 1 
attribute is selected. The value Thlower is 0. Thus shrinkage threshold values in the range 
[0, Thmax] map to the search space of sets of features in NSC. In the proposed approach, 
a chromosome is a range of shrinkage thresholds, each shrinkage threshold maps to a 
subset of features, therefore each chromosome maps to a number of subsets of features. 
This mapping is different from the commonly used binary representation in FS in 
which, a chromosome is a string of binary (bit) of 0 and 1, and each gene (bit) value 
maps to 1 feature, with each chromosome mapping to only 1 set of selected features.  
To illustrate the impact of Thmax in the “time-to-convergence” in NSC-GA, Figure 5-3 
and Figure 5-4, respectively, showed examples of convergence plots of fitness from 
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executing NSC-GA with and without employing Thmax  when analysing the AD training 
data. 
 
 
Figure 5-3 Example of convergence plot for AD training dataset with the application of 
Thmax calculation using NSC-GA 
 
 
Figure 5-4 Example of convergence plot for AD training dataset without the application 
of Thmax calculation and Thupper > Thmax 
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As seen in Figure 5-3 and Figure 5-4, the algorithm achieved the same maximum fitness 
of 0. 887. However, it can be also seen that, with the application of the Thmax, the 
algorithm reached convergence much quicker, at the 47
th
 generation in comparison to 
the 916
th
 generation for the algorithm that did not use Thmax.  In this instance, the 
approach that did not use Thmax required more than 20 times the number of generations 
compared to the one using Thmax. The approach with the application of Thmax reached 
the fitness of 0.78 in the 1
st
 generation, while the other approach (without Thmax 
calculation) required 820 generations before reaching the same fitness value of 0.78. 
The algorithm without the application of Thmax spent much more computational time to 
obtain the same result as that of the one with Thmax calculation. This is not only 
unnecessary but also contradictory to attempts by many previous researchers whom 
have tried to develop algorithms or strategies to improve computational time for GA (Li 
and Love (1997), Ahujaa and Orlinb (2000), Ilonen, Kamarainen and Lampinen (2003), 
and Snyder and Daskin (2006). 
 
 
Figure 5-5 Example of convergence plot for AD training dataset without the application 
of Thmax calculation and the value of Thupper < Thmax 
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Figure 5-5 shows an example of the convergence plot of fitness for analysing the impact 
of Thmax, using the same Ray et al. training dataset as before and where the upper limit 
of shrinkage threshold value is less than the associated of Thmax value (i.e. the initial 
population of chromosomes is initialized to be in the range [0, thupper] (i.e. thupper < 
Thmax). As seen in this figure, the algorithm is stuck in a local optima and premature 
convergence occurred. A maximum fitness of 0.727 is obtained after running for a very 
large number of generations (100,000). The optimal shrinkage threshold obtained has 
resulted in a set of 48 features with corresponding classification accuracy of 86.95% on 
the unseen test set. In comparison, as demonstrated in Figure 5-3, a fitness of 0.887 
resulting in a set of 11 features with corresponding classification accuracy of 89.49% on 
unseen test data in the case involving the use of Thmax. 
 
Thmax is a simple procedure that involved a single iteration to calculate Thmax and the 
computational time to obtain Thmax is up to around 1 second for each of seven datasets 
using a personal computer i7, CPU speed of 3.4 GHz with 16 GB memory, Windows 7 
and NetBeans 7.2. The calculation of Thmax needed to be carried out once only for each 
dataset. For example, it took 0.0105 seconds to obtain Thmax for the Ray et al.  AD 
training dataset, 0.167 seconds for the Colon cancer dataset, 0.41 second for Leukemia, 
0.180 second for Lymphoma, 0.95 second for Lung cancer, 0.971 second for Prostate  
cancer and 1.06 seconds for Ovarian cancer dataset. It can also be seen that the 
application of Thmax in the proposed GA based approach maximizes the performance of 
the algorithm, resulting in a global convergence using less computational time. 
 
5.2.1.3. Fitness evaluation using NSC as a fitness evaluator 
 
The NSC algorithm as described in Section 2.3.3 was implemented and employed as a 
fitness evaluator in this approach to evaluate the fitness of the chromosomes using the 
training dataset.  
 
5.2.2. Steps in the proposed approach, NSC-GA 
 
The following sections describe the steps in NSC-GA. 
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5.2.2.1. Step 1: Thmax calculation 
 
To find the value of Thmax for the dataset in question, the approach estimates the value 
of Thmax using the procedure shown in Figure 5-6. 
 
Input 
        Training dataset (Ts) 
Output 
 Thmax value 
Steps 
      1. Generate a real random number (Rn) in the range [0,1] as an initial shrinkage  
threshold seed using RNG 
      2. Set Thmax = Rn 
      3. Perform NSC FS on Ts using Thmax to select a number of features (N)  
      4. Loop while n ≠ 1     
a. If no feature selected n = 0 
 Generate Rn 
 Decrease Thmax by Rn, Thmax = Thmax - Rn  
 Perform NSC FS on Ts using updated Thmax to select n 
b. Else  
 Generate Rn 
 Increase Thmax by Rn, Thmax = Thmax + Rn  
 Perform NSC FS on Ts using updated Thmax to select N 
      5. Return Thmax 
 
 
Figure 5-6 Algorithm for calculating Thmax  
 
As seen in the algorithm in Figure 5-6, the value of Thmax is adjusted up or down using 
steps of values associated with random numbers in the range [0, 1]. This process repeats 
until Thmax reaches the value that results in only one feature being selected using NSC, 
i.e., Thmax of the training dataset has been determined. 
 
5.2.2.2. Step 2: GA search optimization 
 
The following section describes steps involving the application of GA in NSC-GA. 
 
a) Population initialization 
After Thmax has been calculated, a population of chromosomes is then initialized. Each 
shrinkage threshold in a chromosome (essentially each chromosome represents a range 
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of values for shrinkage thresholds) is initialized to a real number, generated randomly in 
the range of [0, Thmax] using a RNG. The number of shrinkage threshold values in the 
chromosome equals to the length (n) of the chromosome, i.e. the number of genes in the 
chromosome. Theoretically, n can be as large as ∞, but in this proposed approach, n = 
10 is chosen. That is, each chromosome consists of 10 shrinkage thresholds. The size of 
10 is chosen empirically to balance the computational time and obtaining the optimal 
shrinkage threshold. For example, a chromosome of size 10 is illustrated as a range of 
10 real numbers, as follows. 
2.312 3.523 1.133 1.034 2.334 9.234 0.211 5.354 8.142 10.299 
 
Figure 5-7 describes the algorithm used to initialize the population and Figure 5-8 
shows an example of an initial population.  
 
   Input: 
Thmax 
Length of chromosome, n 
Size of population, p 
   Output: 
An initialized population of p rows and n columns  
   Steps: 
        1. Set population (Ip) as a 2 dimensional array of p rows and n columns of real  
numbers 
        2. Set Ip = { } 
        3. For counter1 from 1 to p 
3.1 For counter2 from 1 to n 
a. Generate a real random number (Rn) in the range [1, Thmax] using a  
RNG 
b. Store Rn to Ip[counter1][counter2] 
 
Figure 5-7 Initial population algorithm using RNG 
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Figure 5-8 An example of an initial population 
 
Figure 5-8 shows an example of an initial population of N chromosomes by M 
shrinkage threshold values. That is, each chromosome consists of M shrinkage 
thresholds. After the population has been initialized, the next step is to employ the NSC 
algorithm as a fitness evaluator to evaluate the fitness of each chromosome. 
 
b) Fitness evaluation 
GA was described in Section 2.4.4 and implemented, and employed in this study. The 
GA here uses an objective function to optimize the search for finding optimal shrinkage 
thresholds that leads to the selection of the smallest set of features with the highest 
classification accuracy. The objective function, f, is an aggregation of two fitness 
functions, f1 and f2, calculated using Equations (5.1), (5.2) and (5.3). 
 
        f = f1 + f2  (5.1) 
 
f1 = (Ntotal - Natt) / Ntotal (5.2) 
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f
 
  
     
           
  (5.3) 
 
 where Ntotal is the total number of attributes (features) of the dataset 
            Natt is the number of attributes selected by NSC  
            f2 is an overall training classification accuracy for the selected set of attributes  
   using NSC. 
            TP is true positive for correct prediction to the disease class 
            TN is true negative for correct prediction to the normal class 
            FP is false positive for incorrect prediction to disease class 
            FN is false negative for incorrect prediction to normal class 
 
f1 is computed based on the number of attributes selected over the total of number of 
attributes in the training dataset. That is, the smaller the set of features, the higher the 
fitness value for f1. Thus f1 is designed for evaluating the fitness of a shrinkage 
threshold that leads to a minimum number of attributes. 
 
f2 is computed based on the classification accuracy, associated with the training data, in 
the form of TP and TN over a total number of samples in the  training dataset (i.e. TP, 
FP, TN and FN). Thus f2 is designed for evaluating the fitness of a shrinkage threshold 
that leads to the maximum classification accuracy. 
 
Since each chromosome (range) consists of a number of shrinkage threshold values, 
therefore the overall fitness of a chromosome is calculated, as the average of fitness 
values associated with each of the shrinkage thresholds in the chromosome, using 
Equation (5.4). 
FitnessInd= ∑  
 
   th / M   (5.4)    
           
where M is the number of shrinkage thresholds in a chromosome. 
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c) GA operators 
Selection, crossover and mutation operators for real encodings are used in NSC-GA.  
The same tournament selection procedure employed in the RST-GA approach proposed 
in Chapter 4 is also employed here to select the parent chromosomes for crossover. 
 
The same single point crossover employed in Chapter 4 is used here to recombine the 2 
selected parent chromosomes to produce 2 offspring chromosomes using the probability 
of crossover (Pc) listed in Table 5-4. 
 
Uniform mutation (Eiben & Smith, 2007) is used for real-encoded chromosomes. 
Uniform mutation has been described in Section 2.4.4.1 and is employed here to modify 
offspring chromosomes using the mutation rate (Pm) listed in Table 5-4. Uniform 
mutation modifies a chromosome by replacing its gene value with a mutated number, 
Nmut , which is calculated using Equation (5.5). 
 
Nmut = Lb + (Rn * (Ub - Lb))     (5.5)  
 
where Lb is lower bound of chromosome, Rn is a random number generated by RNG, Ub 
is upper bound of chromosome. 
 
d) Generation of New population  
Two parents and 2 offspring chromosomes from the previous step involving selection, 
crossover and mutation are evaluated for their fitness and the best 2 chromosomes are 
selected and placed into the new population. A single elitist strategy is also employed to 
allow the best candidate solution in the previous generation to be retained and placed 
into the new generation to improve the search in evolutionary algorithms (Ahn & 
Ramakrishna, 2010). The process of selection, crossover and mutation iterates until the 
generation of the new population is completed. The procedure for generating a new 
population in NSC-GA is the same as the one in RST-GA (Figure 4-8), except that 
uniform mutation instead of the bit flip mutation is employed here.  
 
The following figure shows an example of the process of selection, crossover, mutation, 
in new population generation. 
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Figure 5-9 An example of creating a new population  
 
e) Checking for convergence in NSC-GA 
The process of fitness evaluation, selection, crossover, mutation and new population 
generation is repeated until the convergence of fitness takes place or if a predefined 
maximum number of generations have been executed. The procedure of verifying the 
convergence status and terminating the GA have been described in Section 3.3 and 3.4, 
respectively. Upon convergence, the fittest chromosome (optimal solution) is selected.  
 
The process of determining parameter settings used in NSC-GA is described in Section 
5.3. 
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5.3. Parameter settings for GA 
 
As discussed previously, one of the aims of this study is to investigate the incorporation 
of evolutionary algorithms in developing techniques for analysing high dimensional 
biological datasets. An aspect associated with the use of evolutionary algorithms 
involves finding appropriate values for its parameters (Eiben & Smith, 2003). 
Population size, crossover and mutation probability rate are some of the crucial 
parameters which affect the performance of evolutionary algorithms where their specific 
values may cause the algorithm either to converge to a local (premature convergence) or 
global optimal solution. This process is known as parameter tuning, in which 
appropriate parameter settings are determined to ensure that the algorithm will perform 
at its best (M. Srinivas & Patnaik, 1994).   
 
A traditional parameter tuning approach empirically finds a set of parameter values 
which is then subsequently applied to the evolutionary algorithm for processing the 
various problem instances. This is usually a very time-consuming and hard task 
(Nannen, Smit, & Eiben, 2008) as there are many choices of values associated with the 
parameters and little is known about the effect of these parameter values on the 
performance of the algorithm. Often this process is guided by conventions (e.g. low 
mutation rate), ad hoc choices and experimental comparisons carried out on a limited 
scale. Dovgan, Tu ar and Filipic (2011) carried out experiments, comparing parameter 
tuning methods for evolutionary algorithms and their findings showed that “there is no 
best value for each parameter, but there are wide ranges of good parameter values” 
(Franken et al., 2011, p. 2), and that there’s some value in conducting parameter tuning. 
Recently a study by Fraser and Arcuri (2011) confirmed that parameter tuning can have 
an impact on the performance of the evolutionary algorithm but if this is not performed 
properly, it is highly likely to result in obtaining parameter  configurations which are 
worse than values already found in the literature. One of the main conclusions from 
their study is that “using default values coming from the literature is a viable option” 
(Fraser & Arcuri, 2011, p. 26), specifically in the case where parameter tuning is 
expensive and the investigation is focused on examining the performance of new 
techniques (rather than comparisons between techniques). They argued that it would 
make more sense to use the available time for analysing a larger number of case studies 
than to spend that time on parameter tuning.   
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Section 5.3.1 describes the procedure for selection of the parameter settings which will 
be employed in approaches in the remaining part of this thesis. The outcomes of this 
process are presented in Section 5.3.2 with a summary of the results listed in Table 5-3. 
 
5.3.1. Parameter settings 
 
In order to find an appropriate set of values for the GA parameters, empirical parameter 
tuning involving 4 sets of commonly used parameter settings from the literature are 
conducted.  The  parameters that are tuned (highlighted in blue in Table 5-2) include 
population size, crossover probability rate (Pc), and mutation probability rate (Pm), with 
each set of these values being taken from DeJong (1975), Grefenstette (1986), Goldberg 
(1989), and Alander (1992) respectively (Table 5-2). These sets of parameter settings 
have been widely used in applications involving the GA and have been considered as 
“standard parameter values” for the GA (Harik & Lobo, 1999). The aim of the 
parameter tuning process in this study is to determine which of these four sets of 
“standard parameter values”, will encourage more exploration and less exploitation in 
the population, and achieves an appropriate balance between selection pressure and 
diversity so that global convergence can be achieved in a reasonable amount of time.  
 
In other words, during parameter tuning, the evaluation is on the suitability of each the 
sets of parameter values for one algorithm using specific datasets and the end product is 
a specific set of parameter values. Suitability is measured in terms of achieving 
maximum fitness at convergence and the required computation time. For example, we 
can have the situation where there are two sets where the algorithm can converge to the 
same maximum fitness but one set provides a lower selection pressure than the other and 
so may take a longer computation time to reach convergence. Obviously in this case, the 
set of parameter values that allowed the algorithm to converge to the same maximum 
fitness and using a shorter computation time will subsequently be chosen in the 
application of the algorithm to solve the specific problem. Thus, computation time in 
obtaining maximum fitness at convergence is used to evaluate one set of parameter 
values against another set.   
 
The tuning process involved separate trials that employ each of the 4 sets of parameter 
settings in the NSC-GA and for all the seven datasets described in Section 3.1. The 
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results obtained from these experiments are analyzed and the set of parameter values 
which gave the best results in terms of computational time for convergence and 
maximum fitness were then selected to be used in the proposed approaches in this study.  
 
An entire tuning trial involving each of the 4 parameter sets using each of the 7 datasets 
(i.e. 4 x (1 x7) = 28 runs) takes 119,339 minutes to complete. Owing to this lengthy 
computational time, three independent trials of the tuning process are carried out. The 
following table, Table 5.1, shows the computational time of using a personal computer 
i7, CPU speed of 3.4 GHz with16 GB memory, Windows 7 and NetBeans 7.2 for one 
trial involving each parameter setting for each dataset.  
 
Table 5-1 Computational time spent for one trial involving the 4 parameter settings 
Datasets 
Running time (minutes) 
Dejong (1975) Grefensette (1986) Goldberg (1989) Alander (1992) 
Ray et al.  AD 102 45 45 
64 
Alon et al. 
Colon 2241 644 724 
795 
Leukemia 2844 2314 1969 
4895 
Lung 11288 7721 6764 
10816 
Lymphoma 3377 1456 1086 
1625 
Ovarian 11180 7721 8596 
10026 
Prostate 5473 5352 3436 
6740 
 
 
Table 5-2 Four sets of parameter settings used in the tuning process 
 Dejong Grefensette Goldberg Alander 
Population size 50 30 30 50 
Pc 0.06 0.9 0.6 0.5 
Pm 0.001 0.01 0.033 0.002 
Maximum generations 5000 
Selection Tournament 
Crossover Single point 
Mutation Uniform 
Elitist One 
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5.3.2. Results of parameter tuning 
 
The following section presents the results from one typical independent trial.  For each of 
the seven datasets, NSC-GA is applied using each of the 4 sets of parameter settings 
shown in Table 5-2 for one typical trial. Plots demonstrating convergence of fitness 
associated with each of the 4 sets of parameter settings as well as a typical plot of the 
state of convergence associated with one set of parameter settings is shown for each 
dataset. A summary of the results for the 3 independent trials is also shown in Table 5-3. 
 
5.3.2.1. Ray et al. AD data 
 
 
 
Figure 5-10 Typical convergence of fitness plots for AD data associated with each of 
the 4 different parameter settings from DeJong, Genfenstette, Goldberg and Alander 
 
Figure 5-10 shows the convergence of fitness plots from running NSC-GA on the AD 
dataset using each of the 4 parameter settings from Table 5-2. The algorithm converged 
to the maximum fitness of 1.775 for each of the 4 sets of parameter settings. However, 
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the convergence associated with each of the 4 sets of parameter settings occurred at 
different generations. With DeJong’s set of parameter settings, convergence occurred 
after 197 generations and with Grefensette’s and Alander’s set of parameter settings, the 
convergence occurred after 64 and 162 generations, respectively. Whilst with 
Goldberg’s set of parameter settings, convergence occurred after 35 generations. With 
this dataset, the algorithm using Goldberg’s parameter settings outperformed the other 3 
sets of parameter settings in terms of obtaining the global optimum with the same 
maximum fitness value and a quicker convergence. 
 
The state of convergence associated with each run of the algorithm using one of the 4 
sets of parameter settings is monitored using Srinivas and Patnaik (1994)’s method, see 
Section 3.3. The red line plot in Figure 5-11 shows the difference between the maximum 
and average fitness of the population (i.e.  fmax – favg ) and demonstrates the state of 
convergence of the algorithm associated with using Goldberg’s parameter settings. The 
value of (fmax – favg ) is expected to be very small for a population that has converged to a 
global optimum than for a population with members spread over the entire search space.  
That is, a value closer to 0 would imply a convergence closer to the global optimum. 
 
 
Figure 5-11  An example plot of the state of convergence: (fmax – favg ) versus 
generations (using Goldberg’s set of parameter settings) 
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As seen in Figure 5-11, the value for (fmax – favg ) was relatively high (values shown on 
the right-hand vertical axis) in the earlier generations (<10) and  it decreases to values 
very close to zero around 35
th
 generations. This coincides with the maximum fitness of 
1.775.   
 
The following figure shows the state of convergence associated with one run of the 
algorithm for each of the 4 sets of parameter settings using Srinivas and Patnaik 
(1994)’s method. 
 
 
Figure 5-12 An example plot of the state of convergence: (fmax – favg ) versus generations 
for 4 sets of parameter settings 
 
As seen in Figure 5-12, the value for (fmax – favg ) was relatively high for each set of 
parameter settings in the earlier generations (<10) and  it decreases to 0 around 35 
generations for Goldberg’s parameter settings, 64 generations for Grefensette’s, 162 
generations for Alander’s and 197 generations for Dejong’s . 
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5.3.2.2. Alon et al. Colon cancer data 
 
 
 
Figure 5-13  Typical convergence of fitness plots for Colon cancer data associated with 
each of the  4 different parameter settings from DeJong, Grefenstette, Goldberg and 
Alander. 
 
Figure 5-13 shows the convergence of fitness plots of running NSC-GA on the Colon 
cancer dataset for each of the 4 sets of parameter settings. The algorithm converged 
with different maximum fitness values and involved a different number of generations 
for each of the 4 sets. With Goldberg’s parameter settings, convergence occurred after 
238 generations with the maximum fitness of 1.833, whilst with the other 3 sets of 
parameter settings,   their maximum fitness at convergence is lower than Goldberg’s 
value. In terms of the number of generations required for convergence, the algorithm 
took 2199 generations using DeJong’s set of parameter settings. In the case of using 
Grefenstette’s  and Alander’s set of parameter settings with the Colon cancer dataset, 
the algorithm required a smaller number of generations (in comparison to Goldberg’s 
set) to converge. Therefore the algorithm with Goldberg’s set of parameter settings 
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outperformed the other 3 sets of parameter settings in terms of obtaining a higher 
maximum fitness.  
 
5.3.2.3. Leukemia cancer data 
 
 
Figure 5-14  Typical convergence of fitness plots for Leukemia cancer data associated 
with parameter settings from DeJong, Grefenstette, Goldberg and Alander 
 
Figure 5-14 shows the convergence of fitness plots of running NSC-GA on the 
Leukemia cancer dataset for each of the 4 sets of parameter settings. The algorithm 
converged to the global optimum with the same maximum fitness of 1.973 for each of 
the 4 sets of parameter settings. However, the number of generations that the algorithm 
has to run to achieve convergence is different.   With Goldberg’s set of parameter 
settings, convergence occurred after 42 generations, with Grefenstette’s set of parameter 
settings, convergence occurred after 129 generations, with DeJong’s set, convergence 
occurred after 732 generations and lastly with Alander’s set, convergence occurred after 
1050 generations. Therefore the algorithm with Goldberg’s parameter settings 
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outperformed the other parameter settings in terms of obtaining the global optimum 
with the same maximum fitness but used less computational time. 
 
The state of convergence associated with each run of the algorithm using one of the 4 
sets of parameter settings for the Leukemia cancer data is also monitored using the 
method proposed by Srinivas and Patnaik (1994).  The plots obtained here for each of 
the 4 sets of parameters are similar in nature to that shown in Figure 5-11 and Figure 
5-12. 
 
5.3.2.4. Lung cancer data 
 
 
Figure 5-15 Typical convergence of fitness plots for Lung cancer data with 4 different 
parameter settings from DeJong, Grefenstette, Goldberg and Alander 
 
The convergence of fitness plots from running NSC-GA on the Lung cancer dataset for 
each of the 4 sets of parameter settings is shown in Figure 5-15. It can be seen that the 
algorithm converged with the same maximum fitness of 1.999 for each of the 4 sets of 
parameter settings. However, these convergence started at different generations; with 
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Goldberg’s set of parameter settings, the convergence occurred after 32 generations, 
with Grefenstette’s set of parameters, the convergence occurred after  60 generations, 
DeJong’s set parameters, the convergence occurred after 212 generations and Alander’s 
set of parameters, the convergence occurred after 155 generations. With this dataset, the 
algorithm using Goldberg’s set of parameter settings achieved the global optimum with 
the same maximum fitness. 
 
The state of convergence associated with each run of the algorithm using one of the 4 
sets of parameter settings for the Lung cancer data is again monitored.  The plots 
obtained here for each of the 4 sets of parameters are similar in nature to that shown in 
Figure 5-11 and Figure 5-12. 
 
5.3.2.5. Lymphoma cancer data 
 
 
Figure 5-16  Typical convergence of fitness plots for Lymphoma cancer data for each of 
the 4 sets of parameter settings: DeJong, Grefenstette, Goldberg and Alander. 
 
Figure 5-16 shows the convergence of fitness plots of running NSC-GA on the 
Lymphoma cancer dataset and each of the 4 sets of parameter settings. The algorithm 
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converged, producing the same maximum fitness of 1.968 for each of the 4 sets of 
parameter settings. However, the number of generations required for convergence 
differs, with Goldberg’s set of parameter settings, convergence occurred after 133 
generations, with Alander’s set of parameter settings, convergence occurred after  312 
generations, with Grefensette’s set of parameter settings, convergence occurred after 
387 generations and lastly with DeJong’s, the convergence occurred after 1217 
generations. Again, running the algorithm with Goldberg’s set of parameter settings on 
this dataset resulted in obtaining the global optimum. 
 
5.3.2.6. Ovarian cancer data 
 
 
Figure 5-17  Typical convergence of fitness plots for Ovarian cancer data using each of 
the 4 different parameter settings from DeJong, Grefenstette, Goldberg and Alander 
 
From Figure 5-17, it can be seen that the algorithm converged to different maximum 
fitness values for each of the 4 sets of parameter settings on the Ovarian cancer dataset.  
With Goldberg’s and Grefensette’s set of parameter settings, both achieved a maximum 
fitness of 1.989 but convergence occurred after 120 and 573 generations, respectively. 
Whilst with DeJong’s and Alander’s sets of parameter settings, convergence occurred 
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after 180 and 47generations, respectively and both with a maximum fitness value 
smaller than 1.989. In this instance, the algorithm using Goldberg’s set of parameter 
settings obtains a higher fitness value. 
 
5.3.2.7. Prostate cancer data 
 
 
Figure 5-18 Typical convergence of fitness plots for Prostate cancer data with 4 
different parameter settings from DeJong, Grefenstette, Goldberg and Alander  
 
As seen in Figure 5-18, the algorithm converged to the global optimum with the same 
maximum fitness of 1.94 for each of the 4 sets of parameter settings. Again, the 
algorithm using Goldberg’s set of parameter settings outperformed the other three sets 
of parameter settings in terms of computational time (faster convergence). 
 
The results of parameter settings using the 4 parameter settings of DeJong, Grefensette, 
Goldberg and Alander are summarized in Table 5-3. 
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Table 5-3 Summary of results of running the algorithm using each of the 4 sets of 
parameter settings for 3 independent runs 
 
From Table 5-3, it can be seen that the algorithm, using Goldberg’s set of parameter 
settings, consistently achieves maximum fitness in each of the three runs for all of the 
seven datasets. In comparison, the algorithm using any one of the remaining three sets 
of parameters only achieve similar results in some of the runs for some of the seven 
datasets. In addition, on examining Table 5-1, the algorithm using Goldberg’s set of 
parameter settings also consistently used least computation time to achieve 
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convergence. Based on these observations, Goldberg’s set of parameter settings is 
considered to be more suitable than the other three sets of parameter values.  
 
Note that while the number of generations has been provided in terms of when 
convergence starts to occur, it is not used to measure the performance of the algorithm. 
It is only used as an indicative measure of computation time associated with a set of 
values for GA parameters used by the algorithm against the seven datasets in this study 
as these seven datasets are of different complexity (varying from 120 variables in the 
AD dataset to 15154 in Ovarian cancer dataset). 
 
Given the lengthy computational time associated with the tuning process (see Table 5-1) 
and the aim of the study is to explore the feasibility of incorporating evolutionary 
approaches for finding interesting biomarkers that can differentiate between two classes 
(e.g. diseased vs. healthy) of biological data, a “near optimal” set of parameter settings 
that can be applied across a range of datasets and algorithms is acceptable.  This is 
unlike the case where the aim is related to comparisons between the performances of 
one evolutionary algorithm against another evolutionary algorithm (that is, to show the 
performance of one evolutionary algorithm as being superior), where it is then 
important to ensure parameters associated with each of these algorithms are optimally 
tuned. Arcuri and Fraser (2011) has argued that, in the case where parameter tuning is 
expensive and the investigation is focused on examining the performance of new 
techniques, using a set of default values is acceptable. Hence, Goldberg’s set of 
parameter settings will subsequently be used in the evolutionary-based approaches 
described in Chapter 5, 6 and 7 in this study.  The following table shows the complete 
set of parameter settings.  
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Table 5-4 Parameter settings used in Chapter 5, 6 and 7 
Parameters Values/operators 
Population Size 30 
Chromosome length  
- Real encoding 
10 
Crossover probability (Pc) 0.6 
Mutation Probability (Pm) 0.033 
Maximum generations 1000 
Selection Tournament 
Crossover Single Point 
Mutation Uniform 
Elitist Single 
 
Note that the set of parameters shown in Table 5-4 is the same as the one (Goldberg’s) 
in Table 5-2, except for the maximum number of generations which is now set for 1000 
instead of 5000. This is due to the fact that with the Goldberg’s parameter settings, the 
algorithm obtains the global optimum with the maximum fitness in less than 1000 
generations for all seven datasets, thus allowing some savings in computational time. As 
the approach also checks the state of convergence, the number of generations in specific 
instances can be varied if required. The set of parameter setting is to be selected on the 
basis that it consistently allows the algorithm to converge with maximum fitness using 
less computation time. 
 
5.4. Experiment results 
 
The proposed approach was evaluated using seven datasets: AD, Colon, Leukemia, 
Ovarian, Lymphoma, Lung and Prostate cancer datasets. For each dataset, 15 
independent runs of NSC-GA were executed using the respective training data and 
parameter values shown in Table 5-4. For each run, 10 fold CV strategy described in 
Section 3.2 was employed to evaluate the selected feature sets. The optimal set of 
features was then used to construct the NSC classifier to classify the unseen test data 
associated with the dataset. The classification results for classifying the unseen test data 
were recorded and the average classification result from 15 independent runs was 
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calculated. The following sections detail the results obtained from applying NSC-GA on 
each of the seven datasets. Where appropriate, the comparison of the performance of the 
proposed algorithm with existing work is based on classification accuracy and the 
selected feature sets. 
 
5.4.1. Ray et al.  Alzheimer’s Disease (AD) data 
 
As mentioned previously in Section 3.1.1, this dataset consists of 120 attributes. The 
training set consists of 43 AD and 40 NDC samples and 2 test sets: the AD test set 
consists of 42 AD, 50 NAD samples and the MCI test set consists of 22 AD and 25 
NAD samples. More details about this dataset can be found in Section 3.1. 
 
The optimal shrinkage thresholds obtained upon convergence were used to evaluate the 
training dataset first, and then applied to the unseen test dataset using the NSC 
classifier. A convergence plot from one of the typical runs is shown in  and results are 
in Table 5-5. 
 
Table 5-5 Classification results for the AD data using NSC-GA approach and from Ray 
et al. (2007) 
Approach 
Alzheimer 
AD MCI 
No of 
attributes 
Average classification 
accuracy on unseen 
test dataset (%) 
Average classification 
accuracy on unseen test 
dataset (%) 
Proposed approach 
NSC-GA 11 89.49 79 
NSC  (Ray et al., 
2007) 18 89 81 
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Figure 5-19 A typical convergence of fitness plot for the training set of AD 
 
As seen in Figure 5-19, convergence occurred after 28 generations with the maximum 
fitness of 1.775. Although convergence was achieved in 28 generations, the optimal 
solution actually involved a total of 8400 evaluations which is not a small number given 
that this dataset with only 120 variables is considered to be of “low dimensionality” 
relative to most other biological datasets. The length of chromosomes is 10, 
representing 10 shrinkage threshold values. With a population size of 30, the evaluation 
in each generation involved 30* 10 shrinkage threshold values. Convergence after 28 
generations would mean that a total of 8400 evaluations.  
 
The optimal chromosome obtained for each of the runs had the same maximum fitness 
of 1.775, which resulted in a set of 11 features. This set of 11 features (proteins) is a 
subset of the 18 biomarkers (proteins) found in Ray et al. (2007)’s experiment  and is 
shown in Table 5-6 . 
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Table 5-6 List of 11 proteins selected using NSC-GA 
Features (Proteins) 
PDGF-BB_1 RANTES_1 IL-1a_1 TNF-a_1 EGF_1 M-CSF_1 
ICAM-1_1 IL-11_1 IL-3_1 GCSF_1 ANG-2_1  
 
The same set of 11 proteins was obtained from each of the 15 independent runs. The 
average classification accuracy from 15 runs for the unseen AD test set was 89.49% and 
for the unseen MCI test set was 79% using the set of 11 proteins found in this study. 
These are similar to the result of 89% for unseen AD test set and 81% for the unseen 
MCI test dataset using 18 proteins obtained in Ray et al. (2007)’s study. The remaining 
7 proteins excluded here from the original 18 protein signatures (Ray et al., 2007) were 
also not included in the 6 and 5 protein signatures found in Ravetti and Moscato 
(2008)’s study. According to Ray and Wyss-coray (2010), TRAIL-R4 and IGFBP-6 
proteins from the  7 excluded proteins are optional in the list of biomarkers for a 
diagnostic analysis of AD. 
 
5.4.2. Alon et al. Colon cancer data 
 
The Colon dataset consists of 2000 attributes, 40 Tumour (T) and 22 Normal (N) 
samples. The training set consists of 30 T and 16 N samples, and the test set consists of 
10 T and 6 N samples. More details about this dataset can be found in Section 3.1. 
 
Using the same procedure, 15 independent runs of NSC-GA was executed with 10 fold 
CV using the Colon dataset with the GA parameter setting listed in Table 5-4. The 
optimal shrinkage threshold value from the fittest chromosome upon convergence was 
used to evaluate on the training dataset first, and then applied to the unseen test dataset 
using the classifier in the NSC.  A convergence of fitness plot from one of the typical 
runs is shown in Figure 5-20 and classification results using the optimal sets of features 
are in Table 5-7. 
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Table 5-7 Classification results, for the Colon data using NSC-GA approach, and from 
Klassen and Kim (2009) 
Approach 
Colon 
No of attributes Average classification 
accuracy on unseen test 
dataset (%) 
Proposed approach NSC-GA 
28 
6 
100 
93.75 
NSC  (Klassen & Kim, 2009) 16 75 
 
 
Figure 5-20 A typical convergence plot for the training set of Colon cancer data 
 
As seen in Figure 5-20, the convergence of fitness occurred after 362 generations with 
the maximum fitness of 1.833. Nine runs had the maximum fitness of 1.833 which gave 
the same set of 28 features (genes) for the Colon dataset. Six runs had the maximum 
fitness of 1.823 which gave the same set of 6 genes which is a subset of the 28 gene set. 
The average classification accuracy from 15 independent runs was 97.5% on the unseen 
test set (93.75% for 6 gene set and 100% for 28 gene set) in comparison to 75% 
classification accuracy using 16 genes reported in Klassen and Kim (2009)’s 
experiments. It is not possible to check the set of 28 and 6 genes found by the proposed 
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approach against the set of 16 genes from Klassen and Kim (2009) as these were not 
listed in their study. The set of 28 genes from this study are listed by their accession 
number in Table 5-8 (the highlighted genes belong to the set of 6 genes). 
 
Table 5-8  Twenty eight genes selected for Colon cancer data using NSC-GA 
Gene accession numbers 
T95018 X55715 M63391 H40560 T92451 T57619 R78934 
T58861 M26697 M76378 R87126 H43887 H64489 M22382 
T71025 Z24727 Z50753 X12671 T47377 L05144 H55758 
M64110 M76378 T60155 M76378 J02854 X86693 T60778 
 
 
5.4.3. Leukemia cancer data 
 
The Leukemia dataset consists of 7129 attributes, 47 ALL and 25 AML samples. The 
training set consisting of 27 ALL and 11 AML samples, and the test set consisting of 20 
ALL and 14 AML samples. More details about this dataset can be found in Section 3.1. 
 
Similar to the experiments above, 15 independent runs with 10 fold CV were carried out 
using the Leukemia dataset. A convergence of fitness plot from one of the typical runs 
is shown in Figure 5-21 and classification results on unseen test dataset are in Table 5-9. 
 
Table 5-9 Classification results for the Leukemia data using NSC-GA approach and 
from Tibshirani et al. (2002), Klassen and Kim (2009), S. Wang and Zhu (2007) and J. 
Fan and Fan (2008) 
Approach 
Leukemia 
No of 
attributes 
Average classification 
accuracy on unseen 
test dataset (%) 
Proposed approach NSC-GA 9 97.05 
NSC  (Tibshirani et al., 2002) 21 94.12 
NSC  (Klassen & Kim, 2009) 21 94.12 
ALP-NSC, AHP-NSC (S. Wang & Zhu, 2007) 16 94.12 
 FAIR (Fan & Fan, 2008) 11 97.05 
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Figure 5-21 A typical convergence plot for the training set of Leukemia cancer data. 
 
As seen in Figure 5-21, the convergence occurred after 109
 
generations with the 
maximum fitness of 1.973. The optimal shrinkage thresholds obtained from each of the 
15 independent runs had the same maximum fitness of 1.973 which produced the same 
set of 9 features (genes) for the Leukemia cancer dataset.  The set of nine features gave 
the classification accuracy of 97.05% on the unseen test dataset. Seven out of the nine 
genes listed in Table 5-10 (highlighted genes) are a subset of the 16 genes reported in S. 
Wang and Zhu’s study (2007).  Two genes having accession numbers M96326 and 
M28310 are not present in that set of 16 genes. It is not possible to check the set of 9 
genes found using NSC-GA against the set of 11 genes in J. Fan and Fan (2008) as 
these were not listed in their study. 
 
The proposed approach achieved a higher classification accuracy 97.05% using a 
smaller  number of genes, 9, as compared to 94.12% classification accuracy with 21 
genes reported in Tibshirani et al. (2002) and Klassen and Kim (2009), and 94.12% 
using 16 genes reported in S. Wang and Zhu (2007), and achieved the same 
classification accuracy of 97.05 but using the smaller set of 9 features compared to J. 
Fan and Fan (2008). The set of 9 genes from this study are listed by their accession 
number in Table 5-10. An interesting point here is, when comparing the results obtained 
via NSC-GA with those reported by Tibshirani et al. (2002), Klassen and Kim (2009), 
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and S. Wang and Zhu (2007); all involved the same method, NSC, with S. Wang and 
Zhu (2007) having made attempts to improve the the original NSC approach via 
adaptive L1-norm penalized NSC (ALP-NSC) and adaptive hierarchically penalized 
NSC (AHP-NSC).  The results reported  for NSC-GA is an average of 15 runs and is 
obtained by trying to automatically find the optimal value for the shrinkage threshold 
for the original NSC method. The NSC-GA results lends support to the hypothesis, “ an 
automatic approach that can effectively explore the search space to find a more precise 
shrinkage threshold value for NSC may result in an optimal value leading to a better 
classification result”, as it produced a shrinkage threshold value that leads to the 
selection of 9 genes with a classification accuracy of 97.05%. 
 
Table 5-10 Nine genes selected by the proposed NSC-GA for Leukemia cancer data 
Gene 
accession 
number 
Gene definition 
M27891 CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage) 
M84526 Human adipsin/complement factor D mRNA, complete cds 
M96326 Human azurocidin gene, complete cds 
U46751 
Phosphotyrosine independent ligand p62 for the Lck SH2 domain 
mRNA 
U50136 Leukotriene C4 synthase (LTC4S) gene 
X17042 Human mRNA for hematopoetic proteoglycan core protein 
X95735 Homo sapiens mRNA for zyxin 
M28310 Mus musculus 3/10 metalloproteinase inhibitor gene, exon 3 
Y00787 
Human mRNA for MDNCF (monocyte-derived neutrophil 
chemotactic factor) 
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5.4.4. Ovarian cancer data 
 
The Ovarian dataset consists of 15154 attributes, 162 Disease (D) and 91Normal (N) 
samples. The training set consists of 81 D and 45 N samples, and the test set consists of 
81 D and 46 N samples. More details about this dataset can be found in Section 3.1. 
Similar to the experiments above, 15 independent runs with 10 fold CV were carried out 
using the Ovarian dataset. A convergence of fitness plot from one typical run is shown 
in Figure 5-22 and classification results on the unseen test dataset are in Table 5-11. 
 
Table 5-11 Classification results for the Ovarian data using NSC-GA approach and 
from Foss (2010) 
Approach 
Ovarian 
No of attributes 
Average classification 
accuracy on unseen test 
dataset (%) 
Proposed approach NSC-GA 7 96.06 
GCLUS and SERA (Foss, 2010) 47 97.63 
 
 
Figure 5-22 A typical convergence plot for the training set of Ovarian cancer data 
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As seen in Figure 5-22, the convergence occurred after 115 generations at the maximum 
fitness of 1.989. The optimal shrinkage thresholds obtained for each of the 15 
independent runs had the same maximum fitness of 1.989 which produced the same set 
of 7 features (peptides), MZ244.36855, MZ244.66041, MZ244.95245, Z245.24466, 
MZ245.8296, MZ245.53704 and MZ246.12233. These 7 peptides are a subset of 47 
peptides reported in Foss (2010). Six peptides (in bold) are among the top 10 peptides 
reported in Yap, Tan and Pang (2013). The average classification accuracy  from 15 
independent runs on the Ovarian unseen test dataset using this set of 7 selected peptides 
was 96.06%, compared to 97.63% using the set of 47 peptides using the Implementation 
of the MAXCLUS framework (GCLUS) and Statistical Error Rate estimation 
Algorithm (SERA) in Foss (2010).   
 
5.4.5. Lymphoma cancer data 
 
The Lymphoma dataset consists of 4026 attributes, 24 GGL and 23 ACL samples. The 
training set consisting of 17 GCL and 17 ACL samples, and the test set consisting of 
seven GGL and six ACL samples. More details about this dataset can be found in 
Section 3.1. 
 
Fifteen independent runs with 10 fold CV were carried out using the Lymphoma 
dataset. A convergence of fitness plot from one of the typical runs is shown in Figure 
5-23 and classification results on unseen test dataset are in Table 5-12. 
 
Table 5-12 Classification results for the Lymphoma data using NSC-GA approach and 
from Klassen and Kim (2009) 
Approach 
Lymphoma 
No of attributes 
Average classification 
accuracy on unseen test 
dataset (%) 
Proposed approach NSC-GA 
7 
12 
128 
129 
132 
95.45 
95.45 
100 
100 
100 
NSC  (Klassen & Kim, 2009) 25 86.6 
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Figure 5-23 A typical convergence plot for the training set of Lymphoma cancer data 
 
As seen in Figure 5-23, the convergence occurred after 145 generations with the 
maximum fitness of 1.968. From the 15 independent runs, 10 runs resulted in a 
shrinkage threshold that mapped to the same set of 128 features, one run resulted in a 
set of 129 features, one run resulted in a set of 132 features, one run gave a set of 7 
features, and one run gave a set of 12 features. The set of 128, 129 and 132 features 
leads to the same classification accuracy of 100% and the set of 7 and 12 features 
resulted in the same classification accuracy of 95.45 on the unseen test set. The average 
classification accuracy from 15 runs was 99.39% on the unseen test set. The smaller set 
of features is a subset of the larger set, e.g., set of 7 features is a subset of the set of 12 
features and both are subsets of the set of 128 features.  Biomedical domain knowledge 
can be used to examine these sets further to make better informed decision for 
subsequent diagnostic test development. The set of 7 and 12 genes are listed by their 
accession number in Table 5-13. 
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Table 5-13 The sets of 7 and 12 genes selected by NSC-GA for Lymphoma cancer data 
Gene accession 
number 
Set 
12 genes 7 genes 
GENE3327X √ √ 
GENE3329X √ √ 
GENE3330X √ √ 
GENE3332X √ √ 
GENE3361X √ √ 
GENE3258X √ √ 
GENE3256X √ √ 
GENE3328X √  
GENE3314X √  
GENE3260X √  
GENE1252X √  
GENE3967X √  
 
5.4.6. Lung cancer data 
 
The Lung dataset consists of 12533 attributes, 150 ADCA and 31 MPM samples. The 
training set consisting of 134 ADCA and 15MPM samples, and the test set consisting of 
16 ADCA and 16 MPM samples. More details about this dataset can be found in 
Section 3.1. 
 
Fifteen independent runs with 10 fold CV were carried out using the Lymphoma 
dataset. A convergence of fitness plot from one of the typical runs is shown in Figure 
5-24 and classification results on unseen test dataset are in Table 5-14. 
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Table 5-14  Classification results for the Lung data from NSC-GA approach and from 
Klassen and Kim (2009), Tai and Pan (2007) and J. Fan and Fan (2008) 
Approach 
Lung 
No of attributes Average 
classification 
accuracy on 
unseen test 
dataset (%) 
Proposed approach NSC-GA 
8 
9 
10 
11 
100 
NSC  (Klassen & Kim, 2009) 5 93.7 
Weighted NSC (Tai & Pan, 2007) 6 99.99 
 FAIR (Fan & Fan, 2008) 31 95.3 
 
 
Figure 5-24 A typical convergence plot for the training set of Lung cancer data 
 
As seen in Figure 5-24, the convergence occurred after 88 generations with the 
maximum fitness of 1.999. Three runs resulted in the same set of 8 features for the Lung 
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cancer dataset, 6 runs resulted in a set of 9 features, 2 runs resulted in a set of 10 
features and 4 runs resulted in a set of 11 features. The average classification accuracy 
of the sets of 8, 9, 10 and 11 features is 100% on the unseen test set. The set of 8, 9, 10 
and 11 listed by their accession genes are number in Table 5-15. 
 
Table 5-15 The sets of 8, 9, 10 and 11 genes selected by NSC-GA, for Lung cancer data 
Gene accession number 
 
Set 
11 genes  10 genes 9 genes 8 genes 
32551_at √ √ √ √ 
33328_at √ √ √ √ 
34320_at √ √ √ √ 
36533_at √ √ √ √ 
37157_at √ √ √ √ 
37716_at √ √ √ √ 
37954_at √ √ √ √ 
40936_at √ √ √ √ 
33833_at √ √ √  
33327_at √ √   
35823_at √    
 
 
5.4.7. Prostate cancer data 
 
The Prostate dataset consists of 12600 attributes, 77 Tumour (T) and 59 Normal (N) 
samples. The training set consisting of 52 T and 50N samples, and the test set consisting 
of 25 T and 9 N samples. More details about this dataset can be found in Section 3.1. 
 
Fifteen independent runs with 10 fold CV were carried out using the Prostate dataset. A 
convergence of fitness plot from one of the typical runs is shown in Figure 5-25 and 
classification results on the unseen test dataset are in Table 5-16. 
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Figure 5-25 A typical convergence plot for the training set of Prostate cancer data 
 
As seen in Figure 5-25, the convergence occurred after 99 generations with the 
maximum fitness of 1.94. The optimal shrinkage thresholds obtained for each of the 15 
independent runs had the same maximum fitness of 1.94 which produced the same set 
of 6 genes, 31444_s_at, 41468_at, 37639_at, 38406_f_at, 769_s_at and 556_s_at. The 
average classification accuracy using the 6 gene set from 15 runs on the unseen test set 
was 90.2%, as shown in Table 5-16. 
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Table 5-16 Classification results for the Prostate data from NSC-GA approach and from 
Klassen and Kim (2009), Tai and Pan (2007) and J. Fan and Fan (2008) 
Approach 
Prostate 
No of 
attributes 
C1 
(Tumour) 
C2 
(Normal) 
Average 
classification 
accuracy on 
unseen test 
dataset (%) 
Proposed approach NSC-GA 6 80 100 90.2 
NSC  (Klassen & Kim, 
2009) 
6  
 
90.91 
Weighted NSC (Tai & Pan, 
2007) 
10  
 
60.51 
 FAIR (Fan & Fan, 2008) 2   73.52 
 
The column headings C1 and C2 in the table stand for average classification accuracy 
(%) on the Prostate unseen test dataset for the Tumour class and Normal class, 
respectively. The column heading “Average Test” stands for the overall average 
classification accuracy (%) on the Prostate unseen test dataset for the 15 independent 
run. “Average Test” is calculated using Equation (5.3).  
 
A summary of the results for the AD, Colon, Leukemia, Ovarian, Lymphoma, Lung and 
Prostate cancer datasets are shown in Table 5-17. 
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Table 5-17 Classification results for AD, Colon, Leukemia, Ovarian, Lymphoma, Lung and Prostate cancer data using NSC-GA 
Approach 
Alzheimer 
Colon Leukemia Ovarian Lymphoma Lung Prostate 
AD MCI 
 No 
attr 
Test 
(%) 
Test 
(%) 
No 
attr 
Test 
(%) 
No 
attr 
Test 
(%) 
No 
attr 
Test 
(%) 
No 
attr 
Test 
(%) 
No 
attr 
Test 
(%) 
No 
attr 
Test 
(%) 
Proposed approach 
NSC-GA 
 
11 
 
89.49 
 
79 
 
28 
 
6 
 
100 
 
93.75  
 
 
 
9 
 
97.05 
 
7 
 
96.06 
 
7 
12 
128 
129 
132 
 
95.45 
 
100 
 
 
 
8 
9 
10 
11 
 
100 
 
6 
 
90.2 
NSC  (Ray et al., 2007) 18 89 81       
      
NSC  (Tibshirani et al., 
2002) 
     21 94.12   
      
NSC  (Klassen & Kim, 
2009) 
   16 75 21 94.12   25 86.6 5 93.7 6 90.91 
ALP-NSC, AHP-NSC 
(S. Wang & Zhu, 2007) 
     16 94.12   
      
Weighted NSC 
(Tai & Pan, 2007) 
         
  
6 99.55 10 60.51 
 FAIR 
(Fan & Fan, 2008) 
     11 97.05   
  
31 95.3 2 73.52 
GCLUS & SERA (Foss, 
2010) 
       47 97.63 
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5.5. Discussion 
 
Table 5-17 shows a summary of experimental results achieved by the proposed 
approach, NSC-GA in comparison to existing work that used the same datasets. The 
classification accuracy rate reported for each dataset for NSC-GA is based on the 
average classification accuracy of 15 independent runs. NSC-GA achieved similar 
classification results as in Ray et al. (2007) on AD and MCI independent test datasets, 
and also improved FS and/or classification accuracy on the other 6 datasets in terms of 
obtaining smaller sets of features and higher or similar classification accuracy on unseen 
test sets compared to the  existing results (as reported in Klassen and Kim (2009), S. 
Wang and Zhu (2007), J. Fan and Fan (2008), Foss (2010), and Tai and Pan (2007)). 
For example, for the Leukemia cancer dataset, NSC-GA obtained a smaller set of 9 
features and higher classification accuracy of 97.05% and for the Ovarian cancer 
dataset, a smaller set of 7 features was obtained with the similar classification accuracy 
of 96.06%.  In terms of the Lung cancer dataset, Tai and Pan (2007) achieved 99.55 
using a set of 6 features whereas in NSC-GA using 8 features to obtain 100% 
classification accuracy. However, as the actual features used have not been listed in Tai 
and Pan’s paper. It is not possible to compare the results in terms of the actual features. 
 
When comparing results obtained via NSC-GA with other NSC-based approaches 
(Tibshirani et al. (2002), Klassen & Kim (2009), S. Wang & Zhu (2007)), it can be seen 
that  NSC-GA generally found optimal feature sets that have a smaller number of 
features and better classification results. This outcome is achieved by using GA to 
automatically explore the search space to find a more precise shrinkage threshold value 
for NSC, thus overcoming limitations typically associated with “trial and error” 
approaches. Unlike approaches (e.g. S. Wang & Zhu (2007)) that attempts to improve 
the performance of NSC by modifying it, this result is obtained using the original NSC 
algorithm, thus potentially the proposed approach can also be incorporated into 
modified NSC for further improvements. 
 
Having information as shown in Table 5-17, with the Colon, Lymphoma and Lung 
cancer datasets, each are associated with multiple sets of features which are subsets of 
each other. This allows the domain expert to make informed decision in terms of sets of 
features that could be selected for further investigations. For example, in the case of the 
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Colon cancer dataset, one can make decisions based on the tradeoffs between 
classification accuracy and size of feature set. It can be seen that in the case of the 
Lymphoma cancer dataset, the set of 6 features resulted in the same classification 
accuracy as the set of 12 features (i.e. 95.45%). The domain expert can examine the 6 
additional features in the set of 12 and use domain knowledge to decide on their 
potential relevance and make decision on subsequent analysis. Equally it is interesting 
to further analyse the Lung cancer dataset where sets with 8, 9, 10 and 11 features 
respectively resulted in classifiers producing the same classification accuracy on the 
unseen test dataset (100%). It appears that a major contributing factor relates to 8 
features and thus may warrant further investigations into the relevance of the remaining 
features. This sort of information for analysis in bioinformatics is important as reducing 
the number of features to a smaller promising set for further investigations would 
reduce costs associated with future experiments and analysis. The set of selected 
features from a biological perspective implies that the level of expressions associated 
with the selected biomarkers differ significantly between disease and non-disease. 
 
From Table 5-16, the NSC classification results associated with the set of 6 features 
mostly showed high specificity but low sensitivity, e.g., sensitivity (C1) is 80% but 
specificity (C2) is 100%, implying the majority of the truly not-at-risk cases will be 
correctly identified, but some of the truly at-risk cases will also be incorrectly identified 
as not-at-risk.  Continuing the investigation about classifier bias that was initiated in 
Chapter 4, further analysis is carried out using the Prostate cancer data and the 
corresponding set of 6 genes identified via NSC-GA. This set of features are used to 
construct 22 different classifiers from WEKA software (Hall et al., 2009) for  
classifying the unseen test dataset. The aim here is to further examine the trend 
observed in Chapter 4 in terms sensitivity and specificity being associated with specific 
classifiers (in this case NSC). The classification results from 22 different classifiers are 
shown in Table 5-18. 
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Table 5-18 Results of classification for the 6 selected genes with 22 WEKA classifiers 
on the Prostate unseen test set 
Classifier 
Set of 6 genes 
C1 (%) C2 (%) Average (%) 
SMO 80 96.2 88.2 
Simple Logistic 88 100 94.1 
Logistic 80 92.3 86.3 
Multilayer Perceptron* 88.8 98.8 93.9 
Bayes Net 80 88.5 84.3 
Naïve Bayes 92 92.3 92.2 
Naïve Bayes Simple 92 88.5 90.2 
Naïve Bayes Up 92 92.3 92.2 
IB1 84 92.3 88.2 
KStar 68 96.2 82.4 
LWL 84 92.3 88.2 
AdaBoost 92 92.3 92.2 
ClassVia Regression 92 92.3 92.2 
Decorate* 82 94.35 88.2 
Multiclass Classifier 80 92.3 86.3 
Random Committee* 92 88.8 90.4 
j48 92 88.5 90.2 
LMT 96 88.5 92.2 
NBTree 72 92.3 82.4 
Part 92 88.5 90.2 
Random Forest* 92.8 91.55 92.2 
Ordinal Classifier 92 88.5 90.2 
 
Mixed results, with regards to the classifiers used and their corresponding sensitivity 
and specificity, were obtained.  Naïve Bayes, Naïve Bayes Updateable, AdaBoost and 
ClassVia Regression (in bold) produced results showing high sensitivity (92%) and high 
specificity (92.3%). However, there are also other classifiers showing behaviour similar 
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to that of the NSC classifiers (i.e. lower sensitivity and higher specificity). Also 
interestingly, there are a number of classifiers demonstrating higher sensitivity (shaded 
cells) than specificity. These results demonstrated that the use of specific classifiers may 
have an impact on the sensitivity and specificity obtained using a set of features in 
classification. Thus in a DM analysis for finding suitable sets of biological markers, a 
number of classifiers should be used instead of just using one. This will avoid missing 
out on sets of features with high discriminatory capabilities that should be further 
investigated in early diagnostic test developments.  
 
5.6. Summary 
 
This chapter describes the proposed approach of incorporating NSC and a single 
objective algorithm, GA, to overcome the limitations of previous approaches such as 
empirical methods with NSC, by 1) searching automatically for the optimal shrinkage 
threshold value for NSC, and 2) obtaining the optimal set of minimal number of features 
for higher classification results. This advantage here is due to the fact that the proposed 
approach employs GA as a search algorithm to find optimal shrinkage thresholds based 
on the fitness evaluation from the NSC. An additional advantage of the proposed 
approach is the use of computers to run the algorithm for finding the optimal shrinkage 
threshold values automatically. This is unlike the traditional NSC approach involving 
manual shrinkage threshold value selection where the user spends a lot of time and 
effort to choose the optimal shrinkage threshold value via trial and error.  
 
A further analysis was also carried out on the Prostate cancer data using the same set of 
6 genes to construct 22 different classifiers from WEKA software (Hall et al., 2009) to 
investigate the impact of using different classifiers on sensitivity and specificity.  
 
To continue the exploration of evolutionary approaches for FS in biological data, the 
following chapter describes an approach incorporating MA for automatically finding 
optimal shrinkage thresholds for NSC, an attempt to further improve upon the NCS-GA 
approach described in this chapter. 
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6. Incorporating the NSC algorithm into MA 
 
Chapter 5 described an approach incorporating NSC into GA (NSC-GA) to 
automatically search for optimal shrinkage thresholds in NSC leading to the selection of 
optimal sets of features with better classification accuracy. According to Elbeltagi, 
Hegazy, & Grierson (Elbeltagi et al., 2005), computation time associated with GA 
processing is intensive.  One of the factors that contribute to the quality of optimal 
solutions in EA is the evaluation of fitness of individuals in the population. That is, the 
better the fitness evaluation the better the quality of the optimal solution. One of the 
approaches to improve GAs both in processing time and quality of optimal solutions is 
the use of a MA (Elbeltagi et al., 2005).  MA (Albrechtsson et al., 2001) is a hybrid 
algorithm that incorporates an EA and a local search (LS) to search for a local optimum 
to further improve its fitness (Elbeltagi et al., 2005; Krasnogor & Smith, 2005; Wu, 
2001b). As a result of increased exploitations, fitness of each chromosome is improved 
significantly in each generation, leading to a faster convergence in population fitness, 
and subsequently, computation time for the evolutionary process is reduced. The quality 
of the optimal solution could also be improved owing to the fact that chromosomes have 
already been evaluated locally by LS before being subjected to a global search for the 
optimal solution.  
 
In this chapter, an approach of incorporating the NSC algorithm into a MA, namely 
NSC-MA, for automatically searching for an optimal range of shrinkage threshold 
values is proposed. The aim here is to explore how to improve the NSC-GA approach.  
 
MA has been described in Section 2.3.5. The following section describes the proposed 
approach of incorporating the NSC algorithm and MA, the results are reported in 
Section 6.2, the discussion is in Section 6.3 and the summary is in Section 6.4. 
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6.1. The proposed approach, NSC-MA. 
 
The combination of EA and LS makes MA more efficient and effective in terms of 
processing time for convergence to optimal solutions, finding smaller sets of features, 
and improving classification accuracy in comparison to other traditional EAs such as 
GA (Elbeltagi et al., 2005; Zhu et al., 2007). Different LS strategies such as pair-wise 
LS (Merz & Freisleben, 1999), Adding Subtracting LS, Improvement First Strategy LS 
and greedy LS (Zhu et al., 2007) have been incorporated into GA in different 
approaches. For example, a LS strategy can be applied to elite chromosomes only or to 
the entire population or only to chromosomes that have been modified by crossover 
and/or mutation operation, etc.  
 
Adding Subtracting LS strategy is carried out to search for a better chromosome in 
terms of fitness by adding or subtracting a small random value generated by a RNG to a 
meme (gene) value in the chromosome to create a new chromosome. The fitness of the 
new chromosome is then evaluated, if improved (i.e. better fitness) the new 
chromosome is retained, otherwise discarded. The process continues for the rest of the 
memes in the chromosome (Elbeltagi et al., 2005). This strategy has been known as a 
greedy search strategy (Zhu et al., 2007) or a hill climbing search strategy where the 
search progresses from the current best chromosome to the one that has a better fitness 
(Kohavi & John, 1997; H. Wang et al., 2009). MA with the greedy search  strategy LS 
outperformed GA in terms of achieving better classification accuracy and processing 
time (Elbeltagi et al., 2005). However, according to Zhu, et al. (2007)’s study, the LS 
with Improvement First Strategy outperformed the greedy search strategy LS. Their 
study also found that the Improvement First Strategy LS when applied to a few of the 
elite chromosomes resulted in better solutions when compared to the approach that 
applied the Improvement First Strategy LS to all chromosomes in the population.  
 
Improvement First Strategy LS was also employed as a LS to find a local optimum for 
offspring generated from crossover and mutation operation. That is, after the application 
of crossover and mutation operators on chromosomes, Improvement First Strategy LS is 
then applied to offspring for searching for a local optimum. According to Krasnogor 
and Smith (2005)’s experiments, MA with Improvement First Strategy LS outperformed 
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other LS strategies such as Multi Start Local Search (MSLS) (Marchiori, 2002), Genetic 
Local Search (Aarts, 1997) and the general procedure of MA (Elbeltagi et al., 2005). 
 
Motivated by the performance of the MA that incorporated the adding and subtracting 
Improvement First Strategy LS (Krasnogor & Smith, 2005), it is combined with the 
NSC algorithm in the development of a hybrid approach for finding optimal threshold 
values in NSC automatically. The basic concepts of NSC (Tibshirani et al., 2002) and 
GA have been reviewed in Section 2.4.3 and Section 2.4.4.1, respectively. The 
following sections describe the NSC-MA approach.  
 
6.1.1. NSC-MA proposed approach 
 
Similar to the NSC-GA approach proposed in Chapter 5, the proposed approach, NSC-
MA, consists of 2 major steps:  
 
Step 1:  This step involved the automatic calculation of Thmax. This procedure is 
performed once only at the beginning of the proposed approach, NSC-MA, to obtain 
Thmax. 
 
Step 2: MA (Albrechtsson et al., 2001) is employed in this step as an optimization 
method to search for optimal sets of shrinkage thresholds for NSC algorithm that lead to 
the selection of optimal sets of features. Also in this step, NSC algorithm is employed as 
a fitness evaluator to evaluate the fitness of each chromosome in terms of the number of 
selected features and its corresponding training classification accuracy. 
 
The framework of the proposed approach, NSC-MA, is illustrated in Figure 6-1 and is 
described in the following section. 
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Figure 6-1 Framework of the proposed approach, NSC-MA, using MA with adding and 
subtracting Improvement First Strategy LS 
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The same concepts associated with chromosome encoding, estimation of the initial 
range of values for the shrinkage threshold and fitness evaluation as previously 
discussed in NSC-GA in Chapter 5 also applies in NSC-MA.   
 
6.1.2. Steps of the proposed approach, NSC-MA 
 
In examining Figure 6-1 and Figure 5-2, it can be seen that the only difference between 
NSC-GA and NSC-MA is an additional component for MA, that is, the incorporation of 
LS into the GA thus converting the GA into a MA. Since the core components of the 
algorithm are essentially steps associated with the GA, many of these have been 
discussed in Chapter 5 and are applicable here. These include the calculation of Thmax 
and some of the steps associated with the GA (i.e. population initialization, fitness 
evaluation, selection, crossover, mutation).  The step “new population generation” used 
in NSC-GA are also used in NSC-MA, but has an addition, the incorporation of the 
“adding and subtracting LS with Improvement First Strategy”. This additional step is 
applied to offspring chromosomes after crossover and mutation to further improve the 
quality of chromosome. Figure 6-2 describes the procedure of adding and subtracting 
LS with Improvement First Strategy. 
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    Input: 
Chromosome (chrom) 
Chromosome length (len) 
     
    Output: 
 An improved local search chromosome (chromls)  
    Steps: 
1. Generate a real random number (Rn) in the range [0, 1] using RNG 
2. Evaluate fitness of chrom 
3. For counter from 1 to len 
a. Add Rn to chrom[counter] to create a new chromosome (chromls) 
b. Evaluate the fitness of chromls 
c. If fitness of chromls > chrom  
 Retain chromls as an improved local search chromosome 
 Exit the loop 
d. Else  
 subtract Rn to chrom[counter] create a new chromosome 
(chromls) 
 evaluate the fitness of chromls 
 If fitness of chromls > chrom  
o retain chromls as an improved local search 
chromosome 
o exit the loop 
 else 
o discard chromls 
     
Figure 6-2 Procedure of adding and subtracting LS with Improvement First Strategy 
 
The procedure for generating a new population in NSC-MA is described in Figure 6-3. 
A single elitist strategy is also employed in this study. The best candidate solution 
(elite) from the previous generation is retained and placed into the new generation to 
improve the search in evolutionary algorithms (Ahn & Ramakrishna, 2010). Also in the 
step of generating a new population, two best offspring chromosomes produced from 
the previous steps via selection, crossover, mutation and LS strategy are placed into the 
new population. These steps are repeated until the generation of the new population is 
completed.  
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Input: 
 Chromosome population (p) 
 Fitness population (Fp) 
 Crossover probability (Pc) 
 Mutation probability (Pm) 
 Elite chromosome (Elite) 
 Chromosome length (lenC) 
Output: 
 New population (Np) 
Steps: 
    1. Set Size = size of population, p 
    2. Set new population (Np) = { } 
    3. Store Elite into Np 
    4. For counter from 1 to ½ Size 
a. Select 2 parent chromosomes using binary tournament selection 
i. Select 2 chromosomes randomly from p 
 Select the best fit chromosome as 1st parent (parent1)  
ii. Select 2 chromosomes randomly from p 
 Select the best fit chromosome as 2nd parent (parent2) 
b. Create 2 offspring chromosomes using parent1 and parent2 
i. Generate a random number (Rn) in the range [0, 1] using RNG 
ii. If    Rn ≤ Pc 
 Perform one point crossover on 2 parents to produce 
offspring1 and offspring2 
 Perform adding and subtracting LS with Improvement First 
Strategy on offspring1 and offspring2 to produce 2 new 
offspring (offspring1lscross and offspring2lscross)  
iii. If    Rn ≤ Pm 
   For counter from 1 to lenC 
 Generate a random number (Rn) in the range [0, 1] using 
RNG 
If Rn ≤ Pm 
 Perform uniform mutation on each bit of offspring1 to 
generate offspring1mut  
 Perform uniform mutation on each bit of offspring2 to 
generate offspring2mut 
 Perform adding and subtracting LS with Improvement 
First Strategy on offspring1mut and offspring2mut to produce 
2 new offspring (offspring1lsmut and offspring2lsmut)  
iv. Evaluate fitness of offspring1lscross, offspring2lscross,  
     offspring1lsmut and offspring2lsmut chromosomes 
c. Store the best 2 chromosomes into Np 
 
Figure 6-3 Algorithm for generating a new population using MA incorporated adding 
and subtracting LS with Improvement First Strategy 
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6.1.3. Parameter settings 
 
The parameter settings for running NSC-MA are shown in Table 6-1. The parameters 
used here are the same as those used in NSC-GA (described in Chapter 5), except for an 
additional parameter “Local Search”. 
 
 Table 6-1 Parameter settings used in the proposed approach, NSC-MA  
Parameters Values/Algorithm 
Population size 30 
Chromosome length 
- Real encoding 
10 
Crossover rate 0.6 
Mutation rate 0.033 
Maximum generation 1000 
Selection Tournament 
Crossover Single point 
Mutation Uniform  
Elitist Single  
Local search  Adding and subtracting with First Improvement Strategy 
 
 
6.2. Experiment results 
 
Similar to the experiments for the NSC-GA approach described in Chapter 5, NSC-MA 
was evaluated using seven datasets: AD, Colon, Leukemia, Ovarian, Lymphoma, Lung 
and Prostate cancer datasets as described in Section 3.1. For each dataset, 15 
independent runs of NSC-MA were executed using the respective training data and 
parameter values shown in Table 6-1. For each run, 10 fold CV strategy described in 
Section 3.2 was employed to evaluate the selected feature sets. The optimal set of 
features was then used to construct the NSC classifier to classify the unseen test data 
associated with the dataset. The classification results for classifying the unseen test data 
were recorded and the average classification result from 15 independent runs was 
calculated. The following sections detail the results obtained from applying the 
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approach on each of the seven datasets. Where appropriate, the comparison of the 
performance of the proposed algorithm with existing work is based on classification 
accuracy and the selected feature sets. 
 
6.2.1. Ray et al.  Alzheimer’s Disease data 
 
As mentioned previously in Section 3.1.1, this dataset consists of 120 attributes. The 
training set consists of 43 AD and 40 NDC samples and 2 test sets: the AD test set 
consists of 42 AD, 50 NAD samples and the MCI test set consists of 22 AD and 25 
NAD samples.  
 
 
Figure 6-4 A comparison convergence of fitness plot for AD training dataset using 
NSC-MA and NSC-GA associated with one typical run 
 
Figure 6-4 shows a plot of convergence of fitness associated with one typical run for 
NSC-MA and NSC-GA. Both algorithms converged to the global optimum with the 
same maximum fitness of 1.775. However, the number of generations that the 
algorithms have to run to achieve convergence of fitness is different.  With the proposed 
approach, NSC-MA, convergence occurred after 14 generations, and with NSC-GA, 
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convergence occurred after 28
 
generations in this case.  From Table 6-2, it can be seen 
that on average NSC-MA takes 18 +/- 2.97 runs to converge versus NSC-GA requiring 
28 +/- 4.68 runs for convergence of fitness. Therefore the NSC-MA takes less 
computational time to obtain the same global optimum as NSC-GA.  This is due to the 
fact that, with NSC-MA, chromosomes in the population have been subjected to the 
local search to further improve the fitness in each generation and subsequently, the 
optimal fitness is obtained in a shorter time. 
 
The same set of 11 features is obtained from 15 independent runs using NSC-MA. 
Classifier constructed from this set of features gave an average classification accuracy 
of 89.34% for the unseen AD test dataset and 76.59% for the unseen MCI test dataset, 
compared to 89.49% and 79%, respectively, using NSC-GA. Although the same set of 
11 features was obtained using the proposed approach, the resulting classification 
accuracy is slightly different from the value obtained using NSC-GA. This is due to the 
fact that the optimal shrinkage threshold values obtained from NSC-MA are only 
slightly different from those using NSC-GA. The nature of shrinkage thresholds 
associated with NSC is that rather than an exact value, a narrow range of values maps to 
the same set of features. Since the optimal threshold value from NSC-GA and NSC-MA 
is only slightly different, both mapped to the same set of 11 features but still produced 
slight differences in classification accuracy. The classification results of NSC-MA in 
comparison to NSC-GA are shown in Table 6-2. 
 
Table 6-2 Classification results and time to converge for NSC-GA and NSC-MA using 
AD data 
Approach 
Alzheimer Average number of  
generations for  
convergence of fitness 
over 15 independent 
runs 
Standard 
deviation 
(Stdev) 
AD MCI 
No of  
attributes 
Unseen 
test data 
(%) 
Unseen 
test data 
(%) 
Proposed 
approach 
NSC-MA 
11 89.34 76.59 18 2.97 
NSC-GA 11 89.49 79 28 4.68 
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6.2.2. Alon et al. Colon cancer data 
 
Details about the Colon dataset can be found in Section 3.1. 
 
 
Figure 6-5 Plots for convergence of fitness from a typical run for Colon training dataset 
using NSC-MA and NSC-GA  
 
As seen in Figure 6-5, both algorithms converged to the global optimum with the same 
maximum fitness of 1.883. However, the number of generations that the algorithms 
have to run to achieve convergence of fitness is different.  With NSC-MA convergence 
occurred after 259 generations, and with NSC-GA, convergence occurred after 363
 
generations in this sample run.  From Table 6-3, it can be seen that on average NSC-
MA takes 274 +/- 178.84 runs to converge versus NSC-GA requiring 309 +/- 194. 98 
runs for convergence of fitness.  The same set of 28 features is obtained from each of 15 
independent runs using NSC-MA and resulted in an average classification accuracy of 
100% for the unseen test cancer dataset. In comparison, sets of 6 and 28 features were 
obtained using NSC-GA with 93.75% and 100% for average classification accuracy on 
the same unseen test dataset, respectively. This shows that the proposed approach NSC-
MA selects sets of features consistently for all 15 independent runs (i.e. the same set of 
28 features is obtained for every run) compared to NSC-GA where 2 sets, one of 6 and 
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one of 28 features were obtained from 15 runs. The classification results of NSC-MA in 
comparison to those associated with NSC-GA are shown in Table 6-3. 
 
Table 6-3 Classification results and time to converge for NSC-GA and NSC-MA using 
the Colon cancer data 
Approach 
Colon 
No of 
attributes 
Unseen test data 
 (%) 
Average number of  
generations for  
convergence of fitness 
over 15 independent runs 
Standard 
deviation  
(Stdev) 
Proposed 
approach 
NSC-MA 
28 100 271 178.84 
NSC-GA 
28 
6 
100 
93.75 
309 194.89 
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6.2.3. Leukemia cancer data 
 
Details about the Leukemia dataset can be found in Section 3.1. 
 
 
Figure 6-6 Plots for convergence of fitness from a typical run for Leukemia training 
dataset using NSC-MA and NSC-GA  
 
As seen in Figure 6-6, both algorithms converged to the global optimum with the same 
maximum fitness of 1.973. In terms of convergence of fitness, NSC-MA took 73 
generations, and NSC-GA took 91
 
generations for this sample run.  From Table 6-4, it 
can be seen that on average NSC-MA takes 54 +/- 38.73 runs to converge versus NSC-
GA requiring 82 +/- 43.57 runs for convergence of fitness.  The same set of 9 features is 
obtained from each of the 15 independent runs using NSC-MA, resulting in an average 
classification accuracy of 97.05% on the Leukemia unseen test dataset. The 
classification results of NSC-MA in comparison to those of NSC-GA are shown in 
Table 6-4. 
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Table 6-4 Classification results and time to converge for NSC-GA and NSC-MA using 
the Leukemia cancer data 
Approach 
Leukemia  
No of 
attributes 
Unseen test 
data  (%) 
Average number of  
generations for  
convergence of fitness 
over 15 independent runs 
Standard 
deviation 
(Stdev) 
Proposed 
approach 
NSC-MA 
9 97.05 54 38.73 
NSC-GA 9 97.05 82 43.57 
 
 
6.2.4. Ovarian cancer data 
 
Details about this dataset can be found in Section 3.1. 
 
 
Figure 6-7 Plots for convergence of fitness from a typical run for Ovarian training 
dataset using NSC-MA and NSC-GA 
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As seen in Figure 6-7, both algorithms converged to the global optimum with the same 
maximum fitness of 1.99. With NSC-MA, convergence occurred after 452 generations, 
and with NSC-GA, convergence occurred after 124
 
generations in this sample run.  
From Table 6-5, it can be seen that on average NSC-MA takes 177 +/- 160.78 runs to 
converge versus NSC-GA requiring 86.88 +/- 24.5 obvious from runs for convergence 
of fitness. NSC-MA found the same set of 7 peptides resulting in the same average 
classification accuracy of 96.06% on the Ovarian cancer unseen test dataset as that 
obtained via NSC-GA. The classification results of NSC-MA in comparison to those of 
NSC-GA are shown in Table 6-5. 
 
Table 6-5 Classification results and time to converge for NSC-GA and NSC-MA using 
the Ovarian cancer data 
Approach 
Ovarian 
No of 
attributes 
Unseen test 
data 
(%) 
Average number of  
generations for  convergence 
of fitness over 15 independent 
runs 
Standard 
deviation 
(Stdev) 
Proposed 
approach 
NSC-MA 
7 96.06 177 160.78 
NSC-GA 7 96.06 86.88 24.5 
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6.2.5. Lymphoma cancer data 
 
Details about this dataset can be found in Section 3.1. 
 
 
Figure 6-8 Plots for convergence of fitness from a typical run for Lymphoma training 
dataset using NSC-MA and NSC-GA 
 
As seen in Figure 6-8, both algorithms converged to the global optimum with the same 
maximum fitness of 1.968. With NSC-MA, convergence occurred after 92 generations, 
and with NSC-GA, convergence occurred after 144
 
generations in this typical run.  
From Table 6-6, it can be seen that on average NSC-MA takes 88 +/- 8.91 runs to 
converge versus NSC-GA requiring 100 +/- 62.42 runs for convergence of fitness. The 
same set of 128 features obtained for each of the 15 independent runs using NSC-MA 
gave the same average classification accuracy of 100% on the Lymphoma unseen test 
dataset. This shows that the proposed approach NSC-MA selects features consistently 
for all 15 independent runs (i.e. the same set of 128 features is obtained for every run) 
compared to the approach NSC-GA where 5 different sets of 128, 129, 132, 7 and 12 
features were selected from the independent 15 runs. The classification results of NSC-
MA in comparison to NSC-GA are shown in Table 6-6. 
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Table 6-6 Classification results and time to converge for NSC-GA and NSC-MA using 
the Lymphoma cancer data 
Approach 
Lymphoma 
No of 
attributes 
Unseen test 
data 
 (%) 
Average number of  generations 
for  convergence of fitness over 
15 independent runs 
Standard 
deviation 
(Stdev) 
Proposed 
approach 
NSC-MA 
128 100 88 8.91 
NSC-GA 
7 
12 
128 
129 
132 
95.45 
95.45 
100 
100 
100 
100 62.42 
 
 
6.2.6. Lung cancer data 
 
Details about this dataset can be found in Section 3.1. 
 
As seen in Figure 6-9, both algorithms converged to the global optimum with the same 
maximum fitness of 1.999. With NSC-MA, convergence occurred after 27 generations, 
and with NSC-GA, convergence occurred after 88 generations in this sample run.  From 
Table 6-7, it can be seen that on average NSC-MA takes 41 +/- 9.5 runs to converge 
versus NSC-GA requiring 68 +/- 53.08 runs for convergence of fitness. The same set of 
8 features obtained from each of the 15 independent runs using NSC-MA gave the same 
average classification accuracy of 100% on the Lung unseen test dataset. In comparison, 
NSC-GA produced 4 different sets consisting of 8, 9, 10, and 11 features from 15 runs. 
The classification results of NSC-MA in comparison to NSC-GA are shown in Table 
6-7. 
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Figure 6-9 Plots for convergence of fitness from a typical run for Lung training dataset 
using NSC-MA and NSC-GA  
 
Table 6-7 Classification results and time to converge for NSC-GA and NSC-MA using 
the Lung cancer data 
Approach 
Lung 
No of 
attributes 
Unseen test 
data 
 (%) 
Average number of  generations 
for  convergence of fitness over 
15 independent runs 
Standard 
deviation 
(Stdev) 
Proposed 
approach 
NSC-MA 
8 100 41 9.5 
NSC-GA 
8 
9 
10 
11 
100 68 53.08 
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6.2.7. Prostate cancer data 
 
Details about this dataset can be found in Section 3.1. 
 
As seen in Figure 6-10, both algorithms converged to the global optimum with the same 
maximum fitness of 1.973. With NSC-MA, convergence occurred after 62 generations, 
and with NSC-GA, convergence occurred after 99 generations in this sample run.  From 
Table 6-8, it can be seen that on average NSC-MA takes 65 +/- 23.62 runs to converge 
versus NSC-GA requiring 82 +/- 32.26 runs for convergence of fitness. The same set of 
6 features obtained from each of the 15 independent runs using NSC-MA gave the same 
average classification accuracy of 90.2% on the Prostate unseen test dataset.  The 
classification results of NSC-MA in comparison to NSC-GA are shown in Table 6-8. 
 
 
Figure 6-10 A comparison convergence of fitness plot for Prostate training dataset using 
NSC-MA and NSC-GA associated with one typical run 
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Table 6-8 Classification results and time to converge for NSC-GA and NSC-MA using 
the Prostate cancer data 
Approach 
Prostate 
No of 
attributes 
Unseen test 
data 
 (%) 
Average number of  generations 
for  convergence of fitness over 
15 independent runs 
Standard 
deviation 
(Stdev) 
Proposed 
approach 
NSC-MA 
6 90.2 65 23.62 
NSC-GA 6 90.2 80 32.26 
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Table 6-9 Summary of results obtained from the NSC-GA and NSC-MA approach 
Dataset 
NSC-GA NSC-MA 
No of  
attributes 
Unseen 
test data 
(%) 
Average number 
of  generations for  
convergence of 
fitness over 15 
independent runs 
Standard 
deviation 
(Stdev) 
No of 
attributes 
Unseen 
test data 
(%) 
Average number 
of  generations for  
convergence of 
fitness over 15 
independent runs 
Standard 
deviation 
(Stdev) 
AD 11 89.49 28 2.97 11 89.34 18 4.68 
Colon 
28 
6 
100 
93.75 
309 194.9 28 100 271 178.84 
Leukemia 9 97.05 82 43.57 9 97.05 54 38.73 
Lymphoma 
7 
12 
128 
129 
132 
95.45 
95.45 
100 
100 
100 
100 62.42 128 100 88 8.91 
Ovarian 7 96.06 86 24.5 7 96.06 177 160.78 
Lung 
8 
9 
10 
11 
100 68 53.08 8 100 41 9.5 
Prostate 6 90.2 80 32.26 6 90.2 65 23.62 
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6.3. Discussion 
 
Table 6-9 shows a summary of experimental results obtained using NSC-MA, in 
comparison to results from NSC-GA on the same datasets. The proposed approach 
achieved the same classification results in terms of the sets of selected features and 
classification accuracy on unseen test sets for the seven datasets. However, the NSC-
MA approach has generally improved performance in terms of computational time for 
all datasets except for the Ovarian and Lymphoma datasets. That is, the NSC-MA 
approach, on average over 15 independent runs, required a smaller number of 
generations for convergence of fitness.   
 
Another difference from NSC-MA when compared to NSC-GA is that, NSC-MA 
consistently obtained the same set of features for each of the 15 independent runs. This 
highlights the advantage of incorporating LS into the previous approach NSC-GA to 
further improve the fitness of candidate solutions and subsequently, that leads to only 
one constant optimal solution being obtained for all the independent runs for the 
respective dataset. For example, for the Lung cancer dataset, the proposed approach 
NSC-MA obtained the same set of 8 genes for each of the 15 independent runs, whilst 
the NSC-GA approach obtained sets with 8, 9, 10, and 11 features from the 15 
independent runs.  
 
Overall, the impact of incorporating MA with NSC for finding shrinkage threshold 
values automatically are (1) reduced computational time and (2) obtaining the same 
feature set over different runs of NSC-MA. 
 
6.4. Summary 
 
This chapter has described the proposed approach of incorporating the NSC and MA to 
automatically search for optimal threshold values for the NSC, and subsequently to be 
used for FS and classification. The approach incorporated the adding and subtracting LS 
with Improvement First Strategy in a MA to optimize the optimal threshold value 
automatically for NSC, and to obtain the sets of relevant features. The results obtained 
shows that with NSC-MA, convergence of fitness is quicker while obtaining the same 
feature set and similar classification accuracy, compared to those obtained via NSC-GA. 
179 
 
In Chapter 7, the investigation of incorporating different similarity distance measures 
into the NSC algorithm in NSC-GA will be described. 
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7. Incorporating different similarity distance measures into the NSC 
algorithm in the NSC-GA approach 
 
The NSC classifier uses Euclidean distance as a measure to assign data points to 
different classes.  Each data point is assigned to the class that it has the shortest 
Euclidean distance. The classification accuracy is calculated based on correct class 
assignment.  The higher the number of data points correctly assigned to its class, the 
higher the resulting classification accuracy. According to Bandyopadhyay and Saha 
(2013, p. 60), “similarity measurement is essential for performing classification”, 
therefore employing a different similarity distance measure in the NSC classifier would 
impact its class prediction of data points and consequently  the classification accuracy. 
 
The aim of this chapter is to investigate the impact of employing different similarity 
distance measures (Mahalanobis, Pearson and Mass distance (MD) measure) in the NSC 
classifier on FS and classification using the same NSC-GA approach, which has been 
proposed and implemented in Chapter 5. Subsequently the impact of incorporating 
different distance measures in NSC*-GA (with * representing M or P or MD) is 
evaluated using the seven biomedical datasets described in Chapter 3. Section 7.1.1 
describes the proposed approaches, NSCM-GA, NSCP-GA and NSCMD-GA, the results 
are reported in Section 7.2, discussion is in Section 7.3 and summary is in Section 7.4. 
 
7.1. NSC
*
-GA proposed approach 
 
Similar to the NSC-GA approach where Euclidean distance is employed in the NSC, the 
proposed approach NSC*-GA consists of the same 2 major steps that have been 
described in Section 5.2.  
 
Considerations for chromosomes encoding, estimation of the initial range of values for 
the shrinkage threshold and fitness evaluation in NSC*-GA are also the same as NSC-
GA and have been discussed in Section 5.2.1. The basic concepts of NSC algorithm 
(Tibshirani et al., 2002) have been reviewed in Section 2.3.3 and different distance 
measures, Euclidean, Mahalanobis (Mahalanobis, 1936), Pearson (Pearson, 1895) and 
MD (Yona et al., 2006) have been reviewed in Section 2.3.6. The following sections 
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describe the proposed approach which incorporates NSC with different similarity 
distance measures, Mahalanobis, Pearson and MD, into GA, denoted as NSCM-GA, 
NSCP-GA and NSCMD-GA, respectively.  
 
7.1.1. NSC-GA with Mahalanobis (NSCM-GA), Pearson (NSCP-GA) and  Mass 
distance measure (NSCMD-GA) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7-1 Framework of NSC*-GA 
 
As seen in Figure 7-1, the core of the framework of NSC*-GA is the same as of the 
framework of NSC-GA. The only difference between the 2 approaches is the different 
distance measure method employed in the NSC classifier. That is, instead of using the 
Euclidean distance as a distance measure in the original implementation of NSC, 
Mahalanobis distance (green box), Pearson (yellow box) and Mass distance (blue box) 
are employed in the NSC classifier to measure the distance between data points and 
classes when performing classification.  The modified NSC*  classifiers (NSC with a 
different distance measure) are NSCM, NSCP and NSCMD with M, P and MD denoting 
Mahalanobis distance, Pearson and Mass distance respectively. These modified 
classifiers are detailed in the following sections. 
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A number of calculations in the original NSC algorithm still apply in NSCM, NSCP and 
NSCMD. These include the calculations of class centroid, overall centroid, relative 
difference, shrunken relative difference, updated class centroid and classification. 
Equations for these calculations are shown in Equation (7.1), (7.2), (7.3), (7.4), (7.5), 
and (7.6), respectively. More details about these equations can be found in Section 
2.4.3. 
 
 Class centroid :   ̅    ∑                         
(7.1) 
 Overall centroid:  ̅i   ∑  i    
 
                
(7.2) 
 Relative difference:       
 ̅i - ̅i 
  (si so)
             
(7.3) 
 Shrunken relative difference:                  |   |       if |   |    
Otherwise 0     
(7.4) 
 
 Updated class centroid:  ̅ i     ̅i     (si   so) d’i           (7.5) 
 
 Classification:                       
                       (7.6) 
 
The following sections describe the specific distance measure employed in NSCM, 
NSCP and NSCMD classifiers respectively. 
 
 NSCM classifier 
The difference between the NSC and NSCM classifier is the calculation of discriminant 
scores for data points, where each data point is assigned to the class that it has the 
closest distance, i.e., the distance is based on a minimal discriminant score.  
 
In NSCM, the calculation of the discriminant score is now obtained using the calculation 
of Mahalanobis distance (     ) as defined by Equation (7.8) and (7.9). Descriptions of 
Mahalanobis distance and associated equations are found in Section 2.3.6.2.  
 
       √         
             (7.7) 
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   where   is a data point 
  µ is a class centroid 
    superfix T is a matrix transpose 
           Σ-1 is an inverse covariance matrix 
 
Hence the calculation of discriminant scores using Mahalanobis distance measure is 
defined by Equation (7.8) as follows. 
 
   (  )             (7.8) 
 
 NSCP classifier 
 In NSCP, the calculation of the discriminant score is now obtained using Pearson 
Correlation. These calculations are defined by Equation (7.9), (7.10) and (7.11). 
Descriptions of Pearson Correlation and associated equations are found in Section 
2.3.6.3.  
  
 Correlation coefficient           r = 
∑ (x- ̅) (y- ̅)
√(x- ̅)
2
 √(y- ̅)
2
                              (7.9) 
       where x is variable value 
                    ̅     ̅ are class centroids 
 
 Pearson correlation measure                            |   |                 (7.10) 
 
 Hence the calculation of discriminant scores using Pearson correlation is defined by 
Equation (7.11) as follows. 
 
   (  )           (7.11) 
 
 NSCMD classifier 
In NSCMD, the calculation of the discriminant score is now obtained using MD. These 
calculation are defined by Equation (7.12), (7.13), 7.14), (7.15) and (7.16) in the 
calculations for Mass Distance. These equations have been described in Section 2.3.6.4. 
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            ∫            
         
         
   (7.12) 
 
          (
 
 
  √  )    
 
      
      (7.13) 
 
           
       
 
     (7.14) 
 
            (∫ (
 
 
  √  )    
 
      
   
         
         
)  (
       
 
  )  (7.15) 
 
Hence the calculation of discriminant scores using mass distance is defined by Equation 
(7.16) as follows. 
 
    
                  (7.16) 
 
As mentioned previously, NSC*-GA comprised of the same 2 major steps as NSC-GA. 
These steps include the automatic Thmax calculation, GA search optimization including 
population initialization, fitness evaluation, GA operators and new population 
generation steps which have been described in Section 5.2.1 and will not be repeated 
here. The same parameter settings used in NSC-GA (Table 5-4) are also used to run 
NSCM-GA, NSCP-GA and NSCMD-GA. 
 
7.2. Experiment results 
 
Similar to the experiments for NSC-GA described in Chapter 5, NSCM-GA, NSCP-GA 
and NSCMD-GA, were evaluated using the same seven datasets. For each dataset, 15 
independent runs of NSC*-GA (i.e. 15 runs for each of NSCM-GA, NSCP-GA and 
NSCMD-GA) were executed using the respective training dataset and parameter settings 
shown in Table 5-4. For each independent run, 10 fold CV strategy described in Section 
3.2 was employed to evaluate the proposed approaches. The optimal set of features 
obtained for each dataset was then used to construct the respective NSC* classifier to 
evaluate the corresponding unseen test dataset. The classification results for the unseen 
test data were recorded and the average classification result from 15 independent runs 
was calculated. The following sections report the results of experiments for each 
approach on each of the seven datasets. Where appropriate, the comparison of the 
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performance of the proposed algorithm with existing work is based on classification 
accuracy and the selected feature sets. 
 
7.2.1. NSCM-GA 
 
7.2.1.1. Ray et al.  AD data 
 
 
Figure 7-2 A typical plot for convergence of fitness for the training data of AD using 
NSCM-GA 
 
As seen in Figure 7-2, convergence in this sample run occurred after 28 generations 
with the maximum fitness of 1.81. The optimal shrinkage threshold obtained for each of 
the runs had the same maximum fitness of 1.81 which produced the set of 18 proteins 
with resulting 97.82% classification accuracy on the unseen test data (Figure 7-1). The 
18 proteins selected by NSCM-GA, for the AD dataset are the same set of 18 proteins 
found by Ray et al. (2007). 
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Table 7-1 Comparison of classification results between NSC-GA and NSCM-GA for AD 
data 
NSC-GA (Euclidean dist.) Proposed NSCM-GA (Mahalanobis dist.) 
Number of 
proteins 
Unseen Test (%) 
Number of 
proteins 
Unseen Test (%) 
11 90.21 18 97.82 
 
 
7.2.1.2. Alon et al. Colon cancer data 
 
 
Figure 7-3 A typical plot for convergence of fitness for the training data of Colon using 
NSCM-GA 
 
As seen in Figure 7-3, convergence in this sample run occurred after 37 generations 
with the maximum fitness of 1.99. The optimal shrinkage threshold obtained for each of 
the runs had the same maximum fitness of 1.99 which produced the set of 7 genes with 
93.54% classification accuracy on the unseen test set. The gene accession numbers of 7 
genes selected by NSCM-GA for Colon dataset are T71025, M76378, M63391, T92451, 
H64489, M76378 and J02854. This set of 7 genes is a subset of the set of 28 genes and 
the superset of the 6 genes which have been found by NSC-GA. As seen in Table 7-2, 
the classification accuracy using the set of 6 and 7 genes are very similar. 
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Table 7-2 Comparison of classification results between NSC-GA and NSCM-GA for 
Colon cancer data 
NSC-GA (Euclidean dist.) Proposed NSCM-GA 
(Mahalanobis dist.) 
Number of 
genes 
Unseen Test (%) 
Number of 
genes 
Unseen Test (%) 
28 
6 
100 
93.75 
7 93.54 
 
 
7.2.1.3. Leukemia cancer data 
 
 
Figure 7-4 A typical plot for convergence of fitness for the training data of Leukemia 
using NSCM-GA 
 
As seen in Figure 7-4, convergence in this sample run occurred after 69 generations 
with the maximum fitness of 1.99. The optimal shrinkage threshold obtained for each of 
the 15 independent runs had the same maximum fitness of 1.99 which produced the 
same set of 9 genes for the Leukemia cancer dataset. As shown in Table 7-3, this set of 
9 genes produced the average classification accuracy of 94.12% on the unseen test set. 
The classification accuracy is slightly different from those obtained using NSC-GA. 
Owing the fact that the optimal shrinkage threshold value obtained from NSCM-GA is 
slightly different from that of NSC-GA. These two slightly different optimal thresholds 
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still mapped to the same set of 9 genes but produced slightly different classification 
accuracy on the same unseen test dataset. 
 
Table 7-3 Comparison of classification results between NSC-GA and NSCM-GA for 
Leukemia data 
NSC-GA (Euclidean dist.)  Proposed NSCM-GA 
(Mahalanobis dist.) 
Number of 
genes 
Unseen Test (%) 
Number of  
genes 
Unseen Test (%) 
9 97.05 9 94.12 
 
 
7.2.1.4. Lymphoma cancer data 
 
As seen in Figure 7-5, convergence in this sample run occurred after 31 generations 
with the maximum fitness of 1.99. The optimal shrinkage threshold obtained for each of 
the 15 independent runs had the same maximum fitness of 1.99 which produced the 
same set of 3 genes for the Lymphoma cancer dataset. This set of 3 genes produced the 
average classification accuracy of 100% on the unseen test set. The 3 gene set with gene 
accession numbers, GENE3327X, GENE3329X and GENE3361X, selected by NSCM-
GA for Lymphoma dataset, is a subset of the following sets consisting of 7, 12, 128, 
129 and 132 genes found using NSC-GA. For this dataset, the proposed approach 
selected a smaller set of genes resulting in a higher classification accuracy on the same 
unseen test dataset. 
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Figure 7-5 A typical plot for convergence of fitness for the training data of Lymphoma 
using NSCM-GA 
 
Table 7-4 Comparison of classification results between NSC-GA and NSCM-GA for 
Lymphoma data 
NSC-GA (Euclidean dist.) Proposed NSCM-GA 
(Mahalanobis dist.) 
Number of 
genes 
Unseen Test (%) 
Number of 
genes 
Unseen Test (%) 
7 
12 
128 
129 
132 
95.45 
95.45 
100 
100 
100 
3 100 
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7.2.1.5. Lung cancer data 
 
 
Figure 7-6 A typical plot for convergence of fitness for the training data of Lung using 
NSCM-GA 
 
As seen in Figure 7-6, convergence in this sample run occurred after 10 generations 
with the maximum fitness of 1.998. The optimal shrinkage threshold obtained for each 
of the 15 independent runs produced the set of 9 and 11 genes for the Lung cancer 
dataset. As shown in Table 7-5, the set of 9 and 11 genes resulted in the average 
classification accuracy of 98.88% on the unseen test set. These sets of 9 and 11 genes 
selected by NSCM-GA are the same set of 9 and 11 genes found by using NSC-GA with 
the classification accuracy of 100%.  
 
Table 7-5 Comparison of classification results between NSC-GA and NSCM-GA for 
Lung data 
NSC-GA (Euclidean dist.) Proposed NSCM-GA (Mahalanobis dist.) 
Number of 
genes 
Unseen Test (%) 
Number of 
genes 
Unseen Test (%) 
7, 8, 9, 10 100 9, 11  98.88 
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7.2.1.6. Ovarian cancer data 
 
 
Figure 7-7 A typical plot for convergence of fitness for the training data of Ovarian 
using NSCM-GA 
 
As seen in Figure 7-7, convergence in this sample run occurred after 46 generations 
with the maximum fitness of 1.98. The optimal shrinkage threshold obtained for each of 
the 15 independent runs had the same maximum fitness of 1.98 which resulted in the set 
of 1 peptide for the Ovarian cancer dataset. As shown in Table 7-6, the set of 1 gene 
(MZ244.36855) gave the average classification accuracy of 96.06% on the unseen test 
set. This set of 1 peptide selected by NSCM-GA is a subset of 7 peptides found using the 
NSC-GA approach but gave the same classification accuracy of 96.06%. It appears that 
a major contributing factor relates to 1 peptide and thus may warrant further 
investigations into the relevance of the remaining features. This sort of information for 
analysis in bioinformatics is important as reducing the number of features to a smaller 
promising set for further investigations would reduce costs associated with future 
experiments and analysis. 
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Table 7-6 Comparison of classification results between NSC-GA and NSCM-GA for 
Ovarian data 
NSC-GA (Euclidean dist.) Proposed NSCM-GA (Mahalanobis dist.) 
Number of genes Unseen Test (%) Number of genes Unseen Test (%) 
7 96.06 1 96.06 
 
 
7.2.1.7. Prostate cancer data 
 
As seen in Figure 7-8, convergence in this sample run occurred after 9 generations with 
the maximum fitness of 1.998. The optimal shrinkage threshold obtained for each of the 
15 independent runs had the same maximum fitness of 1.998 which produced the sets of 
17 genes for the Prostate cancer dataset. As shown in Table 7-7, this set of 17 genes 
resulted in the average classification accuracy of 100% on the unseen test set. The gene 
accession numbers of 17 genes selected by NSCM-GA for Prostate cancer dataset are: 
31444_s_at, 31527_at, 33614_at, 41468_at, 37639_at, 39756_g_at, 40435_at, 
40436_g_at, 36587_at, 36666_at, 37720_at, 38406_f_at, 38429_at, 40282_s_at, 
769_s_at, 556_s_at and 216_at. The gene accession number, 31444_s_at and 769_s_at 
are listed in the prognosis gene patent that indicates high risk for TTD (time to death) 
(Liu & Iba, 2002). In comparison, this set of 17 genes is a superset of the 6 genes 
obtained using NSC-GA which produced a resulting classification accuracy of 90.2% 
on the same unseen test dataset.  
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Figure 7-8 A typical plot for convergence of fitness for the training data of Prostate 
using NSCM-GA 
 
Table 7-7 Comparison of classification results between NSC-GA and NSCM-GA for 
Prostate data 
NSC-GA (Euclidean dist.)  Proposed NSCM-GA (Mahalanobis dist.) 
Number of genes Unseen Test (%) Number of genes Unseen Test (%) 
6 90.2 17 100 
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7.2.2. NSCP-GA approach 
 
Similar to the experiments for NSCM-GA approach, the same parameter settings, 
experimental conditions and evaluation strategy were also used here for evaluating 
NSCP-GA. The results from these experiments are reported as follows. 
 
7.2.2.1. Ray et al.  AD data 
 
 
Figure 7-9 A typical plot for convergence of fitness for the training data of AD using 
NSCP-GA 
 
As seen in Figure 7-9, convergence in this sample run occurred after 251 generations 
with the maximum fitness of 1.768 in this sample run. The optimal shrinkage threshold 
obtained for each of the 15 independent runs had the same maximum fitness of 1.768 
which produced the same set of 9 proteins for the AD dataset. As shown in Table 7-8, 
the set of 9 proteins resulted in the average classification accuracy of 92.39% on unseen 
test dataset, an improvement over the results from the set of 11 proteins obtained via 
NSC-GA. The selected 9 proteins, PDGF-BB_1, RANTES_1, IL-1a_1, TNF-a_1, 
EGF_1, M-CSF_1, ICAM-1_1, IL-3-1 and GCSF_1, are a subset of the sets of 11 and 
18 proteins obtained using NSC-GA and NSCM-GA, respectively, as well as being a 
subset of the 18 proteins in Ray et al. (2007). 
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Table 7-8 Comparison of classification results between NSC-GA and NSCP-GA for AD 
data 
NSC-GA (Euclidean dist.) Proposed NSCP-GA (Pearson dist.) 
Number of genes Unseen Test (%) Number of genes Unseen Test (%) 
11 89.49 9 92.39 
 
 
7.2.2.2. Alon et al. Colon cancer data 
 
 
Figure 7-10 A typical plot for convergence of fitness for the training data of Colon 
using NSCP-GA 
 
As seen in Figure 7-10, convergence in this sample run occurred after 144 generations 
with the maximum fitness of 1.826. Seven runs produced a maximum fitness of 1.826 
which gave the same set of 42 genes and other 8 runs produced a maximum fitness of 
1.823 which mapped to the same set of 6 genes which is a subset of the 42 gene set. As 
shown in Table 7-9, these sets of 42 and 6 genes, each resulted in an average 
classification accuracy of 100% on the unseen test dataset. The set of six genes selected 
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by the proposed approach is the same set of 6 genes found by the NSC-GA approach 
and is also a subset of the sets of 28 genes (from NSC-GA) and 42 genes.  
 
Table 7-9 Comparison of classification results between NSC-GA and NSCP-GA for 
Colon data 
NSC-GA (Euclidean dist.) Proposed NSCP-GA (Pearson dist.) 
Number of genes Unseen Test (%) Number of genes Unseen Test (%) 
28 
6 
100 
93.75 
42 
6 
100 
 
 
7.2.2.3. Leukemia cancer data 
 
 
Figure 7-11 A typical convergence of fitness plot for the training data of Leukemia data 
using NSCP-GA 
 
As seen in Figure 7-11, convergence in this sample run occurred after 91 generations 
with the maximum fitness of 1.99. Three different optimal shrinkage thresholds were 
obtained from the 15 independent runs, each are associated with 7 sets of 4 genes, 5 sets 
of 5 genes and 3 sets of 24 genes respectively. As shown in Table 7-10, these sets of 4, 
5 and 24 genes, each resulted in an average classification accuracy of 100% on unseen 
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test data. The sets of 4 and 5 genes, each is a subset of the 9 gene set produced from 
using NSC-GA.  
 
Table 7-10 Comparison of classification results between NSC-GA and NSCP-GA for 
Leukemia data 
NSC-GA (Euclidean dist.) Proposed NSCP-GA (Pearson dist.) 
Number of genes Unseen Test (%) Number of genes Unseen Test (%) 
9 97.05 
4 
5 
24 
100 
 
 
7.2.2.4. Lymphoma cancer data 
 
 
Figure 7-12 A typical plot for convergence of fitness for the training data of Lymphoma 
using NSCP-GA 
 
As seen in Figure 7-12, convergence in this sample run occurred after 91 generations 
with the maximum fitness of 1.983. Five different optimal shrinkage thresholds 
obtained for the 15 independent runs, each are associated with 5 sets of 72 genes, 3 sets 
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of 73 genes, 5 sets of 75 genes, 1 set of 77 and 80 genes respectively. As shown in 
Table 7-11, these sets of 72, 73, 75, 77 and 80 genes, each produced an average 
classification accuracy of 100% on unseen test data. The sets of 72, 73, 75, 77 and 80 
genes are subset of the 128 gene set produced using NSC-GA. 
 
Table 7-11 Comparison of classification results between NSC-GA and NSCP-GA for 
Lymphoma data 
NSC-GA (Euclidean dist.) Proposed NSCP-GA (Pearson dist.) 
Number of genes Unseen Test (%) Number of genes Unseen Test (%) 
7 
12 
128 
129 
132 
95.45 
95.45 
100 
100 
100 
72 
73 
75 
77 
80 
100 
 
 
7.2.2.5. Lung cancer data 
 
As seen in Figure 7-13, convergence in the sample run occurred after 36 generations 
with the maximum fitness of 1.9996. Three different optimal shrinkage thresholds were 
obtained from the 15 independent runs. Each is associated with 8 sets of 4 genes, 5 sets 
of 5 genes and 2 sets of 7 genes, respectively. The smaller set is a subset of the larger 
set. As shown in Table 7-12, the set of 4, 5 and 7 genes resulted in an average 
classification accuracy of 100% on unseen test data. The set of 7 genes, with gene 
accession numbers 32551_at, 33328_at, 34320_at, 36533_at, 37157_at, 37716_at and 
37954_at. Sets of 4, 5 and 7 genes are each a subset of the sets consisting of 8, 9, 10 and 
11 genes produced using NSC-GA. 
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Figure 7-13 A typical plot for convergence of fitness for the training data of Lung using 
NSCP-GA 
 
Table 7-12 Comparison of classification results between NSC-GA and NSCP-GA for 
Lung data 
NSC-GA (Euclidean dist.) Proposed NSCP-GA (Pearson dist.) 
Number of genes Unseen Test (%) Number of genes Unseen Test (%) 
8 
9 
10 
11 
100 
4 
5 
7 
100 
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7.2.2.6. Ovarian cancer data 
 
 
Figure 7-14 A typical plot for convergence of fitness for the training data of Ovarian 
using NSCP-GA 
 
As seen in Figure 7-14, convergence in this sample run occurred after 7 generations 
with the maximum fitness of 1.984. Four different optimal shrinkage thresholds were 
obtained from the 15 independent runs, each are associated with 2 sets of 2 peptides, 8 
sets of 8 peptides, 3 sets of 9 peptides and 2 set of 10 peptides respectively. As shown in 
Table 7-13, the set of 2 peptides produced an average classification accuracy of 96.85% 
and the set of 8, 9 and 10 genes produced an average classification accuracy of 96.06% 
on unseen test data. The set of the 2 peptides, MZ244.95245 and MZ245.24466, is a 
subset of 7 peptides found by the approach NSC-GA. 
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Table 7-13 Comparison of classification results between NSC-GA and NSCP-GA for 
Ovarian data 
NSC-GA (Euclidean dist.) Proposed NSCP-GA (Pearson dist.) 
Number of peptides Unseen Test (%) Number of peptides Unseen Test (%) 
7 96.06 
2 
8 
9 
10 
96.85 
96.06 
96.06 
96.06 
 
 
7.2.2.7. Prostate cancer data 
 
 
Figure 7-15 A typical plot for convergence of fitness for the training data of Prostate 
using NSCP-GA 
 
As seen in Figure 7-15, convergence in this sample run occurred after 43 generations 
with the maximum fitness of 1.942. The optimal shrinkage threshold obtained for each 
of the 15 independent runs had the same maximum fitness of 1.942 which mapped to 
the same set of five genes. As shown in Table 7-14, this set of five genes produced an 
average classification accuracy of 90.2% on unseen test data. This five gene set, with 
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gene accession numbers 41468_at, 37639_at,  38406_f_at, 769_s_at and 556_s_at , is a 
subset of six genes found using NSC-GA.  
 
Table 7-14 Comparison of classification results between NSC-GA and NSCP-GA for 
Prostate data 
NSC-GA (Euclidean dist.) Proposed NSCP-GA (Pearson dist.) 
Number of genes Unseen Test (%) Number of genes Unseen Test (%) 
6 90.2 5 90.2 
 
 
7.2.3. NSCMD-GA approach 
 
Similar to the experiments for NSCM-GA and NSCP-GA, the same parameter settings, 
experimental conditions and evaluation strategy were also used here for evaluating 
NSCMD-GA. The results from these experiments are reported as follows. 
 
7.2.3.1. Ray et al.  AD data 
 
As seen in Figure 7-16, convergence in this sample run occurred after 51 generations 
with the maximum fitness of 1.84. The optimal shrinkage threshold obtained for each of 
the 15 independent runs had the same maximum fitness of 1.84 which mapped to the 
same set of 4 proteins. As shown in Table 7-15, this set of 4 proteins resulted in an 
average classification accuracy of 91.3% on unseen test data. This 4 protein set, PDGF-
BB_1, RANTES_1, TNF-a_1 and IL-1a_1, is a subset of  the following sets with each 
comprising of 11, 18 and 9 features selected using NSC-GA, NSCM-GA and NSCP-GA, 
respectively, and is also a subset of 18 features in Ray et al. (2007).  
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Figure 7-16 A typical plot for convergence of fitness for the training data of AD using 
NSCMD-GA 
 
Table 7-15  Comparison of classification results between NSC-GA and NSCMD-GA for 
AD data 
NSC-GA (Euclidean dist.) Proposed NSCMD-GA (Mass dist.) 
Number of  proteins Unseen Test (%) Number of  proteins Unseen Test (%) 
11 90.21 4 91.3 
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7.2.3.2. Alon et al. Colon cancer data 
 
 
Figure 7-17 A typical plot for convergence of fitness for the training data of Colon 
using NSCMD-GA 
 
As seen in Figure 7-17, convergence in this sample run occurred after 853 generations 
with the maximum fitness of 1.86. The optimal shrinkage threshold obtained from each 
of the 15 independent runs had the same maximum fitness of 1.86 which mapped to the 
same set of 12 genes. As shown in Table 7-16, this set of 12 genes resulted in an 
average classification accuracy of 100% on the unseen test data. The set of 12 genes has 
gene accession numbers: T71025, Z24727, M76378, M63391, M76378, R87126, 
X12671, M76378, T92451, H43887, T47377 and J02854. This set is also a subset of the 
set of 28 genes found using NSC-GA. The interesting point from the perspective of 
early diagnostic test developments is a small set with high discriminatory potentials and 
here both sets (set of 12 genes and the set of 28 genes) produced the same classification 
accuracy on the unseen test dataset. 
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Table 7-16 Comparison of classification results between NSC-GA and NSCMD-GA for 
Colon data 
NSC-GA (Euclidean dist.) Proposed NSCMD-GA (Mass dist.) 
Number of genes Unseen Test (%) Number of genes Unseen Test (%) 
28 
6 
100 
93.75 
12 100 
 
 
7.2.3.3. Leukemia cancer data 
 
  
Figure 7-18 A typical plot for convergence of fitness for the training data of Leukemia 
using NSCMD-GA 
 
As seen in Figure 7-18, convergence in this sample run occurred after 56 generations 
with the maximum fitness of 1.92. The optimal shrinkage threshold obtained for each of 
the 15 independent runs had the same maximum fitness of 1.92 which mapped to the 
same set of 3 genes. As shown in Table 7-17, this set of 3 genes gave the average 
classification accuracy of 94.12% on unseen test data. The set of 3 genes selected with 
gene accession numbers, M27891, M84526, and X17042, is a subset of 5 features found 
in NSCPGA, and also a subset of 9 genes found in NSC-GA. 
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Table 7-17 Comparison of classification results between NSC-GA and NSCMD-GA for 
Leukemia data 
NSC-GA (Euclidean dist.) Proposed NSCMD-GA (Mass dist.) 
Number of genes Unseen Test (%) Number of genes Unseen Test (%) 
9 97.05 3 94.12 
 
 
7.2.3.4. Lymphoma cancer data 
 
 
Figure 7-19 A typical plot for convergence of fitness for the training data of Lymphoma 
using NSCMD-GA 
 
As seen in Figure 7-19, the convergence in this sample run occurred after 151 
generations with the maximum fitness of 1.997. The optimal shrinkage threshold 
obtained for each of the 15 independent runs had the same maximum fitness of 1.997 
which produced the same set of 3 genes for the Lymphoma cancer dataset. As shown in 
Table 7-18, the set of 3 genes gave the average classification accuracy of 100% on 
unseen test data. The set of 3 genes selected with gene accession numbers, 
GENE3327X, GENE3329X and GENE3361X, is a subset of 7 features found in NSC- 
GA. 
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Table 7-18 Comparison of classification results between NSC-GA and NSCMD-GA for 
Lymphoma data 
NSC-GA (Euclidean dist.) Proposed NSCMD-GA (Mass dist.) 
Number of genes Unseen Test (%) Number of genes Unseen Test (%) 
7 
12 
128 
129 
132 
95.45 
95.45 
100 
100 
100 
3 100 
 
 
7.2.3.5. Lung cancer data 
 
 
Figure 7-20 A typical plot for convergence of fitness for the training data of Lung using 
NSCMD-GA 
 
As seen in Figure 7-20, the convergence in this sample run occurred after 21 
generations with the maximum fitness of 1.997. The optimal shrinkage threshold 
obtained for each of the 15 independent runs had the same maximum fitness of 1.997 
which produced the same set of 2 genes for the Lung cancer dataset. As shown in Table 
7-19, the set of 2 genes gave the average classification accuracy of 63.33% on unseen 
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test data. The set of 2 genes selected with accession numbers, 33328_at and 40936_at, is 
a subset of 8 genes found in NSC-GA. 
 
Table 7-19 Comparison of classification results between NSC-GA and NSCMD-GA for 
Lung data 
NSC-GA (Euclidean dist.)  Proposed NSCM-GA (Mass dist.) 
Number of genes Unseen Test (%) Number of genes Unseen Test (%) 
8 
9 
10 
11 
100 2 63.33 
 
 
7.2.3.6. Ovarian cancer data 
 
 
Figure 7-21 A typical plot for convergence of fitness for the training data of Ovarian 
using NSCMD-GA 
 
As seen in Figure 7-21, the convergence in this sample run occurred after 37 
generations with the maximum fitness of 1.964. The optimal shrinkage thresholds 
obtained for the 15 independent runs produced the 12 sets of 10 peptides, 2 sets of 11 
peptides and 1 set of 20 peptides for the Ovarian cancer dataset. As shown in Table 
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7-20, the set of 10, 11 and 20 peptides gave the average classification accuracy of 
63.33% on unseen test data. The smaller set is a subset of the larger sets. 
 
Table 7-20 Comparison of classification results between NSC-GA and NSCMD-GA for 
Ovarian data 
NSC-GA (Euclidean dist.) Proposed NSCMD-GA (Mass dist.) 
Number of peptides Unseen Test (%) Number of peptides Unseen Test (%) 
7 96.06 
10 
11 
20 
92.12 
92.12 
88.97 
 
 
7.2.3.7. Prostate cancer data 
 
 
Figure 7-22 A typical plot for convergence of fitness for the training data of Prostate 
using NSCMD-GA 
 
As seen in Figure 7-22, the convergence occurred after 43 generations with the 
maximum fitness of 1.94. The optimal shrinkage threshold obtained for each of the 15 
independent runs had the same maximum fitness of 1.94 which produced the same set 
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of 5 genes for the Prostate cancer dataset. As shown in Table 7-21, the set of 5 genes 
gave the average classification accuracy of 94.12% on unseen test data. The set of 5 
genes selected with gene accession numbers are 41468_at, 37639_at, 38406_f_at, 
769_s_at and 556_s_at, which is a subset of 6 genes found in NSC-GA. 
 
Table 7-21 Comparison of classification results between NSC-GA and NSCMD-GA for 
Prostate data 
NSC-GA (Euclidean dist.) Proposed NSCMD-GA (Mass dist.) 
Number of 
genes 
Unseen Test (%) Number of genes 
Unseen Test 
(%) 
6 90.2 5 94.12 
 
 
7.2.4. Summary: selected feature subsets and corresponding classification results 
 
Table 7-22 to Table 7-30 summarised all the features sets that were obtained using 
NSCM-GA, NSCP-GA, NSCMD-GA and NSC-GA on the seven datasets. 
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Table 7-22 Summary of the sets of selected features obtained from NSCM-GA, NSCP-
GA, NSCMD-GA and NSC-GA for AD data 
Proteins 
NSC-GA 
(Euclidean dist.) 
Proposed approaches 
NSCM-GA NSCP-GA NSCMD-GA 
Number of 
proteins 
Number of proteins 
11 18 9 4 
PDGF-BB_1 √ √ √ √ 
RANTES_1 √ √ √ √ 
IL-1a_1 √ √ √ √ 
TNF-a_1 √ √ √ √ 
EGF_1 √ √ √ 
 M-CSF_1 √ √ √ 
 ICAM-1_1 √ √ √ 
 IL-3_1 √ √ √ 
 IL-11_1 √ √ √ 
 GCSF_1 √ √ 
  ANG-2_1 √ √ 
  PARC_1  √ 
  GDNF_1  √ 
  TRAIL R4_1  √ 
  IL-8_1  √ 
  MIP-1d_1  √ 
  IGFBP-6_1  √ 
  MCP-3_1  √ 
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Table 7-23 Summary of the sets of selected features obtained from NSCM-GA, NSCP-
GA, NSCMD-GA and NSC-GA for Colon data  
Gene Accession 
number 
 
NSC-GA 
(Euclidean dist.) 
Proposed approaches 
NSCM-GA NSCP-GA NSCMD-GA 
Number of genes Number of genes 
28 7 6 12 
T71025 √ √ √ √ 
M63391 √ √ √ √ 
R87126 √ √ √ √ 
M76378 √ √ √ √ 
T92451 √ √ √ √ 
 J02854 √ √ √ √ 
M76378 √ √  √ 
R78934 √    
M26697 √    
Z24727 √   √ 
X55715 √    
T60778 √    
T57619 √    
M76378 √   √ 
H64489 √    
Z50753 √    
T60155 √    
M64110 √    
H40560 √    
T58861 √    
M22382 √    
X12671 √   √ 
T95018 √    
X86693 √    
H43887 √   √ 
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T47377 √   √ 
L05144 √    
H55758 √    
 
Table 7-24 Summary of the sets of selected features obtained from NSCM-GA, NSCP-
GA, NSCMD-GA and NSC-GA for Leukemia data  
Gene 
Accession 
number 
 
NSC-GA 
(Euclidean dist.) 
Proposed approaches 
NSCM-GA NSCP-GA NSCMD-GA 
Number of genes Number of genes 
9 9 4 5 24 3 
M27891 √ √ √ √ √ √ 
M84526 √ √ √ √ √ √ 
M96326 √ √ √ √ √ √ 
X17042 √ √ √ √ √  
U50136 √ √  √ √  
U46751 √ √   √  
X95735 √ √   √  
M28130 √ √   √  
Y00787 √ √   √  
L08246     √  
L16896     √  
M11147     √  
M16038     √  
M19507     √  
M55150     √  
M57710     √  
M62762     √  
M63138     √  
M69043     √  
Y12670     √  
X85116     √  
214 
 
J03801     √  
M19045     √  
X14008     √  
 
Table 7-25 Summary of the sets of selected features obtained from NSCM-GA, NSCP-
GA, NSCMD-GA and NSC-GA for Lymphoma data  
Gene 
accession 
number 
NSC-GA 
(Euclidean dist.) 
Proposed approaches 
NSCM-GA NSCP-GA NSCMD-GA 
Number of genes Number of genes 
12 7 3 
The list of 80 
genes is shown in  
 
Table 7-26 
3 
GENE3327X √ √ √ √ 
GENE3329X √ √ √ √ 
GENE3361X √ √ √ √ 
GENE3332X √ √   
GENE3330X √ √   
GENE3258X √ √   
GENE3256X √ √   
GENE3328X √    
GENE3314X √    
GENE3260X √    
GENE1252X √    
GENE3967X √    
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Table 7-26  List of 80 genes in the selected set obtained from NSCP-GA for Lymphoma 
data 
Gene accession numbers 
GENE3940
X 
GENE3554
X 
GENE3325
X 
GENE3338
X 
GENE3259
X 
GENE1212
X 
GENE3966
X 
GENE1693
X 
GENE3941
X 
GENE2496
X 
GENE3326
X 
GENE3341
X 
GENE3256
X 
GENE1213
X 
GENE3967
X 
GENE1694
X 
GENE3939
X 
GENE2326
X 
GENE3327
X 
GENE3314
X 
GENE3261
X 
GENE1251
X 
GENE3968
X 
GENE1697
X 
GENE3946
X 
GENE2106
X 
GENE3328
X 
GENE3312
X 
GENE3263
X 
GENE1252
X 
GENE947X 
GENE1719
X 
GENE3945
X 
GENE2066
X 
GENE3329
X 
GENE3311
X 
GENE3264
X 
GENE1174
X 
GENE3932
X 
GENE1720
X 
GENE3947
X 
GENE2065
X 
GENE3330
X 
GENE3309
X 
GENE3265
X 
GENE1159
X 
GENE3617
X 
GENE3839
X 
GENE3699
X 
GENE3290
X 
GENE3331
X 
GENE3361
X 
GENE3246
X 
GENE3988
X 
GENE3815
X 
GENE1349
X 
GENE3755
X 
GENE3347
X 
GENE3332
X 
GENE3258
X 
GENE2760
X 
GENE3987
X 
GENE384X 
GENE1171
X 
GENE3556
X 
GENE3346
X 
GENE3334
X 
GENE3257
X 
GENE3025
X 
GENE3986
X 
GENE1609
X 
GENE1080
X 
GENE3555
X 
GENE3315
X 
GENE3335
X 
GENE3260
X 
GENE1211
X 
GENE3965
X 
GENE1616
X 
GENE1556
X 
 
Table 7-27 Summary of the sets of selected features obtained from NSCM-GA, NSCP-
GA, NSCMD-GA and NSC-GA for Lung data  
Gene 
accession 
number 
NSC-GA 
(Euclidean dist.) 
Proposed approaches 
NSCM-GA NSCP-GA NSCMD-GA 
Number of genes Number of genes 
11 9 11 4 5 7 2 
33328_at  √ √ √ √ √ √ √ 
40936_at  √ √ √ √ √ √ √ 
34320_at √ √ √ √ √ √  
32551_at √ √ √ √ √ √  
37157_at √ √ √  √ √  
36533_at √ √ √   √  
37954_at √ √ √   √  
37716_at  √ √ √     
33833_at √ √ √     
33327_at √  √     
35823_at √  √     
 
 
216 
 
Table 7-28 Summary of the sets of selected features obtained from NSCM-GA, NSCP-
GA, NSCMD-GA and NSC-GA for Ovarian data  
Gene 
accession 
number 
NSC-GA 
(Euclidean dist.) 
Proposed approaches 
NSCM-GA NSCP-GA NSCMD-GA 
Number of 
Peptides 
Number of Peptides 
7 1 2 8 9 10 10 11 20 
MZ244.36855 √ √ √ √ √ √ √ √ √ 
MZ244.66041 √  √ √ √ √ √ √ √ 
MZ244.95245 √   √ √ √ √ √ √ 
Z245.24466 √   √ √ √ √ √ √ 
MZ245.8296 √   √ √ √ √ √ √ 
MZ245.53704 √   √ √ √ √ √ √ 
MZ246.12233 √   √ √ √ √ √ √ 
MZ246.41524    √ √ √ √ √ √ 
MZ25.589892     √ √ √ √ √ 
MZ25.49556      √ √ √ √ 
MZ25.684398        √ √ 
MZ28.600577         √ 
MZ220.47402         √ 
MZ28.700483         √ 
MZ220.75125         √ 
MZ29.001246         √ 
MZ246.70832         √ 
MZ463.55767         √ 
MZ463.95962         √ 
MZ464.36174         √ 
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Table 7-29 Summary of the sets of selected features obtained from NSCM-GA, NSCP-
GA, NSCMD-GA and NSC-GA for Prostate data  
Gene 
Accession 
number 
NSC-GA 
(Euclidean dist.) 
Proposed approaches 
NSCM-GA NSCP-GA NSCMD-GA 
Number of genes Number of genes 
6 17 5 5 
41468_at √ √ √ √ 
37639_at √ √ √ √ 
38406_f_at √ √ √ √ 
769_s_at √ √ √ √ 
556_s_at √ √ √ √ 
31444_s_at √ √   
31527_at  √   
33614_at  √   
39756_g_at  √   
40435_at  √   
40436_g_at  √   
36587_at  √   
36666_at  √   
37720_at  √   
216_at  √   
38429_at  √   
40282_s_at  √   
 
Table 7-30 shows a summary of classification results associated with using the different 
sets of features, obtained from NSC-GA, NSCM-GA, NSCP-GA and NSCMD-P on the 
AD, Colon, Leukemia, Lymphoma, Lung, Ovarian and Prostate cancer data, on the 
corresponding unseen test dataset. 
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Table 7-30 Summary of classification results for the respective unseen test datasets 
using the corresponding feature sets obtained using  NSC-GA, NSCM-GA, NSCP-GA 
and NSCMD-GA for  each of the seven datasets  
Dataset 
NSC-GA 
(Euclidean dist.) 
Proposed approaches 
NSCM-GA NSCP-GA NSCMD-GA 
No of 
features 
Test 
(%) 
No of 
features 
Test 
(%) 
No of 
features 
Test 
(%) 
No of 
features 
Test 
(%) 
AD 11 90.21 18 97.82 9 92.39 4 91.3 
Colon 
28 
6 
100 7 93.54 
6 
 42 
100 12 100 
Leukemia 9 97.05 9 94.12 
4 
5 
24 
94.12 3 94.12 
lymphoma 
7 
12 
128 
129 
132 
95.45 
95.45 
100 
100 
100 
3 100 
72 
73 
75 
77 
80 
100 3 100 
Lung 
8 
9 
10 
11 
100 
9 
11 
98.88 
4 
5 
7 
100 2 63.33 
Ovarian 7 96.06 1 96.06 
 
2 
8 
9 
10 
 
96.85 
96.06 
96.06 
96.06 
10 
11 
20 
92.12 
92.12 
88.97 
Prostate  6 90.2 17 100 5 90.2 5 94.12 
 
As seen in Table 7-30, the columns of “No of features” list the number of selected 
features using the different approaches, NSC-GA, NSCM-GA, NSCP-GA and NSCMD-
GA, with the smaller set being a subset of the larger set of features for the 
corresponding dataset. Also seen from the table, for AD data, NSCM-GA approach was 
the best in terms of achieving the highest classification accuracy, 97.82%, on unseen 
test data compared with NSC-GA, NSCP-GA and NSCMD-GA. However, NSCMD-GA 
approach selected a smallest set of features, 4, and classification accuracy of 91.3%, that 
was higher than the NSC-GA approach and compatible with the NSCP-GA approach; 
for Colon data, NSCP-GA outperformed the other approaches in terms of selecting a 
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smallest set of relevant features, 6, with highest classification accuracy of 100%; for 
Leukemia data, NSCMD-GA selected a smallest set of relevant features, 3, and still 
retained the same classification accuracy of 94.12% as of NSCM-GA and NSCP-GA 
using 13, 9 and 5 features respectively, and was compatible with NSC-GA of 97.05 
using 9 features. It can be stated that NSCMD-GA approach is able to select a smallest 
set of features and still retain compatible classification accuracy compared to the other 
approaches for AD and Leukemia data; for Lymphoma data, NSCM-GA and NSCMD-
GA outperformed the other approaches for both in selecting a smallest feature set, 3, 
with the highest classification accuracy of 100%; for Lung and Ovarian data, NSCP-GA 
showed its best in overall for selecting small set of 4 and 2 features with the highest 
classification accuracy of 100% and 96.85%, respectively; and for Prostate data, NSCM-
GA selected the larger set of 17 features with the highest classification accuracy of 
100%, NSCMD-GA outperformed NSC-GA and NSCP-GA for selecting a smallest set of 
5 features with higher classification accuracy of 94.12%.  
 
Again, these results showed that the developed techniques support a comprehensive 
analysis, providing a number of multi-variate signatures for each dataset, each with a 
varying number of features. Biomedical researchers can make informed decision based 
on the tradeoffs between classification accuracy and size of feature sets as well as use 
domain knowledge to decide on the potential relevance of features in the different 
signatures. An important aspect of the smaller sets being subsets of the larger set also 
provides some information about the possible correlations/interactions amongst the 
features and the joint behaviour of these features. 
 
7.3. Summary 
 
This chapter has described the proposed approach of implementing different similarity 
distance measures in the NSC classifier and incorporating NSC and GA to 
automatically search for optimal shrinkage threshold values for NSC. The approach 
used the modified NSC classifier with different distance measure as an evaluator to 
evaluate the fitness of the candidate shrinkage threshold values, utilized the GA as a 
search algorithm to search for optimal shrinkage threshold values, and obtained the sets 
of relevant features. The results obtained shows that the new approaches, NSCM-GA, 
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NSCP-GA and NSCMD-GA, are able to select smaller set of features and improve 
classification accuracy compared to the NSC classifier using Euclidean distance.  
 
In the next chapter, the proposed approach of using a multi-objective algorithm to 
incorporate into the NSC algorithm for searching multiple optimal solutions will be 
described in details.  
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8. Incorporating Nearest shrunken centroid and multi-objective 
evolutionary algorithm for searching multiple shrinkage threshold 
solutions 
 
8.1. Introduction 
 
In Chapter 5, the approach of incorporating NSC into GA (NSC-GA) was proposed for 
finding an optimal shrinkage threshold for NSC automatically (Dang et al., 2013). In 
NSC-GA, the approach of aggregating 2 objective functions as a single objective was 
implemented for measuring the fitness of chromosomes. In order to optimize a multi-
objective problem more effectively and to obtain multiple optimal solutions in a single 
run, an approach involving MOEA is developed in this study. The non-dominated 
sorting algorithm (NSGA2) algorithm (Deb et al., 2002) is  an example of an MOEA 
that has been used in bioinformatics. For example, Deb, et al. (2002), Deb and Reddy 
(2003), Mitra and Banka (2006), and Banerjee, Mitra and Banka (2007) employed the 
NSGA2 algorithm to produce multiple feature sets for Colon, Lymphoma and Leukemia 
cancer dataset in their studies. One of the advantages of using MOEAs is its ability to 
evaluate multiple objectives simultaneously in order to find optimal solutions showing 
good tradeoffs between all objective functions (Deb et al., 2002). For example, Deb and 
Reddy (2003) employed NSGA2 to analyse the Leukemia cancer dataset and obtained 
352 different three-gene sets that gave 100% classification accuracy.  
 
Motivated by 1) the effectiveness of MOEA (NSGA2) in its potential to find  multiple 
solutions, 2) the NSC algorithm in FS and classification, and 3) the automated shrinkage 
threshold optimization in NSC-GA,  a hybrid approach incorporating NSGA2 (Deb et 
al., 2002) and NSC algorithm (Tibshirani et al., 2002) is proposed in this chapter to 
automatically find the Pareto front associated with optimal  shrinkage threshold values 
for the NSC.  These optimal shrinkage threshold values mapped to potential sets of 
relevant features for classification. The aim of this study is to see the impact of 
incorporating a MOEA with NSC with the use of multiple objective functions to 
evaluate the fitness of chromosomes in the task for obtaining multiple shrinkage 
threshold solutions. This chapter is an extended version of the paper “NSC-NSGA2: 
Optimal Search for Finding Multiple Thresholds for Nearest Shrunken Centroid” (Dang 
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& Lam, 2013). The proposed approach uses NSC as a fitness evaluator in NSGA2 to 
measure the goodness of feature sets and NSGA2 optimizes the search for multiple 
solutions.  Unlike NSC-GA, where the shrinkage threshold value is selected on the basis 
of a single objective function which is an aggregation of 2 objective functions, the 
proposed approach, NSC-NSGA2, supports finding optimal shrinkage threshold values 
while considering different tradeoffs by simultaneously considering multiple objective 
functions. The proposed approach is evaluated using the evaluation strategy and the 7 
biomedical datasets described in Chapter 3. 
 
Section 8.2, describes the proposed approach, NSC-NSGA2, with evaluation results in 
Section 8.3, details and results for NSC-NSGA2 using 3 objective functions are 
described in Section 8.4. Section 8.5 describes the investigation of using Mahalanobis 
distance in NSC-NSGA2 and followed by the summary in Section 8.6. 
 
8.2. The proposed approach, NSC-NSGA2 
 
Figure 8-1 illustrates the framework of the proposed approach, NSC-NSGA2. There are 
2 main steps consisting of: 
 
Step 1:  This step carries out the procedure for automatic calculation of Thmax. This 
procedure is performed once only at the beginning of NSC-NSGA2. 
 
Step 2: NSGA2 is employed in this step to search for multiple optimal sets of shrinkage 
thresholds for NSC algorithm. The NSC algorithm is employed as a fitness evaluator to 
evaluate the fitness of each chromosome in terms of the number of features selected and 
its training classification accuracy. 
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 Figure 8-1 Framework of the proposed approach, NSC-NSGA2 
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8.2.1. Issues related to the proposed approach, NSC-NSGA2 
 
Chromosomes encoding and fitness evaluation are similar to those used in NSC-GA. 
The same procedure for estimation of the initial range of values for the shrinkage 
threshold described in Section 5.2.1 is also used in NSC-NSGA2. The following section 
describes the issues associated with encoding chromosomes and fitness evaluation. 
 
8.2.1.1. Encoding chromosomes 
 
The aim of the proposed approach is to use a MOEA, specifically NSGA2 to find a 
Pareto front consisting of multiple shrinkage threshold values that are real numbers for 
NSC. Similar to the NSC-GA, the most appropriate encoding representation for 
chromosomes in this study would also be a real-encoding. But unlike the NSC-GA 
approach in which, each chromosome consists of a number of genes (shrinkage 
thresholds), in NSC-NSGA2, each chromosome consists of a single gene only, 
representing one shrinkage threshold value.  
 
8.2.1.2. Fitness evaluation using NSC as a fitness evaluator 
 
The NSC algorithm is also employed as a fitness evaluator in the NSC-NSGA2 
approach for evaluating the fitness of the chromosomes using the training dataset. The 
NSC algorithm uses shrinkage threshold values to perform FS and classification. As a 
result, each shrinkage threshold (chromosome) is associated with a set of features and 
classification accuracy. To investigate the impact of the approach to using more than 2 
objective function, two versions: NSC-NSGA2 and NSC-NSGA2* were implemented 
involving two and three objective functions respectively. The first two objective 
functions (f1 and f2) have been described in Section 5.3.2.2 and the third objective 
function (f3) is defined in Equation 8.6. 
 
The basic concepts of NSC algorithm (Tibshirani et al., 2002) has been reviewed in 
Section 2.3.3. The following sections describe the steps associated with the proposed 
approach, NSC-NSGA2. The parameters used to run NSC-NSGA2 are also described in   
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Table 8-1. 
 
8.2.2. Steps of the proposed approach, NSC-NSGA2 
 
8.2.2.1. Step 1:  Thmax calculation 
 
The same procedure for calculating Thmax described in Section 5.2.2.1 is employed here 
to find the Thmax value (upper bound shrinkage threshold value) for the respective 
dataset. 
 
8.2.2.2. Step 2: Multi-objective evolutionary algorithm search optimization 
 
The study uses NSGA2 and NSC to automatically obtain multiple optimized shrinkage 
threshold values for finding relevant features for classification. The following section 
describes Pareto-based MOEA in general and NSGA2 specifically. 
 
The concept of Pareto optimality and dominance as defined by Coello and Lamont 
(2004), Ayala and Coelho (2008), and Fonseca and Fleming (1995) is: 
 
    X is a Pareto optimal if and only if F( ) = (fi ( ),.., fk ( )) is not dominated by F(  ) 
= (f1 (  ),.., fk (  )) where      X. A solution  1 dominates  2 if and only if f ( 1) less 
than or equal f ( 2), which means: 
 
∀i {1..k}, fi ( 1) ≤  fi ( 2) ⋀ ∃i   {1..k}  : fi ( 1) < fi ( 2) 
 
if no other solutions dominate  1, then  1 is non-dominated. Thus the Pareto front is the 
set of non-dominated solutions.  
 
Figure 8-2 illustrates the Pareto front with a set of solutions. 
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Figure 8-2 Pareto front solutions 
 
According to Ayala and Coelho (2008), a good solution obtained from MOEA must be 
very close to the Pareto front and is also wide spread. In order to achieve this desire  
solution, MOEA first  needs to find a solution set that is close to the Pareto front as 
possible and then search through the Pareto front to obtain a  set of solution which is 
more diverse than the other solution sets in the Front. 
 
MOEA selects non-dominated solutions (Pareto front) based on the Pareto ranking. The 
population is sorted according to Pareto dominance of individuals, and then all the non-
dominated individuals are given the same rank which is a higher rank than the 
dominated individuals. The same rank is given for all non-dominated individuals so that 
they would have the equal probability of being chosen to reproduce offspring. 
According to Coello and  Lamont (2004), the diversity of the Pareto front is maintained 
by different strategies such as fitness sharing and niching, clustering, and use of 
entropy. The use of elitist schemes is very popular in MOEA in recent years. With this 
elitist approach, a second population is used along with the main population to store the 
non-dominated solutions found during the evolutionary process. It is also used to 
improve the diversity of the solutions and to adjust the selection rate of the algorithm 
(Coello & Lamont, 2004). Another approach of using this elitist approach is to combine 
the parent population and its offspring population into a single population as in NSGA2 
(Deb et al., 2002) to maintain the elitist solutions (Coello & Lamont, 2004). The 
following section describes steps involving NSGA2 in the proposed approach. 
 
NSGA2 incorporates the concept of Pareto front into MOEA (Deb et al., 2002) which 
was developed based on NSGA (N. Srinivas & Kalyanmoy, 1994). NSGA2 is an 
improved version of NSGA in terms of less computational time, incorporating elitism to 
      Pareto front solutions  
Dominated solutions 
f2 
f1 
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improve the performance of the algorithm and avoid losing good solutions, and not 
using a sharing parameter provided by the user (Deb et al., 2002). The following figure 
illustrates the framework of NSGA2 with the major phases. 
 
Figure 8-3 Major steps of NSGA2 adapted from Deb et al. (2002) 
 
a) Population initialization 
After the chromosome representation has been determined and the Thmax value has also 
been calculated, a population of chromosomes is then initialized. Each chromosome 
(shrinkage threshold value) is initialized to a real value generated randomly in the range 
[0, Thmax] using RNG. Figure 8-4 describes the procedure used to initialize the 
population and Figure 8-5 shows an example of an initial population. 
 
 
Input: 
 Thmax 
Size of population, p 
Output: 
 An initialized population of p chromosomes 
Steps: 
1. Set population (Ip) as 1dimensional array of size p of real numbers 
2. Set Ip = { } 
3. For counter from 1 to p 
a. Generate a real random number (Rn) in the range [1, Thmax] using a  
RNG 
b. Store Rn to Ip[counter] 
 
Figure 8-4 Initial population algorithm using RNG 
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1.153       25  
2.969      1  
1.176       24 
1.932       14 
0.702       45 
1.337       16 
0.247       87 
2.438       4 
0.001       150 
1.872       15 
 
 
Figure 8-5 An example of an initial population with 10 chromosomes with shrinkage 
threshold values and the number of features in their corresponding sets 
 
As seen in the example in Figure 8-5, each chromosome consists of only one shrinkage 
threshold value which has been initialized to be in the range between 0 and Thmax, that 
is [0, 3], Each shrinkage threshold value is associated with a set of features, for 
example, shrinkage threshold value of 1.153 resulted in a set of the most relevant 25 
features and a value of 0.001 resulted in a set of the entire initial 150 features 
(highlighted row 1 and 9, respectively). Once the initial population has been initialized, 
the next step is to evaluate the fitness of chromosomes in the population.  
 
b) Fitness evaluation in NSC-NSGA2 
In this step, two sub-steps are carried out: firstly, the fitness for each chromosome in the 
population is calculated using two objective functions: f1 and f2 (or three objective 
functions in the case of NSC-NSGA2*), and secondly, chromosomes in the population 
are sorted using the non-dominated sorting algorithm (Deb et al., 2002) shown in Figure 
8-8. 
 
The NSC algorithm described in Section 2.3.3 is employed here as a fitness evaluator to 
determine the fitness of the chromosomes associated with a training dataset. To obtain 
the fitness of the chromosome, firstly, the chromosome (shrinkage threshold) value is 
used in the NSC algorithm to obtain the corresponding set of features and secondly, this 
Gene (shrinkage threshold)  
Chromosomes  
 
   Associated feature sets 
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set of features is then used to construct a classifier that is used to classify the training 
data. The set of features and its classification result are then used in the calculation of 
the fitness of the chromosome. The two objective functions (f1 and f2) have been 
described in Section 5.3.2.2 and are shown as follows. 
 
 f1 = (Ntotal - Natt) / Ntotal   (8.1) 
 
     
     
           
   (8.2) 
 
Objective function f1 is designed for maximizing the fitness of chromosomes (solutions) 
that has a minimum number of features, i.e., the smaller the number of features selected 
the better the fitness for the chromosome, f2 is designed for maximizing the fitness of 
chromosomes that has highest training classification accuracy, i.e., the higher the 
training classification accuracy the better the fitness for the chromosome.  
 
c) Selection and mutation operators 
Selection and mutation operators for real encodings are used in NSC-NSGA2. The 
crowded tournament selection is employed in NSGA2 for chromosome selection. The 
crowded tournament selection is a binary tournament selection with different selection 
criteria based on the rank and crowding distance of the chromosomes. That is, two 
chromosomes are selected randomly from the population to form a tournament group 
(i.e. the size of tournament group is two for a binary tournament) and the best 
chromosome of the group is selected based on the fitness ranked by the non-dominated 
sorting procedure (Deb et al., 2002; Suzuki et al., 1995). In the case of two 
chromosomes with different ranks then choose the one with a better rank. Otherwise, if 
the two chromosomes have the same rank, then the crowding distance algorithm is 
employed to calculate the crowding distance of the chromosomes and the chromosome 
with a smaller crowding distance is chosen (Deb et al., 2002; Suzuki et al., 1995). 
Tournament selection has been described in Section 2.4.4.2, the crowded tournament 
selection and the crowding distance algorithm (Deb et al., 2002) are described in Figure 
8-6 and Figure 8-7, respectively. 
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Input: 
 Population front (P) 
 Population ranks (Prank) 
Output: 
 Best chromosome (Cbest) 
Steps: 
1. Set k = size of binary tournament = 2 
2. For counter from 1 to k 
 Select a chromosome (C1) randomly from P 
 Select a chromosome (C2) randomly from P 
3. Compare the rank of C1 and C2 using Prank 
i. If rank of C1 = rank of C2 
 Perform crowding distance algorithm 
 Select the chromosome (Cbest) with a smaller crowding distance 
ii. Else 
  Select a chromosome (Cbest) with the best rank  
 
Figure 8-6 Crowded tournament selection algorithm used in Deb et al. (2002) 
 
 
Input: 
 Population (P) 
 Objective functions f [f1..fn] 
 Number of objective functions (Nf) 
Output: 
 Individual crowding distance  
Steps: 
1. For each n individual in P 
      Initialize Individual distance (Id) = 0     
2. For counter from 1 to Nf 
a. Sort P based on f 
b. Set Id1  = Idn   ∞       
3. For counter = 2 to (n -1)       
        Idi = Idi+ ((I(i+1).m  - I(i-1).m)/ ∫
   
 
- ∫
   
 
   
  (where I(i).m = value of mth objective function of the kth  
individual in i) 
 
Figure 8-7 Crowding distance algorithm used in Deb et al. (2002) 
 
Note that in Step 2b, the two boundary solutions, i.e., solutions with smallest and largest 
objective function values, are assigned a value of infinite distance (∞) so that the 
boundary solutions are always selected. Step 3 in Figure 8-7 is used to calculate the 
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Euclidean distance for the remaining solutions, i.e., solutions between the boundary 
solutions. 
 
Gaussian distribution probability is employed as the mutation operator to modify the 
value of a gene in a chromosome.  When mutating a single real value, Gaussian 
probability distribution function is first used to get a number and then adding it to the 
value being mutated to produce a new number (Hedvat et al., 2003). The calculation of 
probability distribution,     , for a value   is defined by Equation (8.3) and the 
mutation value,      , is calculated by Equation (8.4). 
 
      (
 
 √  
)  
 (
      
   
)
     (8.3) 
 
                (8.4) 
 
where   is a value of the gene (threshold), σ is a standard deviation,  μ is a mean of the 
value. 
 
σ  1 and μ 0 when mutating a chromosome with only one gene value, hence Equation 
(8.3) can be rewritten using Equation (8.5). 
      (
 
√  
)  
 (
  
 
)
     (8.5) 
 
d) Offspring population (Po) generation 
The new offspring produced from one cycle consisting of the selection and mutation 
process are then placed into the offspring population. The process of creating new 
offspring via the cycle consisting of the selection and mutation process is repeated until 
the population for new offspring of size N (the same size of parent population size) is 
obtained. 
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e) Union (combination) of two populations (Pi and Po) 
Two populations (in the same generation), the first being the parent population (Pi) of 
size N and the second being the offspring population (Po) also of the size N, are then 
combined to make a larger population of size 2N, Pu.  
 
f) Rank the individuals in the combined population, Pu, using the non-dominated  
sorting algorithm (Figure 8-8). All the best chromosomes of rank #1 are placed in Front 
#1, all the next best chromosomes of rank #2 are placed in Front #2, etc., and when the 
sorting algorithm has found a sufficient number of fronts having a specified number of 
chromosomes for the new population, it stops the sorting process (Deb et al., 2002).  
 
For each individual p in population P 
Initialise Sp =                      
               np =0                      
For each individual q in population P 
     If p dominates q then  
 Add q to Sp 
     Else if q dominates p then 
       np = np+1              
     if np=0                              
          prank =1           
          add p to Front1       
Set Front counter i =1 
While Fronti ≠   
    Set Q =              
     For each p in Fronti 
        For each q in Sp               
           nq = nq-1         
                if nq =0      
         qrank = i+1        
   add q to Q       
    i = i+1                       
    set Fronti = Q  
 
Figure 8-8 Non-dominated sorting procedure used in Deb et al. (2002)  
 
g) Generate a new population (Pi+1) of size N 
After the ranked chromosomes in Pu were sorted into Fronts on the basis of their 
respective ranks, a new population (Pi+1) of size N is then created by populating it, 
starting with chromosomes from the front with the highest rank. The process continues 
to incorporate chromosomes, taken from a descending order of ranked fronts. In the 
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event that there are more chromosomes in the ultimate Front to be included for 
completing a population of size N, chromosomes in this front are sorted using the 
crowding distance procedure first and the remaining slots in the population are then 
filled with the required number of “best chromosomes” from  this front. Figure 8-9 
showed the steps involved in generating the new population. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8-9 Steps for generating the new population from the combined population 
 
h) Repeat the process 
The new population Pi+1 undergoes the next iteration consisting of all steps described 
above, i.e., from fitness evaluation to the step for generation of a new population. These 
iterations of steps are repeated until the termination condition is satisfied (i.e. the 
predefined maximum number of generations has been executed).  A Pareto front is the 
output.  The following figure shows an example of a Pareto front of shrinkage threshold 
solutions with their associated objective function values. 
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Figure 8-10 An example of Pareto front of 9 shrinkage threshold solutions 
 
Figure 8-10 shows an example of a Pareto front consisting of 9 shrinkage threshold 
value solutions listed in the “Pareto front” column with their associated objective 
function of f1 and f2 listed in the last 2 columns (Objective fitness column). For example 
for the 1
st
 shrinkage threshold value, 2.8555 (highlighted) in the shrinkage threshold 
value column having associated f1=0.9916 and f2=0.6626 (highlighted) in the objective 
fitness column. 
 
8.2.3. Parameter settings for NSGA2 
 
According to Deb et al. (2002), the mutation rate used in their study was based on 1/n 
where n is the number of attributes. In this study, since the chromosome has only one 
attribute (shrinkage threshold value), the algorithm relies solely on a mutation operator 
to generate new offspring. To adapt to this situation the mutation rate of 1/n is used 
where n is the population size (Goldberg, 1989). The algorithm was executed with the 
population size of 100, and mutation rate of 0.01, i.e., 1/100. The complete set of 
parameter settings used in this study is shown in Table 8-1. As each chromosome 
consists of a single gene, crossover operations are not applicable.  
 
 
 
  
0.9916666666666667  0.6626506024096386  
0.8416666666666667  0.9036144578313254  
0.9666666666666667  0.7228915662650602  
0.9583333333333334  0.7951807228915662  
0.9083333333333333  0.8674698795180723  
0.8666666666666667  0.8795180722891566  
0.9333333333333333  0.8192771084337349  
0.9166666666666666  0.8554216867469878  
0.95    0.8072289156626506  
   
 
2.855559333844611   
1.2154637472872774   
2.194804507510737   
2.0993206348249376   
1.5086645962070784   
1.3642342000485415   
1.7379179051564781   
1.6187309914352315   
1.868299886752155   
Objective fitness Pareto front 
 f1 f2 
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Table 8-1 Parameter set used for NSC-NSGA2 
Parameters Values / Methods 
Population Size 100 
Chromosome Length 
- Real encoding 
1 
 
Mutation Probability 1 / Population size = 0.01 
Generation 1000 
Selection Crowded tournament 
Mutation Gaussian probability distribution 
 
 
8.3. Experiment results 
 
Experiments were carried out to evaluate the proposed approach, NSC-NSGA2, in 
terms of obtaining the Pareto front of shrinkage threshold values associated with the 
NSC for the datasets described in Section 3.1. For each of the 7 datasets, 15 
independent runs of the proposed approach were executed using the respective training 
data. For each run, a stratified 10 fold CV described in Section 3.2 was employed. Each 
shrinkage threshold solution on the Pareto front obtained from each run is used as input 
to the NSC algorithm to obtain its corresponding feature set. This feature set was then 
used to construct the corresponding NSC classifier to classify the unseen test data 
associated with the dataset. Where appropriate, the comparison of the performance of 
the proposed algorithm with existing work is based on classification accuracy and the 
selected feature sets. 
 
Two common characteristics are applicable across the results from the evaluation of the 
approach using each of the seven datasets. These are: 
 The classification results using each of the NSC classifiers on the respective 
unseen test dataset from each run are first recorded and the reported 
classification accuracy in the tables was an average of classification accuracy of 
these classifiers over the 15 independent runs. 
 In terms of the selected feature sets that were obtained as part of the evaluation, 
the smaller feature set is a subset of the larger feature set. For example, in Table 
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8-2, the set with 18 features is the subset of the set with 19 features and 
similarly, the set with one feature is both a subset of the set of 18 as well as the 
set of 19 features. 
 
8.3.1. Ray et al.  AD data 
 
The proposed algorithm, NSC-NSGA2, was executed 15 times with 10 fold CV on AD 
dataset using the NSGA2 parameter setting listed in Table 8-1. The results obtained 
from the 15 independent runs consists of 8 runs where their Pareto fronts has 10 
shrinkage thresholds, 3 runs with Pareto fronts of 9 shrinkage thresholds, 3 runs with 
Pareto fronts of 8 shrinkage thresholds, and 1 run with Pareto fronts of 7 shrinkage 
thresholds. Using these shrinkage thresholds led to selected sets of features consisting of 
1, 4, 5, 6, 7, 8, 9, 10, 11, 15, 16, 17, 18 and 19 features. The convergence plot with a 
typical Pareto optimal front from one of the 15 runs is shown in Figure 8-11 and the 
NSC classification results using each of these sets of features on the unseen test dataset 
are shown in Table 8-3. 
 
 
Figure 8-11 A typical Pareto front plot of objective function f1 against f2 for AD dataset 
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As seen in Table 8-2, the proposed approach found a set of 18 and 19 features which are 
the same set of 18 and 19 features found in (Ray et al., 2007). The approach also found 
the same set of 11 features reported in Chapter 5 using the NSC-GA approach.  
 
Table 8-2 Sets of selected proteins using the proposed approach, NSC-NSGA2, for AD 
data 
 Proteins  
Protein sets 
19 18 17 16 15 11 10 9 8 7 6 5 4 1 
PDGF-BB_1 √ √ √ √ √ √ √ √ √ √ √ √ √ √ 
RANTES_1 √ √ √ √ √ √ √ √ √ √ √ √ √  
IL-1a_1 √ √ √ √ √ √ √ √ √ √ √ √ √  
TNF-a_1 √ √ √ √ √ √ √ √ √ √ √ √ √  
EGF_1 √ √ √ √ √ √ √ √ √ √ √ √   
M-CSF_1 √ √ √ √ √ √ √ √ √ √ √    
ICAM-1_1 √ √ √ √ √ √ √ √ √ √     
IL-3_1 √ √ √ √ √ √ √ √ √      
IL-11_1 √ √ √ √ √ √ √ √       
GCSF_1 √ √ √ √ √ √ √        
ANG-2_1 √ √ √ √ √ √         
PARC_1 √ √ √ √ √          
GDNF_1 √ √ √ √ √          
TRAIL R4_1 √ √ √ √ √          
IL-8_1 √ √ √ √ √          
MIP-1d_1 √ √ √ √           
IGFBP-6_1 √ √ √            
MCP-3_1 √ √             
MDC_1 √              
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Table 8-3 Classification results for the AD data using the sets of selected features from 
NSC-NSGA2 approach 
Number of proteins  
Average classification Accuracy (%) 
(Unseen Test data) 
1  56.98 
4  72.82 
5  76 
6, 7   81.52 
9 82.6 
8  82.78 
10  83.4 
11  87.7 
17 91.3 
16  91.63 
15 92.39 
18 93.84 
19  94.56 
 
From the results it can also be seen that NSC-NSGA2 produced a number of potential 
feature sets that demonstrates the tradeoffs between the numbers of selected features 
and the classification accuracy for the unseen test data. For example, the smallest 
feature set (with 1 feature), the resulting classifier has the lowest classification accuracy 
for the unseen test data (56.98%), whilst the largest feature set (19 features) the 
resulting classifier has the highest test classification accuracy (94.56%) on the unseen 
test data. This type of analysis provides more information than univariate statistics and 
biomedical researchers can use it to gain a better understanding of the possible 
correlations amongst the features as well as the joint behaviour of features in their 
datasets.   
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8.3.2. Alon et al. Colon cancer data 
 
 
Figure 8-12 A typical Pareto front plot of objective function f1 against f2 for the Colon 
cancer dataset 
 
Using the same experimental procedure described above, the proposed algorithm is 
evaluated using the Colon dataset. A typical convergence plot with a Pareto optimal 
front consisting of 7 solutions is shown in Figure 8-12. NSC-NSGA2 found optimal 
shrinkage threshold values from the 15 independent runs that consist of 8 runs with a 
Pareto front of 5 shrinkage thresholds, 4 runs with a Pareto front of 6 shrinkage 
thresholds, 2 runs with a Pareto front of 4 shrinkage thresholds and 1 run with a Pareto 
front of 7 shrinkage thresholds. Using these shrinkage thresholds led to selected sets of 
features consisting 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 21, 23, 38, 39, 40, 42, 43, 44, 45, 47, 48, 
61, 62, 77, 83, 85, 87, 89 and 92 features (genes).  Classification results associated with 
classifiers constructed from these sets of selected features are shown in Table 8-4. An 
interesting point here is that classifiers constructed using feature sets that are supersets 
of the set of 23 features all performed worse than those classifiers constructed from 
feature sets that are subsets of the set of 23 features. The set of 9 genes includes known 
biomarkers associated with Colon cancer from the literature. These are M76378, 
J02854, M63391, Z50753, T71025, R87126, U25138, M82919 and T92451 
(highlighted genes in Table 8-4).  Note that Table 8-4  lists only the sets that have up to 
0.7
0.75
0.8
0.85
0.9
0.95
0.95 0.96 0.97 0.98 0.99 1
Pareto front
f2 
f1 
240 
 
23 genes but the evaluation has been done for all sets of features obtained using NSC-
NSGA2 and shown in Table 8-5. 
 
Table 8-4 Sets of genes selected using the proposed approach, NSC-NSGA2 for Colon 
cancer data 
Gene accession number 
Gene sets 
23 21 10 9 8 7 6 5 4 3 2 1 
M76378 √ √ √ √ √ √ √ √ √ √ √ √ 
J02854 √ √ √ √ √ √ √ √ √ √ √  
M63391 √ √ √ √ √ √ √ √ √ √   
Z50753 √ √ √ √ √ √ √ √ √    
T71025 √ √ √ √ √ √ √ √     
R87126 √ √ √ √ √ √ √      
U25138 √ √ √ √ √ √       
M82919 √ √ √ √ √        
T92451 √ √ √ √         
M76378 √ √ √          
Z24727 √ √           
M76378 √ √           
T56604 √ √           
H43887 √ √           
R36977 √ √           
X86693 √ √           
X63629 √ √           
M36634 √ √           
T67077 √ √           
H06524 √ √           
T60778 √ √           
H67764 √            
X12671 √            
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Table 8-5 Classification results for the Colon cancer data using the sets of selected 
features from NSC-NSGA2 approach 
Number of genes  
Average classification Accuracy (%) 
(Unseen Test data) 
61 , 87, 62, 86  62.5 
77, 83, 85, 92, 89 68.75 
38 , 48 81.25 
39, 40, 42, 43, 44, 45, 47 87.5 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 21, 23 93.75 
 
 
8.3.3. Leukemia cancer data 
 
Using the same experimental procedure as before, the proposed algorithm was evaluated 
using the Leukemia cancer dataset. A typical Pareto optimal front from one of the 15 
independent runs is shown in Figure 8-13. 
 
 
Figure 8-13 A typical plot of a Pareto front of objective function f1 against f2 for the 
Leukemia cancer dataset 
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The Shrinkage threshold solutions obtained from the 15 independent runs led to selected 
sets of features consisting 2, 7, 9, 10, 11 and 13 features. The sets of 2, 7, 9, 10, 11 and 
13 features are listed in Table 8-6.  Five genes are associated with known Leukemia 
biomarkers in the literature; namely M84526_at, U50136_mal_at, D49950_at, 
M16038_at and X17042_at (highlighted genes in Table 8-6). Classifiers constructed 
using the set with 2 and 13 genes produced the same  average classification accuracy, 
91.18%, on unseen test data, and classifiers constructed using  the set of 7, 9, 10 and 11 
genes produced  the same  average classification accuracy of 94.11%. The set of 13 
genes having seven genes in common from the set of 9 genes reported in NSC-GA [7]. 
 
Table 8-6 Sets of genes selected using the proposed approach, NSC-NSGA2 for 
Leukemia cancer data 
Gene accession number 
Gene sets 
13 11 10 9 7 2 
M84526_at √ √ √ √ √ √ 
U50136_rna1_at √ √ √ √ √ √ 
D49950_at √ √ √ √ √  
M16038_at √ √ √ √ √  
M23197_at √ √ √ √ √  
X17042_at √ √ √ √ √  
X95735_at √ √ √ √ √  
M55150_at √ √ √ √   
M57710_at √ √ √ √   
Y00787_s_at √ √ √    
M27891_at √ √     
U82759_at √      
M28130_rna1_s_at √      
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Table 8-7 Classification results for the Leukemia cancer data using the sets of selected 
features from NSC-NSGA2 approach 
Number of genes 
Average classification Accuracy (%) 
(Unseen Test data) 
2, 13 91.18 
7,  9, 10, 11 94.12 
 
 
8.3.4. Ovarian cancer data 
 
Using the same experimental procedure as before, the proposed algorithm was evaluated 
using the Ovarian cancer dataset.  A typical convergence plot of Pareto optimal front 
with 5 solutions is shown in Figure 8-14.  
 
 
Figure 8-14 A typical Pareto front plot of f1 against f2 for Ovarian cancer dataset 
 
The results obtained from the 15 independent runs consist of 8 runs, each with a Pareto 
front of 5 shrinkage thresholds; 4 runs, each with a Pareto front of 3 shrinkage 
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shrinkage thresholds led to selected sets of features consisting 1, 5, 6, 7, 36, 37, 38, 207, 
210, 212, 224, 227 and 230 features. The sets of 1, 5, 6, and 7 features are listed in 
Table 8-8. Classifiers constructed using the sets with 1, 5 and 6 peptides produced the 
same average classification accuracy, 96.85% , on the unseen test data, and the classifier 
constructed using the set of 7 peptides gives 96.06%. The approach also found the same 
set of 7 features reported in Chapter 5 using the NSC-GA approach, which is associated 
with known ovarian peptide biomarkers in the literature. 
 
Table 8-8 Subsets of genes selected using the proposed approach, NSC-NSGA2 for 
Ovarian cancer data 
Gene accession number 
Gene sets 
7 6 5 1 
MZ245.24466 √ √ √ √ 
MZ244.66041 √ √ √  
MZ244.95245 √ √ √  
MZ245.53704 √ √ √  
MZ245.8296 √ √ √  
MZ244.36855 √ √   
MZ246.12233 √    
 
Table 8-9 Classification results for the Ovarian cancer data using the sets of selected 
features from NSC-NSGA2 approach 
Number of  Genes 
Average classification accuracy (%) 
(Unseen Test data) 
Overall 
average 
classification 
accuracy (%) 
(Unseen Test 
data) 
C1(Disease) C2 (Normal) 
207, 210, 212, 224, 227 88.89 91.3 89.76 
230 90.06 91.3 90.55 
7, 36, 37, 38 97.53 93.48 96.06 
1 , 5, 6 97.65 95.65 96.85 
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The column headings C1 and C2 in the table stand for average classification accuracy 
(%) on the Ovarian unseen test dataset for the Disease class and Normal class, 
respectively. The column heading “Overall average classification accuracy” stands for 
the overall average classification (%) for both classes on the Ovarian unseen test dataset 
for the 15 independent run. “Overall average classification accuracy” is calculated using 
Equation (5.3). From Table 8-9, the NSC classification results associated with the sets 
of features mostly showed similar levels of specificity and sensitivity, e.g., sensitivity 
(C1) is 97.65% and specificity (C2) is 95.65%, implying truly not-at-risk and at-risk 
cases will be correctly identified at a very high level of accuracy. 
 
8.3.5. Lymphoma cancer data 
 
Using the same experimental procedure as before, the proposed algorithm was evaluated 
using the Lymphoma cancer dataset.  A typical convergence plot of Pareto optimal front 
with 4 solutions is shown in Figure 8-15.  
 
 
Figure 8-15 A typical Pareto front plot of f1 against f2 for Lymphoma cancer dataset 
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Using these shrinkage thresholds led to selected sets of features consisting 1, 2, 7, 8, 12, 
128, 133, 134 137, 139, 140, 141, 146, 149 and 164 features. The sets of 1, 2, 7, 8 and 
12 features are listed in Table 8-10. Classifiers constructed using the set with 1 feature 
produced 68.18% average classification accuracy for the unseen test data, classifiers 
obtained using the set with 2 features produced 77.72%, classifiers constructed using 
the set with 7, 8 and 12 features produced the same average classification accuracy of 
95.45%, and classifiers obtained using the set with 128, 133, 134, 137, 139, 140, 141, 
146, 149 and 164 features produced 100% respectively. The approach also found the 
same set of 7, 12 and 128 features reported in Chapter 5 using the NSC-GA approach.  
 
Table 8-10 Subsets of genes selected using NSC-NSGA2 for Lymphoma cancer data 
Gene accession number 
 
Gene sets 
12 8 7 2 1 
GENE3361X √ √ √ √ √ 
GENE3329X √ √ √ √  
GENE3327X √ √ √   
GENE3330X √ √ √   
GENE3332X √ √ √   
GENE3258X √ √ √   
GENE3256X √ √ √   
GENE3328X √ √    
GENE3314X √     
GENE3260X √     
GENE1252X √     
GENE3967X √     
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Table 8-11 Classification results for the Lymphoma cancer data using the sets of 
selected features from NSC-NSGA2 approach 
Number of genes 
Average classification Accuracy (%) 
(Unseen Test data) 
1 68.18 
2 72.73 
7, 8, 12 95.45 
128, 133, 134, 137, 139, 140, 
141, 146, 149, 164, 173 
100 
 
 
8.3.6. Lung cancer data 
 
Using the same experimental procedure as before, the proposed was evaluated using the 
Lung cancer dataset. A typical convergence plot of Pareto optimal front with 3 solutions 
is shown in Figure 8-16.  
 
 
Figure 8-16 A typical Pareto front plot of f1 against f2 for Lung cancer dataset 
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The results obtained from the 15 independent runs consist of 14 runs, each with a Pareto 
front of 3 shrinkage thresholds and 1 run with a Pareto front of 4 shrinkage thresholds.  
Using these shrinkage thresholds led to selected sets of features consisting 1, 2, 3, 5, 8, 
9 and 11 features. The sets of 1, 2, 3, 5, 8, 9 and 11 features are listed in Table 8-12. 
Classifiers constructed using the set with 1 feature produced 93.63% average 
classification accuracy for the unseen test data, classifiers obtained using the set with 2 
features produced 94.62%, classifiers obtained using the set with 3 features produced 
95.93%, and classifiers constructed using each of the sets with 5, 8, 9 and 11 features 
respectively, produced 100% respectively. The approach also found the same set of 8, 9 
and 11 features reported in Chapter 5 using the NSC-GA approach.  
 
Table 8-12 Subsets of genes selected using the proposed approach, NSC-NSGA2 for 
Lung cancer data 
Gene accession number 
Gene  sets 
11 9 8 5 3 2 1 
40936_at √ √ √ √ √ √ √ 
33328_at √ √ √ √ √ √  
32551_at √ √ √ √ √   
34320_at √ √ √ √    
37157_at √ √ √ √    
36533_at √ √ √     
37716_at √ √ √     
37954_at √ √ √     
33833_at √ √      
35823_at √       
33327_at √       
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Table 8-13 Classification results for the Lung cancer data using the sets of selected 
features from NSC-NSGA2 approach 
Number of genes  
Average classification Accuracy (%) 
(Unseen Test data) 
1 93.63 
2 94.62 
3 95.93 
5, 8, 9, 11 100 
 
 
8.3.7. Prostate cancer data 
 
As mentioned previously in Section 3.1.6, the Prostate dataset consists of 12600 
attributes, 77 Tumour (T) and 59 Normal (N) samples. The training set consisting of 52 
T and 50N samples, and the unseen test set consisting of 25 T and 9 N samples.   
 
Using the same experimental procedure as before, the proposed algorithm was evaluated 
using the Prostate cancer dataset.  A typical convergence plot of Pareto optimal front 
with 4 solutions is shown in Figure 8-17.   
 
 
Figure 8-17 A typical Pareto front plot of f1 against f2 for Prostate cancer dataset 
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The results obtained from the 15 independent runs consist of 3 runs with a Pareto front 
of 4 shrinkage thresholds, 4 runs with a Pareto front of 3 shrinkage thresholds and 8 
runs with a Pareto front of 2 shrinkage thresholds. Using these shrinkage thresholds led 
to selected sets of features consisting 1, 2, 3, 4, 5, 6 and 8 features. The sets of 1, 2, 3, 4, 
5, 6 and 8 features are listed in Table 8-14. Classifiers constructed using the set with 1 
feature produced 78.43% average classification accuracy for the unseen test data, 
classifiers obtained using the set with 2 features produced 82.48%, classifiers 
constructed using the set with 3 and 4 features produced 88.24% respectively, classifiers 
obtained using the set with 5 features produced 89.8%, classifiers obtained using the set 
with 6 features produced 90.2% and classifiers obtained using the set with 8 features 
produced 92.16%. The approach also found the same set of 6 features reported in 
Chapter 5 using the NSC-GA approach.  
 
Table 8-14 Subsets of features selected using the proposed approach, NSC-NSGA2 for 
Prostate cancer data 
Gene accession number 
Gene sets 
8 6 5 4 3 2 1 
38406_f_at √ √ √ √ √ √ √ 
37639_at √ √ √ √ √ √  
41468_at √ √ √ √ √   
769_s_at √ √ √ √    
556_s_at √ √ √     
31444_s_at √ √      
39532_at √       
31527_at √       
 
  
251 
 
Table 8-15 Classification results for the Prostate cancer data using the sets of selected 
features from NSC-NSGA2 approach 
Number of genes  
Average classification Accuracy (%) 
(Unseen Test data) 
1 78.43 
2 82.48 
3 88.24 
4 88.24 
5 89.8 
6 90.2 
8 92.16 
 
The following section compares the NSC-NSGA2 approach with NSC-GA from the 
perspectives of potential sets of features obtained via both approaches. Table 8-16 lists 
the sets of features (in terms of the number of features) and the average classification 
accuracy of their corresponding classifiers for the corresponding unseen test datasets. 
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Table 8-16 Summary of results for NSC-GA and NSC-NSGA2  
Dataset 
NSC-GA (f = f1+f2) NSC-NSGA2 (f1  and  f2) 
Number 
of 
features 
Average 
Classification 
Accuracy (%) 
(Unseen Test 
data) 
Number of 
features 
Average  
Classification 
Accuracy (%) 
(Unseen Test 
data) 
 
AD 
 
11 89.45 
1  56.98 
4  72.82 
5  76 
6, 7   81.52 
9 82.6 
8  82.78 
10  83.4 
11  87.7 
17 91.3 
16  91.63 
15 92.39 
18 93.84 
19  94.56 
Colon 
 
 
6 
 
 
 
 
93.75 
 
 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 
21, 23 
93.75 
38 , 48 81.25 
39, 40, 42, 43, 44, 45, 47 87.5 
61 , 87, 62, 86  62.5 
77, 83, 85, 92, 89 68.75 
Leukemia 9 97.06 
2, 13 91.18 
7,  9, 10, 11 94.12 
Ovarian 7  96.06 
1 , 5, 6 96.85 
7, 36, 37, 38 96.06 
207, 210, 212, 224, 227 89.76 
230 90.55 
Lymphoma 
 
7 95.45 
1 68.18 
2 72.73 
7, 8, 12 95.45 
128, 133, 134, 137, 139, 
140, 141, 146, 149, 164, 173 
100 
Lung 
 
8 
 
100 
1 93.63 
2 94.62 
3 95.93 
5, 8, 9, 11 100 
Prostate 6 90.2 
1 78.43 
2 82.48 
3, 4 88.24 
5 89.8 
6 90.2 
8 92.16 
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Table 8-16 shows results obtained in Chapter 5 for NSC-GA where the objective 
function was an aggregation of the same two objective functions for NSC-NSGA2, that 
is,   f = 0.5 f1 + 0.5 f2. In this formulation, both objective functions were given equal 
weightings and using a GA, single optimal sets of relevant features were obtained at the 
end of each run for AD, Colon, Leukemia, Ovarian, Lymphoma, Lung and Prostate 
cancer datasets. With the proposed approach in this chapter, NSC-NSGA2, two 
objective functions (f1 and f2) are assessed simultaneously and multiple optimal sets of 
relevant features are obtained for each dataset at the end of each run.  
 
Having information as shown in Table 8-16 with regards to the joint classification 
behaviour of various sets of features allows the domain expert to make informed 
decision in terms of sets of features that would be selected for further investigations. For 
example in the case of the AD dataset, one can make decisions based on the tradeoffs 
between classification accuracy and size of feature set. The set of 6 features resulted in 
the same classification accuracy as the set of 7 features (i.e. 81.52%). The domain 
expert can examine the 7th feature and use domain knowledge to decide on it potential 
relevance and make decision on subsequent analysis. Equally it is interesting to further 
analyse the Colon cancer dataset where sets with 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 21 and 23 
features respectively resulted in classifiers producing the same classification accuracy 
on the unseen test dataset (93.75%). It appears that a major contributing factor relates to 
1 feature and thus may warrant further investigations into the relevance of the remaining 
features. A similar situation can also be seen with the Leukemia cancer dataset where 
sets with 7, 9, 10 and 11 features respectively resulted in classifiers returning the same 
classification (94.12%) on the unseen test dataset (a major contributing factor relates to 
7 features); with Ovarian cancer dataset where sets with 1, 5 and 6 features, 
respectively, resulted in classifiers returning the same classification (96.85%) on the 
unseen test dataset (a major contributing factor relates to 1 features), and sets with 7, 36, 
37 and 38 features, resulted in classifiers returning the same classification (96.06%) on 
the unseen test dataset (a major contributing factor relates to 7 features); with 
Lymphoma cancer dataset where sets with 7, 8 and 12 features, respectively, resulted in 
classifiers returning the same classification (95.45%) on the unseen test dataset (a major 
contributing factor relates to 7 features); with Lung cancer dataset where sets with 5, 8, 
9 and 11 features, respectively, resulted in classifiers returning the same classification 
(100%) on the unseen test dataset (a major contributing factor relates to 5 features), and  
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with Prostate cancer dataset where sets with 3 and 4 features, respectively, resulted in 
classifiers returning the same classification (88.24%) on the unseen test dataset (a major 
contributing factor relates to 3 features). This sort of information for analysis in 
bioinformatics is important as reducing the number of features to a smaller promising 
set for further investigations would reduce costs associated with future experiments and 
analysis. 
 
8.4. NSC-NSGA2 with 3 objective functions 
 
To further examine the proposed approach, the following section detailed work that 
investigated the impact of employing more than 2 objective functions for FS. In 
addition to    and   , a 3
rd
 objective function (f3) is also employed in NSC-NSGA2, and 
this is denoted as NSC-NSGA2*.    is calculated using Equation (8.6). 
 
    (∑
∑    
  
 
 
 
 )         (8.6) 
 
where    
  is the positive shrunken relative difference of selected features 
           n is the total number of features selected  
             is the number of classes 
              is an average of    
  for selected features 
 
f3 is designed for maximizing the fitness of chromosomes that has a maximum shrunken 
relative difference,    
 , for the features selected. As mentioned previously, in NSC, the 
class centroid of attributes is shrunk toward the overall class centroid and attributes with 
at least one positive relative shrunken class centroid are considered as important and are 
selected (i.e. class centroids and overall class centroid are different). The attributes can 
be ranked based on the value of    
 . That is, the larger the value of    
  the better the 
rank of attributes. Therefore, f3 is employed in the proposed approach to maximize the 
set that consists of attributes with better ranks, (i.e. the best overall average value of    
  
for the set), with the aim to improve the fitness evaluation for chromosomes that leads 
to the selection of smaller feature sets with the same or higher classification accuracy.  
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Table 8-17 Result from applying 2 and 3 objective functions for the proposed approach, 
NSC-NSGA2, on AD and Leukemia dataset 
Dataset 
NSC-NSGA2 
(f1,   f2) 
NSC-NSGA2* 
(f1,  f2, f3) 
Number of 
features 
Average 
Classification 
Accuracy (%) 
(Unseen Test 
data) 
Number of features 
Average  
classification 
Accuracy (%) 
(Unseen Test 
data) 
AD 
1 56.98 1 56.07 
4 72.82 4 72.83 
5 76 5 75.47 
6, 7 81.52 6 79.98 
9 82.6 7 81.52 
8 82.78 8 83.02 
10 83.4 9 82.60 
11 87.7 10 83.52 
17 91.3 11 89.72 
16 91.63 12 90.21 
15 92.39 13, 14 92.39 
18 93.84 16 91.67 
19  94.56 17 91.3 
 
18, 19 94.56 
33 92.39 
38 90.21 
67 85.86 
Leukemia 
2, 13 91.18 2, 3, 11, 13, 15 91.18 
7,  9, 10, 11 94.12 7 92.02 
 
8, 10 94.12 
62 85.29 
176, 336, 884, 889 88.23 
 
From the limited analysis using the AD dataset with 120 features and the Leukemia 
dataset with 7129 features, it can be seen from Table 8-17 that the NSC-NSGA2* 
approach resulted in a bigger number of different sets of selected features when 
compared to the approach with 2 objective functions (NSC-NSGA2). Among these 
additional  sets of selected features, some sets are smaller but have the same average 
NSC classification accuracy, e.g., for AD dataset, the sets with 13 and 14 features using 
the 3 objective approach that gave the same classification accuracy (92.39%) as that of 
the set with 15 features using the 2 objective approach, for Leukemia dataset, the set 
with 8 features using the NSC-NSGA2* approach that gave the same classification 
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accuracy (94.12%) as that of the sets with 9, 10 and 11 features using the NSC-NSGA2 
approach. 
 
8.5. The proposed approach, NSC-NSGA2 with Mahalanobis distance measure 
 
According to Bandyopadhyay and Saha (2013, p. 60), “similarity measurement is 
essential for performing classification”, thus in order to investigate the impact of 
employing a different similarity distance measure in the NSC classifier on the Pareto 
front obtained from NSC-NSGA2, the study carried out a further experiment to replace 
Euclidean distance in the NSC classifier with Mahalanobis distance.  This  is one of the 
most common distance measures that has been used for feature-based similarity search, 
specifically in datasets where correlation exists between features (Emrich et al., 2013).  
 
Using the same experimental procedure outlined in Section 8.3, NSCM-NSGA2 (NSC 
with Mahalanobis distance) was evaluated using the Leukemia cancer dataset and the 
NSGA2 parameter settings listed in Table 8-1 as a proof of concept. A typical Pareto 
optimal front from one of the 15 runs is shown in Figure 8-18. 
 
 
Figure 8-18 A typical Pareto front plot of f1 against f2 for Leukemia cancer dataset using 
the NSCM-NSGA2 approach 
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The results obtained from running 15 independent runs of NSCM-NSGA2 led to the 
selection of sets with 2, 5, 6, 7, 8, 9, 10, 11 features.  
 
Table 8-18 Sets of genes obtained by NSCM-NSGA2 for the Leukemia cancer data 
Gene accession number 
Gene sets 
11 10 9 8 7 6 5 2 
M84526_at √ √ √ √ √ √ √ √ 
U50136_rna1_at √ √ √ √ √ √ √ √ 
D49950_at √ √ √ √ √ √ √  
M16038_at √ √ √ √ √ √ √  
M23197_at √ √ √ √ √ √ √  
X17042_at √ √ √ √ √ √   
X95735_at √ √ √ √ √    
M55150_at √ √ √ √     
M57710_at √ √ √      
Y00787_s_at √ √       
M27891_at √        
 
As seen in Table 8-18, sets of 2, 5, 6, 7, 8, 9, 10 and 11 genes obtained are the same as 
those using NSC-NSGA2. The sets of 5, 6 and 8 genes are additional sets obtained 
using NSCM-NSGA2. 
 
Table 8-19 Results from NSC-NSGA2 and NSCM-NSGA2 for Leukemia cancer dataset 
Dataset 
Euclidean 
NSC-NSGA2 (f1  and  f2) 
Mahalanobis 
NSCM-NSGA2 (f1  and  f2) 
Number of  
genes 
Average 
Classification 
Accuracy (%) 
(Unseen Test data) 
Number of 
genes  
Average 
Classification 
Accuracy (%) 
(Unseen Test data) 
Leukemia 
2, 13 91.18 
2 , 5 88.24 
6, 9 94.12 
7, 9, 10, 11 94.12 
7, 8 97.06 
10, 11 100 
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The classification results using classifiers constructed using these sets of features on the 
unseen test data are shown in Table 8-19. It is interesting to note that NSCM-NSGA2 did 
not produce the set of 13 features associated with NSC-NSGA2 and that there are some 
differences in the classification accuracy associated with the different classifiers from 
the two approaches. For example, the classifiers constructed from the set of 7 and 8 
features obtained the same average classification accuracy of 97.06%  in comparison to 
the classifier constructed using the set of 9 features from NSC-NSGA2 that obtained  
94.12%  average classification accuracy. Similar to other analysis in this study, the 
optimal shrinkage threshold values obtained from NSCM-NSGA2 can be slightly 
different from those obtained using NSC-NSGA2 but are still in the range that map to 
the same set of features but may slightly impact on the classification accuracy.  From 
this limited analysis here, it can be seen that the use of another similarity measure in the 
approach can produce some different sets of features. This implies that to 
comprehensively analyse biological datasets, researchers should examine them using 
techniques that support different similarity measures and a number of selection criteria. 
Having information in Table 8-19 can help biomedical researchers to make informed 
decisions about sets of features that would be selected for further investigations. For 
example it will be interesting to examine the set of 6 features obtained via NSCM-
NSGA2 and the set of 7 features obtained via NSCM-NSGA2 in terms of the 7
th
 feature 
(set of 6 being the subset of 7 features) in terms of its known biological relevance to the 
specific disease.  
 
8.6. Summary 
 
This chapter has described the proposed approach of incorporating NSC and MOEA 
(NSGA2) to automatically search for multiple optimal shrinkage threshold values for 
NSC. The approach used NSC as an evaluator to evaluate the fitness of the candidate 
shrinkage threshold values, utilized the MOEA (NSGA2) as a multi-objective search 
algorithm to search for Pareto front of multiple shrinkage threshold values that lead to 
the selection of corresponding sets of relevant features. The proposed approach was 
evaluated using 7 public biomedical datasets: AD, Colon, Leukemia, Ovarian, 
Lymphoma, Lung and Prostate cancer data. The proposed approach shows the 
effectiveness of using a multi objective approach, NSC-NSGA2, over a single 
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aggregated objective function used in NSC-GA involving a single objective approach as 
described in Chapter 5.  
 
This chapter has also described work that incorporated 3 objective functions in NSC-
NSGA2 for studying the impact of using more than two objective functions for FS. This 
approach was evaluated using the AD and Leukemia dataset. The results from the study 
showed that the approach NSC-NSGA2* obtained a bigger number of different sets of 
selected features when compared to the approach using 2 objective functions (NSC-
NSGA2).  In some cases, NSC-NSGA2* obtained some sets having a smaller number of 
features that produced classifiers that obtained the same average NSC classification 
accuracy as those associated with a classifier constructed from a superset of features. 
 
To examine the impact of using a different similarity measure, this study implemented 
NSCM-NSGA2 where Mahalanobis distance is used in NSC instead of Euclidian 
distance. The approach was evaluated using the Leukemia cancer dataset. The results 
showed that some additional sets of features were produced and their corresponding 
classifiers produced similar classification results. This implies that to comprehensively 
analyse biological datasets, researchers need to examine them using techniques that 
support different similarity measures and a number of selection criteria.  
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9. Conclusion and Future work 
 
This thesis presented the investigation of evolutionary-based FS techniques for 
analysing biological datasets acquired via mass throughput technologies. These 
biological datasets are typically high dimensional with only a small number of samples; 
making the task of their analysis especially challenging.  Section 9.1 summarises the 
key findings from this study and Section 9.2 outlines suggestions for future work. 
 
9.1. Conclusion 
 
As the area of bioinformatics become increasingly “data rich”, the need for appropriate 
techniques that can be used for a comprehensive analysis of these huge volumes of data 
is imperative. This thesis contributed towards a better understanding of the development 
of evolutionary-based FS techniques for analysing biological data from mass throughput 
technologies. The thesis also demonstrated the impact of employing different similarity 
measure in NSC and showed the need to consider classifier-biased when examining the 
sensitivity and specificity associated with a specific classifier constructed from a set of 
features. 
 
This study has addressed the following aims: 
 Aim 1: To investigate and develop FS algorithms that  incorporates various 
evolutionary strategies, specifically investigating the use of  evolutionary 
strategies in conjunction with Rough Set Theory and Nearest Shrunken 
Centroid; 
 Aim 2: To evaluate  the developed algorithms in terms of finding the “most 
relevant” biomarkers contained in biological datasets and  
 Aim 3: To evaluate the goodness of extracted feature subsets for relevance 
(examined in terms of existing biomedical domain knowledge and classification 
accuracy form the perspectives of sensitivity and specificity associated with 
different classifiers). The project aims to generate sets of features for 
construction of good predictive models for classifying diseased samples from 
control. 
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In addressing Aim 1, this study has developed evolutionary-based FS techniques that 
incorporated GA, MA and MOEA. The first approach involved the development of 
RST-GA, a hybrid approach involving the GA, RST and k-means. This approach is 
described in Chapter 4 and consisted of 3 phases: feature reduction, distinction table 
generation and FS via GA optimization. In the first phase, features of high dimensional 
data were reduced effectively. In this phase, quartile statistics was employed to generate 
initial starting centroids for k-means clustering. The final centroids obtained from k-
means were used for the feature reduction process. In the second phase, the criteria (i.e. 
generation rules) used in Banerjee, Mitra, & Banka’s study (2007) was also applied to 
generate a distinction table with a smaller dimension. Finally, in the third phase, GA 
was employed to search for optimal feature sets based on the distinction table generated 
in the previous phase. The study showed that the smaller feature sets obtained using 
RST-GA produced classifiers that  gave similar classification accuracy for the Colon 
cancer dataset  and the Leukemia data in comparison to the results reported in Banerjee, 
et al. (2007).  
 
A second approach described in Chapter 5, NSC-GA, incorporates NSC and GA to 
automatically search for an optimal range of shrinkage threshold values for the NSC. 
The NSC is a deterministic FS algorithm which selects the same set of features for 
shrinkage threshold values in the same range.  The optimal shrinkage thresholds are 
used in NSC to obtain the corresponding sets of selected features.  The study showed 
that the feature sets obtained using NSC-GA are smaller. Corresponding classifiers 
constructed from these feature sets produced similar or higher classification accuracy 
for seven datasets in comparison with other NSC-based approaches reported in previous 
studies. While the sets of relevant features obtained using the NSC-GA from every 
independent run is more consistent, multiple sets consisting of features where the 
smaller sets are subsets of the bigger sets were also obtained from the runs of the NSC-
GA. This is important in terms of allowing biomedical researchers to investigate the sets 
of features for biological relevance in subsequent clinical studies. 
 
To continue the exploration of evolutionary approaches for FS in biological data, 
Chapter 6 described an approach MA for automatically finding optimal shrinkage 
thresholds for NSC in an attempt to further improve upon NCS-GA. The aim was to 
explore improvements that can be made on the NSC-GA approach. The impact of 
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incorporating MA with NSC for finding shrinkage threshold values automatically are 
reduced computational time and obtaining the same feature set over different runs of 
NSC-MA. Chapter 8 described NSC-NSGA2, a hybrid approach incorporating NSGA2 
and NSC to automatically find the Pareto front associated with optimal shrinkage 
threshold values for the NSC.  Unlike GA which involved a single objective function, 
the aim here was to examine the impact of incorporating a MOEA with NSC with the 
use of multiple objective functions for obtaining multiple shrinkage threshold solutions. 
Unlike existing techniques, the developed approaches here support FS by 
simultaneously considering tradeoffs between a number of criteria (e.g. high 
classification accuracy and a small number of features).  Multiple sets of potential 
features (biomarkers) obtained via the developed approach can be further investigated to 
explore both diagnostic and biological relevance.   
 
Lastly, this study examined the impact of using different similarity measures in NSC-
GA and NSC-NSGA2. Euclidean distance is the distance measure originally used in 
NSC to assign data points to different classes.  Chapter 7 described the approach of 
implementing different similarity distance measures (i.e. Mahalanobis, Pearson and 
Mass distance) in the NSC classifier and incorporating NSC and GA to automatically 
search for optimal shrinkage threshold values for NSC. The use of distance measures 
such as Mahalanobis overcomes some of the limitations associated Euclidean distance 
(e.g. assumption that the features are uncorrelated). From the perspective of using a 
different distance measure in a multi-objective approach, NSCM-NSGA2 was 
implemented using Mahalanobis distance in NSC instead of Euclidian distance. As a 
proof of concept, it was evaluated using the Leukemia cancer dataset. Additional sets of 
selected features were obtained and their corresponding classifiers produced similar 
classification results. This implies that to comprehensively analyse biological datasets, 
researchers need to examine them using techniques that support different similarity 
measures and a number of selection criteria.  
 
In addressing Aim 2 and Aim 3, seven datasets and the evaluation strategy described in 
Chapter 3 were used to evaluate the developed approaches in this study. The 
dimensionality of these datasets ranged from 120 to 15,154 attributes. In terms the 
relevance and the “goodness” of the selected sets of features, these were evaluated by 
constructing different classifiers using the suite of classifiers from WEKA and 
263 
 
examining the corresponding classification accuracy   on unseen test datasets (in terms 
of diagnostic relevance). From these analyses, the study demonstrated that the use of 
specific classifiers may have an impact on the sensitivity and specificity obtained using 
a set of features in classification and recommended that in DM for finding suitable sets 
of biological markers, a number of classifiers should be employed to examine the 
diagnostic relevance. This will avoid incidences of dismissing sets of features with high 
discriminatory capabilities that should be further investigated in early diagnostic test 
developments. From the perspective of biological relevance, this study is limited to 
examining the relevance of the extracted feature sets against known biomarkers from 
literature associated with the relevant domains.  For example, Table 4-3 listed genes 
found by the RST-GA approach which are already known in the biomedical literature to 
be associated with the Colon Cancer. The common features selected across different 
approaches for the seven datasets are listed in Table 9-1. 
 
Table 9-1 Common features selected across difference approaches 
Datasets 
Approaches 
NSC-GA NSCM-GA NSCP-GA NSCMD-GA NSC-MA NSC-
NSGA2 
Common features 
AD PDGF-BB_1, RANTES_1, IL-1a_1, TNF-a_1 
Colon T71025, M63391, R87126, M76378, T92451, J02854, 
Leukemia M27891, M84526, M96326 
Lymphoma GENE3327X, GENE3329X, GENE3361X 
Lung 33328_at, 40936_at 
Ovarian MZ244.36855, MZ244.66041, MZ244.95245, Z245.24466, MZ245.8296, 
MZ245.53704, MZ246.12233 
Prostate 41468_at, 37639_at, 38406_f_at, 769_s_at, 556_s_at 
 
Since the primary theme being the investigation of evolutionary approaches for analysis 
of biological datasets, the NSC-GA approach was developed to first explore the use of 
GA to find the shrinkage threshold value for NSC. The next logical step from NSC-GA 
was to investigate how this technique can be further improved, leading to the 
development of NSC-MA, the use of memetic algorithm. Another venue of 
improvements for the NSC relates to impact of similarity measures used and the 
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investigation here led to the development of NSCM-GA, NSCp-GA and NSCMD-GA. 
Finally, NSC-NSGA2 was developed to explore the use of multiple objectives for 
feature selection, improving upon the previous approaches in this study that involved a 
single objective. 
 
The following table also summarises the advantages and limitations of the proposed 
approaches. 
 
Table 9-2 Advantages and limitation of the developed approaches 
Proposed 
approaches 
Advantages  Limitations  
RST-GA 
 Number of attributes is reduced 
before applying the GA. 
 Less computational time 
Feature instability  
NSC-GA 
 Feature stability  
 Explore interaction of features 
More computational time 
compared to the RST-GA 
approach. 
 
NSC-MA 
NSCM-GA 
NSCP-GA 
NSCMD-GA 
NSC-NSGA2 
 Multiple sets of features 
obtained in one run 
 Feature stability 
 Explore interaction of features 
 
 
 
9.2. Future work 
 
Future directions from this research could examine:   
 Investigations and development of FS techniques that combines RST and 
different evolutionary algorithms such as MA and other MOEA approaches for 
analysing biological datasets. Existing work involving evolutionary-based RST 
for analysis of biological data is limited, probably owing to its computational 
intensiveness.   
  Incorporation of RST into the developed approaches of NSC-GA, NSCM-GA, 
NSCP-GA and NSCMD-GA to reduce computational time of these approaches.   
Here, RST can be used as a feature reduction algorithm to reduce the number of 
features for high dimensional data as an initial step before the NSC-GA 
approach is used to optimize the search of optimal sets of features.   
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 Due to time constrains, the investigations involving MOEA has only examined 
NSGA2 and a maximum of 3 objectives. Subsequent investigations could 
examine the use of other MOEAs and the impact of employing more than 3 
objective functions. 
 NSC-based approaches are very much targeted for analysis of bioinformatics 
data, extended to being applied to other high dimensional biological data 
generated using other techniques. Potentially, the RST-GA approach can be 
applied to any domain for feature selection. 
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